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They begin to tear at the chest, working at the ribs with a handsaw, then using the 
knife to worry through the great vessels. The doctors are visibly excited, bright as 
eggs. There shall be a paper in this, societies addressed, circles of illuminati: 
'some thoughts, hm, upon the Case of the Late Jm Dyer. An Enquiry into...the 
Curious and Remarkable...who until his twenty-something year was insensible 
to...knew not...entirely without sensation...feeling...knowledge of...pain. With 
proofs, illustrations, exhibits and so forth. '
(Andrew Miller, 'Ingenious Pain')
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Summary
Within the central nervous system, both the monoaminergic and 
cholinergic systems are recognised as having a significant role in the 
regulation of nociceptive processing at the level of the spinal dorsal 
horn producing a depression of the nociceptive signal. Despite this, 
relatively little is known of the mechanisms and neuronal circuits which 
are responsible for the action of these systems. In producing their 
action the descending monoaminergic pathways from the brainstem, 
which utilise serotonin and noradrenaline may potentially operate via 
pre- and/or post-synaptic pathways at either direct or indirect sites. For 
both the monoaminergic and cholinergic systems multiple receptor 
subtypes exist and the role of each individual subtype is ill understood. 
In this series of experiments, the relationship of the monoamines to 
identified neurons of the dorsal horn is first examined. Then, in a 
separate series of studies the distribution of the muscarinic m2 
receptor is examined in the spinal cord with particular reference to the 
distribution of this receptor in the dorsal horn and the cells which are 
targeted.
Adult Albino Swiss rats were used throughout. These were 
anaesthetised with pentobarbatone (1ml of 60mg/ml, i.p.) and perfused 
prior to removal of mid-lumbar or thoracic spinal cord blocks. These 
blocks were then sectioned in either the transverse or parasagittal 
plane then reacted with the primary antibody cocktail required for each 
protocol. Following this the sections were transferred to solutions of 
fluorophore-coupled secondary antibodies or, for ultrastructural 
studies, antibodies coupled to biotin or immunogold. The sections 
were then processed for analysis using three-colour confocal laser 
scanning microscopy or electron microscopy.
In sections reacted with serotonin a dense plexus of axons and 
terminals was identified in the dorsal horn corresponding to the region 
of lamina l / l lo  from which axons emerged which appeared to encircle 
the somata and proximal dendrites of neurons within lamina lll/IV 
forming 'basket-like' associations. Numerous noradrenergic profiles 
(revealed with dopamine-p-hydroxylase immunoreactivity) were also 
noted corresponding to lamina I/ll however these did not appear to 
cluster around the proximal regions of dorsal horn neurons. Examining 
the relationship of these monoaminergic axons and terminals to 
specific dorsal horn neuronal subtypes demonstrated few contacts with 
no evidence of clustering on either excitatory or inhibitory dorsal horn 
interneurons revealed with antibodies to GABA, glycine, somatostatin, 
neurotensin, choline acetyltransferase, nitric oxide synthase (NOS) or 
the p-opioid receptor. In contrast, cells immunoreactive for the 
substance P receptor neurokinin-1 (NK-1), located in lamina lll/IV and 
lamina I, received relatively high contact frequencies form serotonin 
when compared to the dorsal horn interneurons. These contacts were 
clustered around the proximal dendrites and somata. In addition in 
approximately 50% of the NK-1-immunoreactive neurons in lamina 
lll/IV the 'basket-like' arrangement of serotonin axons was observed. 
This correlated with a higher frequency of contacts on these cells. 
Ultrastructural observations on the relationship of serotonin terminals 
to GABA-immunoreactive somata showed several close associations 
however synaptic specialisations were not identified.
In material reacted with the muscarinic m2 acetylcholine receptor 
immunolabelled profiles were identified in the dorsal horn, ventral horn, 
intermediate grey and around the central canal in lamina X. In the
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dorsal horn approximately 23% of neurons were immunoreactive for 
the m2 receptor Examination of the relationship of this receptor to 
specific dorsal horn neuronal subtypes revealed that some cells 
immunoreactive for either GABA, NOS, NK-1, parvalbumin or the 
somatostatin2A receptor were m2 positive with the ratio in part 
dependant on laminar location. No neurotensin-immunoreactive 
neurons were m2 receptor-immunoreactive. Throughout the dorsal 
horn and lamina X 41% of cholinergic neurons were m2 receptor- 
immunoreactive. In the ventral horn larger rather than smaller 
motoneurons were found to be receptor positive and these neurons 
were also noted to receive greater numbers of cholinergic terminals.
These investigations have demonstrated that the cells of the dorsal 
horn which are NK-1-immunoreactive are unique amongst the neurons 
studied in receiving significantly greater frequencies of serotonin 
contacts than the dorsal horn interneurons examined. Furthermore, 
within lamina lll/IV a subpopulation of NK-1-immunoreactive neurons 
has been identified which are associated with a clustering of 
serotonergic axons around the proximal dendrites and somata, a 
relationship which corresponds to a greater number of serotonin 
contacts on these cells. The neurons of the dorsal horn which are 
nerokinin-1-immunoreactive are recognised as being almost 
exclusively tract neurons that project to higher centres associated with 
nociceptive processing. This identification of a specific relationship 
between serotonergic profiles and NK-1 neurons of the dorsal horn 
and the relatively few contacts made by serotonergic and 
noradrenergic terminals on dorsal horn interneurons suggests a 
targeted action on projection tract neurons with a more diffuse, 
perhaps non-synaptic action on local dorsal horn cells.
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The expression of the muscarinic m2 acetylcholine receptor on 
neurons throughout the spinal grey implies a wide role for this receptor 
in both sensory and motor processing. This somatic expression had 
not previously been described. Further to this diffuse expression these 
studies have demonstrated that there is a selective distribution of the 
receptor amongst particular neuronal subtypes in the dorsal horn and 
a greater expression of the receptor on larger, presumed a- 
motoneurons of the ventral horn. This data provides valuable 
information into the possible roles of this specific cholinergic receptor 
in the spinal cord.
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Chapter 1 : The monoaminergic system in the
spinal cord
13
1.1 Introduction
It is commonly accepted that, under certain conditions, one's 
awareness of an unpleasant or painful stimulus can be suppressed. In 
man this is most frequently experienced during physical exertion 
(Henry, 1982) or under extremes of stress such as on the battlefield 
(Beecher, 1946). This endogenous antinociceptive system would 
appear in part to originate within the brainstem as demonstrated by 
Reynolds (1969) who by stimulating in the region of the midbrain was 
able to perform a laparotomy on unanaesthetised rats. Similarly in man 
central stimulation in the region of the thalamus can produce analgesic 
effects (Tsubokawa et ai, 1982). The mechanism by which this 
anti nociception arises is clearly of some significance in understanding 
the process of nociception which may then guide the development of 
targeted therapies for clinical use. By sectioning the spinal cord, 
thereby interrupting the pathways to and from the brainstem, a 
significant reduction in endogenous antinociceptive response is noted 
suggesting a descending influence on the spinal cord (Berge, 1982). 
Strongly implicated in this descending antinociceptive pathway are the 
monoamines in particular serotonin and noradrenaline which originate 
within nuclei in the brainstem. In regards to these neurotransmitters a 
great many investigations have provided invaluable information on 
their roles in antinociception however little is understood of the neural 
circuitry within the spinal dorsal horn which may produce these effects. 
This study is directed at identifying the neurons of the spinal dorsal 
horn in the rat which receive contacts from descending monoaminergic 
axons
14
1.2 Origins of Serotonergic Neurons
The serotonin observed at the level of the spinal cord Is considered to 
derive exclusively from descending brain stem efferents. This 
conclusion has arisen from the marked decrease in serotonin 
immunoreactivity following transection of the cord (Dahlstrom & Fuxe, 
1965, Magnusson, 1973). In addition there has been a repeated failure 
to conclusively demonstrate serotonergic somata in the spinal cord 
though some initial data has suggested monoamine somata at this 
level. For example, in their study of the monkey spinal cord Lamotte, 
Johns & de Lanerolle (1982) proposed a population of serotonergic 
neurons in lamina X at all spinal cord levels using both serotonin 
immunocytochemistry and the Falck-Hillarp method of formaldehyde 
induced fluorescence (Faick et al, 1962). However, this observation 
has not been reliably reproduced in any Investigations since. It would 
seem likely therefore that the group of cells they describe may either 
be a group of neurons with a similar fluorescence to serotonin using 
the Falck-Hillarp method (Bjorklund, FaIck & Stenevi, 1970) or they 
may be cells accumulating rather than synthesising serotonin ( Kojima 
et al, 1983).
In their series of studies investigating the distribution and projections of 
serotonergic neurons in the brain stem of the cat Taber, Brodai and 
Walberg(1960) identified eight groups of serotonergic neurons within 
the brain stem. Dahlstrom and Fuxe (1965) in their review of the 
monoaminergic systems of the rat brain stem added to this number by 
suggesting that in fact nine groups could be identified (groups B1-9). 
Occasional serotonergic neurons can also be observed in pontine 
nuclei associated with catecholamine neurons such as the locus 
coeruleus and subcoeruleus (Leger et al, 1979; Bowker, Westlund &
15
Coulter, 1981). As with the noradrenergic system this subdivision 
based on anatomical location has been extended to demonstrate a 
selective distribution arising from each nucleus .
B1 Group
Serotonin immunofluorescence reveals a cluster of cells in the caudal 
part of the medulla oblongata in the rat within the nucleus raphe 
pallidus (Taber et al, 1960; Dahlstrom & Fuxe, 1965). As with other 
raphe nuclei this region exhibits a relatively high density of serotonin 
(Palkovits, Brownstein & Saalvedra, 1974). Initial studies of retrograde 
cell death following spinal cord transection indicated that cells within 
the nucleus raphe pallidus had a significant projection to the spinal 
cord in the cat (Brodai, Taber & Walberg, 1960). This has 
subsequently been confirmed by the anterograde transport of a variety 
of tracers which have also revealed that this projection terminates in 
the ventral horn of rat (Bowker, Westlund & Coulter, 1981; Jones & 
Light, 1990), cat (Bobillier et al, 1976; Basbaum & Fields, 1979) and 
primate (Bowker, Westlund & Coulter, 1982). By combining retrograde 
transport techniques with serotonin immunofluorescence the majority 
of these cells are confirmed as serotonergic (Bowker, Steinbusch & 
Coulter, 1981; Bowker, Westlund & Coulter, 1981). In addition to a 
projection to the ventral horn, the B1 group of cells also contributes a 
significant projection to the intermediolateral cell column (Loewy & 
Mckellar, 1981).
B2 Group
The B2 group of cells is located within, and in immediate proximity to, 
the nucleus raphe obscurus (Taber, Brodai & Walberg, 1960; 
Dahlstrom & Fuxe, 1965; Steinbusch, 1981). As with the B1 cell group
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retrograde cell death in the cat (Brodai, Taber & Walberg, 1960) and 
HRP transport studies in rat (Bowker, Steinbusch & Coulter, 1981; 
Bowker, Westlund & Coulter, 1981) and primate (Bowker, Westlund & 
Coulter, 1982) have demonstrated a significant projection form this 
group of cells to the spinal cord. Similarly, the cells of the nucleus 
raphe obscurus appear to target the ventral horn (Bobillier et al, 1976; 
Martin, Jordan & Willis, 1978; Basbaum & Fields, 1979) and 
intermediolateral cell column (Loewy & Mckellar, 1981).
83 Cell Group
Corresponding to the nucleus raphe magnus, the cells of the B3 group 
represent the largest collection of serotonergic neurons in the brain 
stem (Brodai, Taber & Walberg, 1960; Palkovits, Brownstein & 
Saalvedra, 1974; Steinbusch, 1981). Employing the anterograde 
transport of tritiated amino acids Basbaum, Clanton and Fields (1978) 
were able to demonstrate a bilateral projection from the nucleus raphe 
magnus to the cat spinal cord. In particular, to the regions of the 
marginal zone, substantia gelatinosa and laminae V, VI and VII. In the 
corresponding primate investigations a similar projection from the 
nucleus raphe magnus to laminae I, II and V has been identified 
(Basbaum, Ralston & Ralston, 1986). This projection gains further 
support from retrograde transport studies where tracer injected to the 
lumbar enlargement can subsequently be demonstrated in the nucleus 
raphe magnus in the cat (Martin, Jordan & Willis, 1978) and in the rat 
(Bowker, Steinbusch & Coulter, 1981; Bowker, Westlund & Coulter, 
1981). A projection to the intermediolateral cell column has also been 
demonstrated by anterograde HRP transport (Loewy et al, 1981).
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That the nucleus raphe magnus contributes a major serotonergic input 
to the spinal cord is supported by the marked reduction in serotonin- 
immunoreactive profiles in the cord following a lesion in the nucleus 
raphe magnus with the loss of immunoreactivity greatest in the dorsal 
horn (Oliveras et al, 1977). This projection from the nucleus raphe 
magnus to the spinal cord would appear to be proportionately greater 
than from any other serotonergic brain stem nucleus (Brodai, Taber & 
Walberg, 1960). In addition, injection of kainic acid to the region of the 
nucleus raphe magnus causes an increase in the expression of the 
proto-oncogene c-fos in the dorsal horn, with no c-fos expression 
detected in the ventral horn (Bett & Sandkuhler, 1995). 
Correspondingly, stimulation of the nucleus raphe magnus results in a 
detectable release of serotonin at the level of the spinal cord in the rat 
(Rivot, Chiang & Besson, 1982; Hammond, Tyce & Yaksh, 1985).
It is clear that the serotonergic cells of the medullary raphe nuclei 
contribute a significant projection to the spinal cord. Indeed 
quantitative analysis suggests the majority of serotonergic neurons in 
these nuclei project to the spinal cord (Bowker, Westlund & Coulter, 
1981). There is also a degree of selectivity in their projection with the 
cells of the nucleus raphe pallidus (B1) and nucleus raphe obscuris 
(B2) primarily projecting to the ventral horn whilst the cells of the 
nucleus raphe magnus (B3) project to the dorsal horn. All three nuclei 
project to the intermediolateral cell column.
Group B4
This small group of cells lies close to the midline in the region of the 
nucleus vestibularis medialis (Dahlstrom & Fuxe, 1965; Steinbusch,
18
1981). So far, no evidence of a projection from this region to the spinal 
cord has been detected (see Bowker, Westlund & Coulter, 1981).
Group 85
The majority of the serotonin-immunoreactive neurons within the B5 
group lie within the intermediate part of the nucleus raphe pontis 
(Taber, Brodai & Walberg, I960; Dahlstom & Fuxe, 1965; Steinbusch, 
1981). Following a lesion to the spinal cord a few cells within this 
group undergo cell death (Brodai, Taber & Walberg, 1960). Retrograde 
transport of HRP confirms the presence of a minor projection from the 
nucleus raphe pontis to the cord (Martin, Jordan & Willis, 1978; 
Bowker, Westlund & Coulter, 1981).
Groups 86 and 87
The B7 cell group corresponds to the region of the nucleus raphe 
dorsalis in the primate (Kapadia, de Lanerolle, & LaMotte, 1985) and 
the rat (Dahlstrom & Fuxe, 1965; Steinbusch, 1981) with a caudal 
extension of cells in the region of the rostral part of the fourth ventricle 
near the midline (B6 group of Dahlstrom & Fuxe). Lesioning of the 
nucleus raphe dorsalis in the cat, rat and guinea pig is not associated 
with a reduction in the serotonin content of the lumbar enlargement 
(Oliveras et al, 1977) nor is cell death within the nucleus raphe dorsalis 
observed on lesioning of the lumbar spinal cord (Brodai, Taber & 
Walberg,1960). Whilst suggesting that the serotonergic neurons in this 
region do not project to the spinal cord this observation would appear 
to be dependant on the region of cord examined, the species and the 
experimental conditions. Thus, when tracer is injected to the cervical 
cord in the rat a small number of neurons are identified in the nucleus 
raphe dorsalis (Bowker, Westlund & Coulter, 1981). In their series of
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experiments on the retrograde transport of wheat germ agglutinin 
conjugated to HRP Mantyh & Peschanski (1982) identified labelled 
cells in the region of the nucleus raphe dorsalis in the rat following 
injection of tracer to the lumbar cord. However approximately 40% 
fewer cells were labelled when compared to the same injection to the 
cervical cord. This observation of a greater number of cells identified 
following a cervical as opposed to a lumbar cord injection has also 
been documented in cat and monkey with the greatest numbers of 
cells identified in the cat. Again, this projection appears directed at the 
spinal dorsal horn (Wang & Nakai, 1994).
B8 Group
Serotonergic neurons within the B8 group lie within the nucleus 
centralis superior and adjacent areas in the brain stem (Steinbusch, 
1981). To date, a projection from this region to the spinal cord has not 
been Identified (Brodai, Taber & Walberg, 1960; Bowker, Westlund 
and Coulter, 1981).
89 Group
The more diffuse cells of the B9 group are located within the medial 
lemniscus in the brainstem with occasional, scattered neurons lying 
dorsal to the medial lemniscus (Dahlstrom & Fuxe, 1965; Steinbusch, 
1981). As with the B7 group of cells, the projection from this group of 
serotonergic neurons appears to be directed selectively towards the 
cervical cord with no projection to the lumbar cord (Bowker, Westlund 
& Coulter, 1981).
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Thus though the descending pontine and midbrain serotonergic 
projection is less extensive there would appear to be a significant 
projection from groups B5, B7 and B9, those from the latter two 
directed towards the cervical cord. No descending spinal projection 
has been reported for groups B6 and B8. Quantitatively it is estimated 
that less than half of midbrain serotonergic neurons have a spinal 
projection (Bowker, Westlund & Coulter, 1981).
1.3 Distribution of serotonergic terminais in the spinai grey
Serotonergic terminals are located throughout the spinal grey matter 
their density varying within the different laminae. In quantitative 
estimates of the serotonin content in punch specimens sampled from 
various regions of the spinal cord in a variety of species the highest 
concentration of serotonin is present in the ventral horn with a 
correspondingly lower concentration in the dorsal horn. In keeping with 
this observation, serotonin-immunoreactive profiles in the rat 
(Steinbusch, 1981; Hadjiconstantinou, 1984) and primate (Kojima et al, 
1983) are found in the highest density in the ventral horn where they 
are closely associated with motor nuclei. The superficial laminae of the 
dorsal horn are also associated with relatively high serotonin 
concentrations (Oliveras et al, 1977; Hadjiconstantinou, 1984) with the 
highest density of serotonin-immunoreactive profiles occurring in the 
region of lamina I and Ho, few profiles in lamina ll| and copious, diffuse 
serotonin-immunoreactive profiles in laminae IN-VI. This arrangement 
has been confirmed in rat (Steinbusch, 1981; Maxwell, Leranth & 
Verhofstad, 1983; Marlier et al, 1991), cat (Ruda & Gobel, 1980; Ruda, 
Coffield & Steinbusch, 1982; Light, Kavookjian & Petrusz, 1983) and 
primate (Kojima et al, 1983). As has been discussed, no serotonin-
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immunoreactive somata have been confidently identified in the spinal 
grey in any of the investigations performed to date.
1.4 Ultrastructure of serotonergic profiles in the dorsal horn.
Serotonergic axons within the dorsal horn run in a predominantly 
rostrocaudal direction with multiple en-passant varicosities along their 
length (Light, Kavookjian & Petrusz, 1983). Initial autoradiographic 
studies of the fine structure of serotonergic varicosities in the cat 
medullary dorsal horn identified several ultrastructural subtypes based 
on varicosity shape and the size, shape and density of vesicles (Ruda 
& Gobel, 1980). Subsequent immunocytochemical studies in cat (Ruda 
et al 1982; Light et al, 1983) and rat (Marlier et al, 1991) have shown 
there to be two types of serotonin varicosity based on morphology that 
display some variation in frequency throughout the dorsal horn 
laminae. The commonest varicosity described is found in all laminae, 
is dome shaped and is associated with numerous flat or oval, 
agranular vesicles with occasional larger dense core vesicles. 
Typically these varicosities are associated with a single symmetrical 
synaptic specialisation (Gray type II synapse) in the cat dorsal horn 
(Ruda et al, 1982; Light et al, 1983). By contrast, few synapses are 
noted in the rat dorsal horn (Maxwell, Leranth & Verhofstad, 1983). 
The second morphological subtype of serotonin varicosity described in 
the dorsal horn is primarily located in lamina I and lamina IIq. These 
are typified by large scalloped, or more often oval, varicosities with 
many large dense core vesicles in addition to smaller agranular 
vesicles. Again these are associated with symmetrical synapses where 
present though synaptic specialisations are infrequent when compared 
with the dome shaped varicosities in both the cat (Ruda et al, 1982;
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Light et al, 1983) and the rat (Maxwell, Leranth & Verhofstad, 1983; 
Marlier et al, 1991).
Serotonin-immunoreactive varicosities as described above are often 
associated with dendritic profiles with which axo-dendritic synapses 
can be identified. Similarly axo-somatic contacts have been 
documented. In contrast, few axo-axonic synapses have been 
recorded Involving serotonin in the dorsal horn (Maxwell, Leranth & 
Verhofstad, 1983). As noted, synaptic specialisations are more often 
identified in relation to dome shaped varicosities and are commoner in 
the cat dorsal horn. It has been shown though that those serotonin- 
immunoreactive varicosities not associated with a classical synaptic 
specialisation are often closely opposed to cell bodies or dendrites of 
neurons in the dorsal horn in both rat and cat (Maxwell, Leranth & 
Verhofstad, 1983; Ruda et al, 1982; Light et al, 1983; Marlier et al, 
1991).
1. 5 Serotonin receptors in the spinai grey
To date there are some fourteen or more serotonin receptors 
recognised with seven distinct receptor families identified (Hoyer & 
Martin, 1997; Martin et al, 1998). These have been termed 5-HT1.7 with 
all being metabotropic save the 5-HT3 family which are ligand gated. 
As a greater understanding of these receptors is gained there is a 
seemingly continuous re-classification and expansion of the sub-types 
of receptor recognised (see Saxena, DeVries & Villalon, 1998) such 
that any discussion of the 5-HT receptor distribution is made with the 
qualification that it represents the information based on the 
classification at the time of writing. As regards dorsal horn activity and
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distribution it is the 5-HTi, 5 -HT2, 5 HT3 and 5-HTy families that are 
regarded of greatest significance and hence these will be discussed.
5 -HT1 subtype
The 5-HT1 receptor family can be subdivided into 5-H T ia , 5-H T ib , 5- 
HTid, 5-HT ie and 5-HT if - Of these, autoradiographic studies have 
identified 1A and 1B subtypes within the spinal grey matter in rat 
(Pazos & Palacios, 1985; Marlier et al 1991; Laporte et al, 1995) and 
human (Pazos, Probst & Palacios, 1987a), with the highest density of 
receptor localised to the superficial dorsal horn laminae. Lesser 
densities of receptor were identified in the ventral horn, lamina X and 
the intermediolateral cell column though the gradation with the 1B 
receptor was less marked than with 1A receptor. Using an anti- 
idiotypic antibody, which detects 5-H T ib , 5-HT2 and 5-HT2c receptors, 
preferential staining in the superficial dorsal horn was again noted in 
association with dendrites and somata. Rarely was an associated 
synaptic specialisation seen (Ridet, Tamir & Privât, 1994). Dorsal 
rhizotomy results in an approximately 20% reduction in 5-H T ia and 5- 
HTib receptor binding (Laporte et al, 1995) with a similar reduction 
following neonatal capsaicin treatment (Daval et al, 1987). Thus, in 
addition to a somatic and dendritic distribution within the dorsal horn, 
these receptors are also thought to be present on primary afferent 
terminals.
5-HT2 re ce p to r su b typ e
In contrast with the 5-HTi receptor family autoradiographic studies in 
rat (Marlier et al, 1991; Thor et al, 1993) and human (Pazos, Probst & 
Palacios, 1987b) have shown the 5 -HT2 receptor subtype to be 
associated with a greater density of binding in the ventral horn. Little
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or no binding has been observed in the dorsal horn. In situ 
hybridisation for 5-HT2a or 5-HT2c (formerly 1C) receptor mRNA 
(Pompeiano, Palacios & Mengod, 1994) and immunocytochemistry 
with a monoclonal antibody to the 5 -HT2A receptor (Cornea-Hébert et 
al, 1999) confirms a greater density in the ventral horn than in the 
dorsal horn.
5 -HT3 receptor subtype
Binding of the 5-HT3 receptor is greatest in the superficial layers of the 
dorsal horn with little in the remainder of the spinal grey (Glaum & 
Anderson, 1988). As noted for the 5-HTi receptors the density of 5- 
HT3 binding is significantly reduced on neonatal capsaicin treatment or 
dorsal rhizotomy thus suggesting a significant expression on primary 
afferent terminals (Hamon et al, 1989; Kidd et al 1993; Laporte et al,
1995).
5 -HT7 receptor subtype
As with the 5-HT3 receptor, 5-HT7 receptor binding is greatest in the 
superficial dorsal horn with less noted elsewhere (Gustafson et al,
1996).
1.6 Actions of serotonin in the dorsal horn 
Effects of brainstem stimulation
The serotonergic system has a significant role in the modulation of 
sensory information processed at the level of the spinal dorsal horn. 
This modulatory effect is proposed to originate in brainstem 
serotonergic neurons located in the dorsal raphe complex and be 
mediated by serotonergic terminals within the dorsal horn. As might be 
expected stimulation of the brainstem serotonergic nuclei produces a
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measurable rise in serotonin concentration in cerebrospinal fluid 
around the spinal cord in rats (Hammond, Tyce & Yaksh, 1985), cats 
(Sorkin, McAdoo & Willis, 1993), and primates (Sorkin, McAdoo & 
Willis, 1992). The observation of a reduced number of dorsal horn cells 
expressing the immediate early gene c-fos in response to a 
nociceptive stimulus when the dorsolateral funiculus is intact as 
compared to when it is lesioned suggests this release of serotonin may 
translate to an influence on the activity of dorsal horn neurons (Liu et 
al 1997, 1999). In addition, cells immunoreactive for c-fos increase in 
number following stimulation of the raphe nuclei (Bett & Sandkühler, 
1995; Sandkühler, 1996). Though over interpretation of observations 
related to the expression of c-fos can be a pitfall, these results would 
appear to imply both an inhibitory (reduces the number of cells 
expressing c-fos when pathway Intact) and an excitatory (increased 
numbers of dorsal horn c-fos cells on brainstem stimulation) influence 
of descending serotonergic systems on dorsal horn neurons.
Whilst the predominant behavioural and electrophysiological evidence 
favours an inhibitory action of descending projections on the 
nociceptive reflexes and dorsal horn cells there have been reports of 
excitation of cells within the superficial laminae of the dorsal horn 
following stimulation of the descending tracts (Dubuisson & Wall, 
1980). One possible interpretation is that the pathways may operate 
partly via excitation of local inhibitory dorsal horn interneurons so 
producing a net inhibition. In addition, the depolarisation of spinal cord 
primary afferent fibres following raphe nuclei stimulation in the cat 
suggests brainstem induced antinociception may operate via 
presynaptic inhibition of nociceptive primary afferent terminals 
(Proudfit, Larson & Anderson, 1980; Lovick, 1983). In both the
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investigations cited it is notable that this brainstem elicited primary 
afferent depolarisation required both 5-HT and GABA for successful 
transmission. This may imply co-transmission of GABA with serotonin 
from terminals containing both serotonin and glutamic acid 
decarboxylase (Maxwell et al, 1996). As has been discussed the 
morphological correlate of pre-synaptic inhibition the axo-axonic 
synapse has not been described for serotonergic terminals in the 
dorsal horn. An alternative suggestion may be that local dorsal horn 
GABAergic neurons are involved in the pathway mediating descending 
inhibition. To further complicate matters a number of transmitters other 
than serotonin are released in the spinal dorsal horn on raphe 
stimulation with measurable increases in amino acids such as 
glutamate, aspartate, glycine and serine being detected (Sorkin, 
McAdoo & Willis, 1996).
Stimulation of the brainstem increases the threshold for the 
behavioural response to a nociceptive stimulus (Oliveras et al, 1975; 
Guilbaud et al, 1977), which in the rat is at least partly mediated by the 
5-HTia receptor (Lin, Peng & Willis, 1996a). The response of individual 
dorsal horn neurons to nociceptive stimuli is similarly reduced when 
the brainstem is stimulated (Belcher, Ryall & Schaffner, 1978; Sorkin, 
McAdoo & Willis, 1993) with 5-HTia antagonists again reducing the 
effectiveness of this descending inhibition (Lin, Peng & Willis, 1996a). 
In addition to the putative role for the 5-HTia receptor, specific 5-HT3 
receptor antagonists partly inhibit brainstem-induced antinociception 
thereby suggesting a role for this receptor in descending nociceptive 
pathways (Peng, Lin & Willis, 1996a). Thus, brainstem-induced 
antinociception may operate in part through dorsal horn neurons 
expressing 5-H T ia or 5 -HT3 receptors.
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Effects of serotonin
The intrathecal application of serotonin has repeatedly been shown to 
produce an attenuation in behavioural response to a number of 
nociceptive stimuli such as paw pressure (Bardin et al, 1997a,b), 
thermal (Lin, Peng & Willis, 1996; Bardin et al, 1997a; Glaum, Proudfit 
& Anderson, 1988,1990; Xu, Qiu & Han, 1994) and chemical pain 
(Bardin et al, 1997a). This attenuation of nociceptive behavioural 
responses results from an action mediated by specific serotonin 
receptor subtypes. Among the receptor types implicated is the 5-HTia 
subtype. Intrathecal administration of a specific 5-HTia agonist results 
in an anti-nociceptive action which is inhibited by 5-HTia antagonists. 
These antagonists also produce an inhibition of part of the 
antinociceptive action of 5-HT (Xu, Qui & Hen, 1994; Lin, Peng & 
Willis, 1996). Though this pattern of action is the commonest 
encountered, there have been occasional reports of 5-HTia receptor 
agonists having either a facilitatory effect (Crisp et al, 1991) or no 
effect (Solomon & Gebhart, 1988) on the nociceptive response. 
Similarly, the results regarding the 5-HTib receptor have proved 
inconclusive with evidence of 5-HTib agonists producing either an 
increase in nociceptive threshold (Xu, Qui & Hen, 1994) or no effect on 
nociceptive threshold (Lin, Peng & Willis, 1996). When investigated in 
behavioural experiments the 5-HT2 receptor does not appear to be 
involved in the nociceptive response (Xu, Qui & Hen, 1994). In 
contrast the 5-HT3 receptor subtype may have a role in 
antinociception. As with the 5-HTi subtypes the data is mixed with 
either no effect (Xu, Qui & Hen, 1994; Ali et al, 1996) or an 
antinociceptive action reported (Glaum, Proudfit & Anderson, 1988, 
1990; Bardin et al 1997). To date then the behavioural studies of the
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action of serotonin have provided conflicting reports on the roles of 
specific serotonergic receptor subtypes. A number of possible reasons 
for this variation in observations exist such as the recognised 
variations in circuitry that exist between different experimental animals 
(see section 1.7) and the variable response within the serotonergic 
system dependant in part on the stimulus employed (Bardin et al 
1997a).
Recording the responses of neurons which are located in or originate 
in the dorsal horn, numerous studies have demonstrated an inhibitory 
action of serotonin on neurons processing nociceptive information in 
rat (El-Yassir, Fleetwood-Walker & Mitchell, 1988), cat (Belcher, Ryall 
& Schaffner, 1978; Headley, Duggan & Griersmith, 1978) and primate 
(Jordan et al, 1979). As is the case with noradrenaline however, the 
action of serotonin is not exclusively inhibitory and a facilitatory action 
on dorsal horn cells has also been observed. In the cat Todd & Millar
(1983) reported that 68% of units within laminae I, II and III were 
excited in response to the ionophoretic application of serotonin. When 
serotonin is iontophoresed to the substantia gelatinosa and a 
nociceptive stimulus administered, the effects of serotonin on deeper 
dorsal horn neurons can be recorded. Under these circumstances 
though the majority cells in lamina IV or V are inhibited, some are also 
excited (Headley, Duggan & Griersmith, 1978). In contrast when 
serotonin was iontophoresed around cells in lamina IVA/, excitation 
was not observed. Thus, though the bulk of dorsal horn nociceptive 
neurons are inhibited following the application of serotonin, occasional 
cells are excited (El-Yassir, Fleetwood-Walker & Mitchell, 1988). This 
effect is not confined solely to recordings from cells in the dorsal horn 
with similar responses from spinothalamic tract cells in the thalamus
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noted following the administration of serotonin around their origin in 
the dorsal horn (Jordan et al, 1979).
The responses of a number of projection tracts to serotonin has been 
extensively investigated and the results have shown a somewhat 
variable response dependent on the tract under observation and the 
nature of the stimulus. For example, group II muscle spindle afferent 
responses conveyed in the spinocervical tract, postsynaptic dorsal 
column and dorsal spinocerebellar tract neurons in Clarke's column 
are facilitated by serotonin (Jankowska et al, 1997). Those of the 
dorsal spinocerebellar tract neurons located in the dorsal horn 
however were inhibited (Jankowska et al 1995, 1997). This is in 
contrast to the response to low threshold cutaneous afferents within 
these tracts where serotonin produces facilitation (Jankowska et al, 
1997).
Using receptor specific agonists and antagonists the serotonin 
receptor subtypes implicated in these responses have been explored. 
These investigations have suggested both the 5-HT ia and 5-H T ib 
receptors may be involved in the depressive action of serotonin on 
dorsal horn cells (El-Yassir, Fleetwood-Walker & Mitchell, 1988; 
Gjerstad, Tjolsen & Hole, 1997) whilst the 5 -HT2 receptor does not 
appear to be involved (El-Yassir, Fleetwood-Walker & Mitchell, 1988). 
A variable response at the 5 -HT3 receptor has been documented with 
facilitation of nociceptive neurons to a noxious stimulus at low doses of 
an agonist which becomes inhibitory at higher concentrations (Ali et al, 
1996).
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As previously noted stimulation of brainstem serotonergic nuclei 
results in depolarisation of primary afferent fibres. Application of 
serotonin to in vitro slice preparations of rat spinal cord produces a 
depression of spontaneous dorsal root potentials with a slow 
depolarisation of primary afferents and depression of transmission 
between primary afferents and dorsal horn cells (Hentall & Fields, 
1983; Lopez-Garcia & King, 1996). To date it has been suggested that 
this response is mediated via the 5 -HT2 and GABAa receptor subtypes 
(Thompson & Wall, 1996). As has been discussed, with no axo-axonic 
synapses associated with serotonergic terminals in the dorsal horn, 
this presynaptic action may perhaps be mediated via local dorsal horn 
GABAergic neurons or by non-synaptic transmission.
31
1.7 Origins of Noradrenergic Neurons
As in the case of the serotonergic terminals, despite numerous studies 
of the noradrenergic system no noradrenergic neurons have been 
identified within the spinal cord, furthermore lesioning of the spinal 
cord produces a reduction in noradrenergic immunoreactivity caudal to 
the lesion (Magnusson & Rosengran, 1963). Noradrenergic terminals 
in the spinal cord therefore are regarded as having a supraspinal 
origin. In their original topographical and morphological study of the rat 
CNS, Dahlstrom and Fuxe (1964) described seven groups of 
noradrenergic neurons within the brain stem (A1-A7) localised to the 
medulla (A1-A4) and pons (A5-A7). At the time, they accepted their 
division was 'partly artificial' and subsequent morphological studies in 
primates (Garver & Sladek, 1976; Westlund et al 1984) and humans 
(Farley and Hornykiewicz, 1977) have found the boundaries between 
cell groups to be less distinct with less adherence to discrete 
anatomical boundaries. In an extensive review of the central 
noradrenergic system, Moor and Bloom (1979) proposed the 
noradrenergic neurons need not be divided beyond the locus 
coeruleus system (A6 group) and a diffuse lateral tegmental system 
which included the subcoeruleus (A7 group). Since that review a 
further population discrete from the lateral tegmental group has 
subsequently been proposed within the dorsomedial medulla (A2 
group; Bjorklund and Lindvall 1986). Thus three systems of 
noradrenergic neurons may be described originating within the brain 
stem. However, the original observations of Dahlstrom and Fuxe 
remain in use as a descriptive classification of noradrenergic cell 
localisation. In addition to these noradrenergic cell groups PNMT- 
immunocytochemistry reveals three groups of neurons within the 
medulla, presumed to be adrenergic (Carlton et al, 1989; Hôkfeit et al
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1974), with high levels of adrenaline detected in these regions by 
quantification methods (Saavedra et al 1974).
Efferent projections from these noradrenergic nuclei have been traced 
throughout the central nervous system with projections to the cerebral 
cortex, cerebellum, hypothalamus, midbrain, medulla and spinal cord 
all described In rat (Dahlstrom and Fuxe, 1964; Grzanna and Fritschy 
1991; Jones and Moore, 1977; Olsen and Fuxe, 1971; Swanson and 
Hartmann, 1975) and primate (Garver and Sladek, 1976; Westlund et 
al 1984). This ubiquitous distribution initially implied that the 
noradrenergic system had a diffuse influence within the CNS rather 
than a target specific role (Descarries, Watkins and Laplerre, 1977). 
However, this original hypothesis has now been revised with the 
availability of improved electrophysiological and tracer techniques. It is 
now clear that a high degree of selectivity of projection from the 
noradrenergic nuclei to the spinal cord and the remaining CNS exists.
A1 and A2 groups
Located within the ventrolateral (A1) and dorsomedial (A2) medulla 
these cell groups were first suggested to project to the spinal cord 
following the original Dahlstrom and Fuxe (1965) studies where they 
observed an accumulation of catecholamine within somata in these 
regions, reflected as an increased immunofluorescence, following 
transection of the spinal cord in rats. Subsequent lesioning studies 
have demonstrated a projection from the A1 group, and to a lesser 
extent the A2 group, to the intermediolateral cell column with no 
projection to the dorsal or ventral horns (Fleetwood-Walker & Coote, 
1981). Retrograde tracer studies with injection to the thoracic cord 
have supported this observation in rat (Satoh et al, 1977), rabbit
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(Blessing et ai, 1981) and primate (Carlton et al, 1991). Furthermore, 
stimulation in the thoracic cord produces antidromic responses that 
can be detected within the A1 group (Fleetwood-Walker, Coote & 
Gilbey, 1983). The morphological and electrophysiological evidence 
therefore supports a role for the A1 group in autonomic processing.
A number of non-noradrenergic cells have been detected by 
retrograde tracer techniques lying within the A1 and A2 cell groups in 
rat (Westlund et al, 1983) and primate (Westlund et al, 1984). Though 
several groups have concluded that noradrenergic neurons do project 
to the spinal cord (Dahlstrom & Fuxe, 1965; Satoh et al, 1977; Smolen, 
Glazer and Ross, 1979) there is growing evidence to suggest the 
splnally projecting neurons emanating from the A1 and A2 groups are 
not noradrenergic (Blessing et al, 1981; Westlund et al, 1981, 1982, 
1984, 1983). The rostral location of spinally projecting neurons within 
the A1 group (Blessing et al, 1981) does however correspond to the 
C l group of adrenergic neurons in the brainstem (Carlton et al, 1989; 
Hôkfeit et al, 1974, Moore and Bloom, 1979, Saavedra et al, 1974). A 
projection from this group of adrenergic neurons to the spinal cord has 
been shown using a combined retrograde transport and PNMT- 
immunocytochemistry technique (Ross et al, 1981).
A4 cell group
Located in the caudal pons in the lateral roof of the fourth ventricle and 
continuous rostrally with cells within the locus coeruleus (A6 group) 
this group of noradrenergic cells does not appear to contribute a 
significant projection to the spinal cord (Dahlstrom & Fuxe, 1964; 
Kuypers et al, 1975; Blessing et al 1981; Westlund et al, 1984).
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A5 cell group
The A5 group of noradrenergic cells represents a pontine extension of 
the A1 group with cells located in the ventrolateral brainstem dorsal 
and lateral to the facial nucleus and the superior olivary complex 
(Dahlstrom & Fuxe, 1964; Westlund et al, 1984). Extensive 
investigation has revealed a significant projection from this group of 
neurons to the spinal cord. Using a double-labelling, retrograde tracer 
technique in primates with HRP injection to the cervical enlargement 
combined with dopamine-p-hydroxylase (D-pH) immunocytochemistry 
Westlund et al (1984) demonstrated a noradrenergic projection to the 
cord from this group. This region they estimated to contribute 11.5% 
of noradrenergic cells projecting to the primate cervical cord. Similar 
studies have confirmed the presence of this projection from the A5 cell 
group in rats (Clark, Yoemans & Proudfit, 1991; Fritschy and Grzanna 
1990; Grzanna and Fritschy, 1991; Westlund et al 1983).
Injection of tracer to the A5 region reveals a projection to the 
intermediolateral cell column in rats (Clark and Proudfit, 1993; Loewy, 
McKellar & Saper, 1979; Loewy et al, 1986). This projection is 
supported by the observation that HRP injected to the lateral horn in 
the thoracic cord retrogradely labels cells within the A5 group 
(Blessing et al, 1981; Fritschy and Grzanna, 1990; Satoh et al, 1977; 
Westlund et al, 1983). A projection from A5 noradrenergic cells to the 
dorsal horn laminae IV-VI and to lamina VII has also been identified 
(Clark and Proudfit, 1993).
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A6 cell group (locus coeruleus)
In studying the noradrenergic immunocytochemistry of the brainstem a 
group of cells located within the nucleus locus coeruleus in the 
dorsolateral pons is easily distinguishable and represents the densest, 
most discrete population of noradrenergic neurons in the CNS 
(Dahlstrom & Fuxe, 1964;Westlund & Coulter, 1980; Westlund et al, 
1984). Retrograde transport has revealed a projection to the spinal 
cord from this population of neurons in rat (Basbaum & Fields, 1979; 
Guyenet, 1980; Westlund et al, 1981, 1983; Jones & Yang, 1985; 
Clark and Proudfit, 1989; Fritschy and Grzanna, 1990), cat (Jones & 
Moore, 1974; Kuypers & Maisky, 1975; Basbaum & Fields, 1979; 
Nakazato, 1987) and primate (Hancock and Fougerousse, 1976; 
Westlund & Coulter, 1980; Westlund et al, 1984). Again Westlund and 
colleagues (1984) have quantified this projection and estimate the 
locus coeruleus neurons to account for 29.3% of noradrenergic cells 
projecting to the cervical cord in primates. Similar studies have 
estimated the proportion to be higher in the rat at 41% (Westlund et al
1983). However there does appear to be a significant species variation 
with fewer locus coeruleus cells in rabbit (Blessing et al, 1981) and cat 
(Stevens, Hodge & Apkarian, 1982; Stevens, Apkarian & Hodge, 1985) 
contributing to the noradrenergic spinal projection.
In the primate, anterograde transport of tritiated amino acid injected to 
the region of the locus coeruleus reveals dense terminal labelling in 
the region of lamina VII-IX and around the central canal (Westlund & 
Coulter, 1980). Similar findings have been reported for rats (Jones & 
Yang, 1985). Further evidence in support of a coeruleospinal 
projection to the ventral horn and lamina X in rats is provided by 
unilateral or bilateral lesion of the locus coeruleus which results in a
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reduction in noradrenaline containing axons in these regions of the 
spinal cord (Nygren & Olsen, 1977; Commissiong et al, 1978; Clark 
and Proudfit, 1991). However, though there is agreement on the 
termination of locus coeruleus noradrenergic fibres within the ventral 
horn and around lamina X there is some disagreement over the 
contribution of locus coeruleus neurons to the noradrenergic 
innervation of the dorsal horn. Injection of tritiated amino acid into the 
locus coeruleus in rat (Jones and Yang, 1985) and primate (Westlund 
and Coulter, 1980) has been reported to produce only light to 
moderate labelling in the dorsal horn suggesting that a major 
coeruleospinal projection to this region does not exist. However, 
anterograde transport studies combined with D-pH- 
immunocytochemistry have indicated a dense projection to the dorsal 
horn in the rat (Fritschy et al, 1987; Fritschy & Grzanna, 1990). This 
apparent disagreement may be a result of a variation in projection of 
locus coeruleus neurons in the different genetic strains of rat used in 
these studies. This hypothesis has been examined by Proudfit and 
Clark (1991) comparing the retrograde transport of fluorogold injected 
to either the dorsal or the ventral horn in two strains of Sprague- 
Dawley-derived rats. Following this they noted a clear difference in 
coeruleospinal projection between the two strains used with Harlan- 
Sprague-Dawley rats (as used by Fritschy et al, 1987) exhibiting a 
bilateral projection to the spinal cord with more neurons labelled 
following injections to the dorsal horn than to the ventral horn. In 
comparison, Sasco-Sprague-Dawley rats were primarily associated 
with a unilateral projection to the ventral horn with only a light input to 
the dorsal horn (Clark and Proudfit, 1989). Hence, the differences 
reported in the projection of locus coeruleus noradrenergic neurons
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may in part be a result of variation in the neural circuitry of the 
substrains of rat employed.
In summary, the locus coeruleus in cat, rat and primate supplies a 
noradrenergic projection, originating in the ventral and caudal regions 
of the nucleus, which terminates primarily in the ventral horn, 
intermediate zone and lamina X. There is however conflicting evidence 
on the projection of the locus coeruleus to the dorsal horn.
A7 cell group
The A7 group of pontine noradrenergic neurons includes neurons 
within the nucleus subcoeruleus, the medial and lateral parabrachial 
nucleus and the Kolliker-Fuse nucleus (Dahlstrom & Fuxe, 1964). 
Retrograde transport of HRP injected to the spinal cord in rat 
(Basbaum & Fields, 1979), cat (Kuypers & Maisky, 1975; Basbaum & 
Fields, 1979) and primate (Hancock & Fougerousse, 1976) reveals 
cells within the A7 group. Further, the retrograde transport of an 
antibody to D-pH (Westlund et al, 1981, 1983, 1984) and double 
labelling immunohistochemical studies (Blessing et al, 1991; Fritschy & 
Grzanna, 1990; Westlund et al 1981, 1983, 1984) have identified these 
cells as noradrenergic.
In quantitative investigations the A7 group has been shown to provide 
the majority of spinally projecting noradrenergic neurons in both rat 
(82%; Westlund et al, 1983) and primate (79%; Westlund et al, 1984). 
Within the A7 group there is some variation in the contribution from 
each of the subnuclei to the descending projection with, in the primate, 
the subcoeruleus contributing 50% of spinally projecting noradrenergic 
neurons, the Kolliker-Fuse nucleus 8% and the parabrachial nuclei 1%
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(Westlund et al, 1984). Similar results have been obtained in the rat 
where the subcoeruleus, Kolliker-Fuse and parabrachial nuclei 
contribute 45%, 5% and 1% of descending noradrenergic cells 
(Westlund et al, 1983). In studies of the cat however the contributions 
to the descending noradrenergic projection from the brain stem nuclei 
have been shown to be significantly different with the principal 
descending noradrenergic axons arising from the Kolliker-Fuse 
nucleus and a relatively minor contribution from subcoeruleus, 
parabrachial nuclei and the A6 group (Stevens et al 1982, 1985).
Within the A7 group of noradrenergic neurons the subcoeruleus, 
Kolliker-Fuse and parabrachial nuclei project to specific laminae of the 
spinal cord. In the rat, anterograde tracing techniques the 
subcoeruleus has been shown to project to the ventral horn whilst the 
parabrachial and Kolliker-Fuse nuclei terminate in the superficial 
dorsal horn (Clark & Proudfit, 1991). Again, this finding is dependant 
on the strain of rat under study with opposite results obtained for an 
alternative strain of rat (Sluka & Westlund, 1992). In primates injection 
of tritiated amino acid to the A7 group produces labelling of the 
intermediolateral cell column, lamina I, the ventral horn and lamina X 
(Westlund & Coulter, 1980)
1.8 Distribution of catecholaminergic terminals in the spinal grey
The presence of catecholamines in the spinal cord has been 
recognised for some time following their identification in specimens 
taken from the spinal cord (von Euler, 1947; Vogt, 1954; Magnusson, 
1973). These investigations however do not give an indication as to 
the origins of the catecholamines detected in these samples. Using 
micropunch samples from specific regions of the spinal grey, Zivin et al
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(1975) established the distribution of the catecholamines was not 
uniform across the spinal cord. In this work, they described the 
concentration of noradrenaline to be greatest in the lateral horn of the 
thoracic spinal cord with progressively lower concentrations in the 
ventral then dorsal horns. Little dopamine or adrenaline was identified 
at the level of the cord. With the development of histofluorescence 
techniques such as the Falck-Hillarp method (Faick et al, 1962) 
catecholamine terminals could be identified in the spinal cord 
(Carlsson et al, 1963; Dahlstrom & Fuxe, 1964) and with this greater 
detail on the specific laminar locations of the catecholamines could be 
derived.
Noradrenaline In the spinal grey
Using immunoreactivity for the noradrenaline synthetic enzyme 
dopamine-p-hydroxylase (D-pH), noradrenergic terminals can be 
identified within the spinal grey of the rat (Westlund et al 1983; Proudfit 
& Clark, 1991; Fritschy & Grzanna, 1990), cat (Westlund et al, 1982; 
Doyle & Maxwell, 1991, 1993) and primate (Westlund et al,1980,
1984). In each species a similar laminar distribution has been 
described with terminals associated with motoneurons in the nuclei of 
the ventral horn (lamina IX of Rexed, 1954), in laminae I, II, IV and VI 
of the dorsal horn and in lamina X. Heavy labelling is also present in 
the region of the intermediolateral cell column (Westlund & Coulter, 
1980).
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1.9 Ultrastructure of catecholamine profiles in the dorsal horn
Catecholamine axons in the dorsal horn display a prominent 
rostrocaudal orientation with fibres running for some distance and 
exhibiting multiple varicosities along their length in both the rat 
(Dahlstrom & Fuxe, 1964; Fritschy & Grzanna, 1990) and cat (Doyle & 
Maxwell, 1991). These axons are typically associated with symmetrical 
synaptic specialisations (Gray type II) in association with dendrites 
(95% of terminals) or somata (5% of terminals). Axo-axonic synapses 
are not formed by catecholaminergic terminals (Hagihira et al, 1990; 
Doyle & Maxwell, 1991). Ultrastructural observations on tissue 
prepared for tyrosine hydroxylase or dopamine-p-hydroxylase 
immunoreactivity reveals boutons to be round or oval shaped with 
predominantly small, irregular, agranular vesicles and occasional 
dense core vesicles (Doyle & Maxwell, 1991,1993). This suggests 
these terminals contain not only catecholamines (agranular vesicles, 
Hôkfeit & Ljungdahl, 1972) but may also contain neuropeptides (dense 
core vesicles, Merighi et al, 1989).
Adrenergic receptors In the spinal grey
A number of adrenergic receptors have been identified (aia, aib, aid, aza, 
azb, azc. Pi, Pz, Ps). These are G protein-coupled, transmembrane 
receptors and are employed in a wide variety of biological systems. Of 
the adrenergic receptors that have been investigated so far, it is the a 
subset that is of greatest significance in the spinal cord.
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ai-Adrenergic receptors
Autoradiographic investigations using tritiated prazosin in rat 
(Simmons & Jones, 1988) and cat (Dashwood et al, 1985) have shown 
ai binding sites throughout the spinal grey with a similar binding 
density in both dorsal and ventral horns. Prazosin is however a non- 
selective ai antagonist therefore, with at least three subtypes of ai 
receptor recognised, more recent investigations have been directed at 
gaining insight into the distribution of each subtype. This has been 
achieved using more selective ligands that have revealed the aia 
receptor subtype to be the predominant subtype expressed in the rat 
dorsal and ventral horns with less aib and little aid receptor detectable 
(Wada et al 1996). In situ hybridisation studies whilst confirming the 
relative densities of the a-adrenoceptor subtypes in the rat suggest the 
a-adrenergic receptors are predominantly localised to the motor nuclei 
of the ventral horn (Day et al, 1997; Domyancic & Morilak, 1997). In 
contrast to this picture in the rat, in situ hybridisation studies in human 
have identified a significantly different pattern of distribution of a^- 
adrenergic receptor subtypes. Here it is the aid-adrenergic receptor 
mRNA which predominates with lesser densities of aia and aib- 
receptor mRNA (Smith et al 1999). As in the equivalent studies in the 
rat these investigators found no convincing evidence of mRNA for the 
ai-adrenoceptor subtypes in the dorsal horn. Thus, the available 
evidence suggests the ai-adrenoceptors are primarily localised to the 
ventral horn motor nuclei with a variation in density of each subtype 
that is species dependant.
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az-Adrenergic receptors
Autoradiographic investigations have identified az-adrenoceptors in the 
spinal grey with a dense concentration in the region of the substantia 
gelatinosa and intermediolateral cell column and lower levels in the 
ventral horn in both rat (Seybold & Elde, 1984; Unnerstall, Kopajtic & 
Kuhar, 1984; Roudet et al, 1994) and human (Unnerstall, Kopajtic & 
Kuhar, 1984). Using subtype specific radioligand binding in rat tissue 
(Uhlen et al, 1997) and in situ hybridisation in human tissue (Smith et 
al, 1995) the predominant subtype has been identified as the aza- 
receptor subtype with little azc binding and intermediate levels of azb 
binding. The availability of specific antibodies to the az-adrenergic 
receptor subtypes has allowed the general observations on the 
distributions of these receptors to be refined to give detail on which 
structures within the spinal cord express each subtype. This work has 
shown aza-receptor-immunoreactivity in the superficial dorsal horn of 
the rat (Rosin et al, 1993) in particular on the terminals of substance-P 
containing primary afferent fibres (Stone et al, 1998). The azc-receptor 
is also present in the superficial dorsal horn however this subtype is 
associated with intrinsic dorsal horn neurons and not found on primary 
afferent terminals (Stone et al, 1998). In addition, a significant azc- 
receptor-immunoreactivity is associated with motor neurons in the 
ventral horn (Rosin et al, 1996).
1.10 Actions of the catecholamines in the dorsal horn 
Effects of brainstem stimulation
Since the early observation that intrathecal injection of adrenaline 
produced an analgesic response in cats (Weber, 1904) it has been 
widely recognised that the catecholamines, in particular noradrenaline.
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may have a role in antinociception though the mechanism by which the 
catecholamines produce this anti-nociceptive response remains 
unclear. At the level of entry of the primary afferent fibres to the spinal 
dorsal horn no noradrenergic somata have been identified though a 
dense noradrenergic innervation derived from several brainstem nuclei 
does exist. In addition, within the dorsal horn specific noradrenergic 
receptor subtypes have been identified. It is therefore likely that 
catecholamine induced analgesia involves the interaction of the 
descending catecholaminergic projection with adrenergic receptors on 
the nociceptive pathways located in the dorsal horn.
Activation of noradrenergic brainstem nuclei produces a detectable 
increase in noradrenaline in superficial horn dialysates and 
cerebrospinal superfusates (Hammond, Tyce & Yaksh, 1985; Abhold & 
Bowker, 1990). The responses to stimulation of noradrenergic 
brainstem nuclei however are complex and not uniform between 
species as may be expected. Locus coeruleus stimulation in the rat 
produces both behavioural (Segal & Sandberg, 1977; Jones & 
Gebhart, 1986; West, Yeomans & Proudfit, 1993; Zhang & Zhao, 
1994) and electrophysiological (Liu & Zhao, 1992; Zhang & Zhao, 
1994) evidence of a reduced nociceptive response. This has been 
variably attributed to an az-adrenoceptor mediated action. In some 
series the behavioural response was found to be attenuated by 
specific az-antagonists (Jones & Gebhart, 1986; Zhang & Zhao, 1994) 
whilst in others the efficacy of the az-antagonists was dependant on 
the strain of rat under study (West, Yeomans & Proudfit, 1993). 
Proudfit and colleagues, elaborating their observations on the 
differences between two stains of rat in their noradrenergic projections, 
identified an attenuation of the antinociceptive response to locus
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coeruleus stimulation in Harlan-Sprague-Dawley rats when a specific 
az-antagonist was administered which was absent in Sasco-Sprague- 
Dawley rats (West, Yeomans & Proudfit, 1993). As has been 
described the locus coeruleus in Harlan-Sprague-Dawley rats projects 
to the dorsal horn whilst in Sasco-Sprague-Dawley the locus coeruleus 
projects mainly to the ventral horn (Proudfit & Clark, 1991). 
Observations based on the whole animal's response to a given 
manipulation are complicated in that not only the sensory response but 
also motor and autonomic responses are produced all of which 
interact to give the final reflex. As an example in Wistar rats the 
antinociceptive motor response of locus coeruleus stimulation is 
antagonised by the az-antagonist yohimbine whilst the response of 
dorsal horn nociceptive neurons is not (Zhang & Zhao, 1994). Thus the 
nociceptive reflex of the intact animal to an unpleasant stimulus relies 
not only on the effects of noradrenaline in the dorsal horn but also in 
the ventral horn which is at least in part az-receptor dependant.
Stimulation of noradrenergic nuclei outside the locus coeruleus in the 
rat is also associated with an analgesic response. Thus, stimulation in 
the region of the ventrolateral pontine tegmentum produces a 
suppression of the thermally induced tail-flick response (Miller & 
Proudfit, 1990) and reduces the responses of dorsal horn neurons to a 
nociceptive stimulus (Liu & Zhao, 1992). Both these responses are az- 
adrenergic receptor dependant. In addition, the response of dorsal 
horn nociceptive neurons to a noxious chemical stimulus (formalin 
injection to the hindpaw) is reduced on lateral reticular nucleus 
stimulation, an effect that is mediated at least in part by az-adrenergic 
receptors (Liu & Zhao, 1992; Zhao, Liu & Zhao, 1993).
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In the cat, as noted for the rat, stimulation of specific brainstem regions 
can influence the responses of dorsal horn neurons to a nociceptive 
stimulus in addition to the behavioural response of the animal. For 
example, in response to locus coeruleus stimulation both behavioural 
and electrophysiological responses to a nociceptive stimulus are 
reduced (Hodge et al, 1983; Zhao & Duggan, 1988). Interestingly this 
effect was not found to be dependant on noradrenaline as depletion of 
spinal noradrenaline did not significantly diminish the effect of locus 
coeruleus stimulation (Hodge et al, 1983) nor did az-antagonists inhibit 
the effect on dorsal horn cells in either rat (Liu & Zhao, 1992; Zhang 
&Zhao, 1994) or cat (Zhao & Duggan, 1988). Whilst the vast majority 
of descending locus coeruleus cells in rat (Westlund et al, 1983) and 
the majority in cat (Stevens et al 1982) contain noradrenaline there is 
evidence of alternative neurotransmitters within the noradrenergic 
brainstem nuclei which may be acting as an independent projection or 
as co-transmitters with the noradrenaline. Within the locus coeruleus, 
neurons containing enkephalin (Charney et al, 1982), galanin (Holets 
et al, 1988) and Neuropeptide Y (Holets et al 1988) have been 
identified and it is entirely feasible that these neurotransmitters may be 
involved in antinociception at the level of the dorsal horn in addition to 
noradrenaline.
Stimulation of brainstem noradrenergic centres other than the locus 
coeruleus in cats is associated primarily with an inhibitory effect on 
dorsal horn neurons and nociceptive reflexes. Kolliker-Fuse nucleus 
stimulation for example is associated with a reduction in the response 
of nociceptive dorsal horn neurons to a noxious stimulus which is 
noradrenaline dependant (Hodge, Apkarian & Stevens, 1986). Unlike
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the situation following locus coeruleus stimulation Kolliker-Fuse 
nucleus stimulation has also been reported to produce inhibition of 
non-nociceptive neurons in the dorsal horn (Zhao & Duggan, 1988). As 
noted previously the Kolliker-Fuse nucleus is the main source of 
descending noradrenergic neurons to the spinal cord in the cat 
(Stevens, Hodge & Apkarian, 1982).
Recently the expression of the proto-oncogene c-fos has been 
employed in the investigation of descending projections on nociceptive 
neurons in the dorsal horn. Using this technique, an increased number 
of c-/bs-lmmunoreactive neurons are noted in the ipsilateral dorsal 
horn in response to a noxious stimulus on lesioning the dorsolateral 
funiculus than when the funiculus is intact (Liu et al, 1997, 1999). 
These results are in support of a descending influence on nociceptive 
processing in the dorsal horn.
Effects of noradrenaline
Though the stimulation of brainstem noradrenergic nuclei results in a 
detectable rise in noradrenaline at the level of the dorsal horn part of 
the response may arise following the release of alternative 
neurotransmitters either co-released with noradrenaline or via a 
separate descending projection. It is therefore of value in the study of 
the actions of the noradrenergic system in nociceptive pathways to 
study noradrenaline and the noradrenergic agonists/antagonists 
independently of brainstem stimulation.
When iontophoresed directly around dorsal horn neurons 
noradrenaline produces a reduction in spontaneous firing and a 
modality specific, dose dependant reduction in stimulus induced firing
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of nociceptive cells in the rat (Reddy & Yaksh, 1980; Miller & Williams,
1989) and cat (Belcher, Ryall & Schaffner, 1978; Headley, Duggan & 
Griersmith, 1978; Reddy & Yaksh, 1980). In addition to this inhibition 
of nociceptive cells there have been occasional reports of a less 
selective effect on cells within lamina III/IV with both nociceptive and 
non-nociceptive responses being inhibited (Headley, Duggan & 
Griersmith, 1978). Noradrenergic agonists increase the nociceptive 
threshold in behavioural experiments (Gorlitz & Frey, 1972; Reddy & 
Yaksh, 1980;Sagen & Proudfit, 1984). This effect directly correlates 
with the affinity of the agonist used for a-adrenergic receptors, 
specifically az-adrenergic receptors (Reddy & Yaksh, 1980; Sagen & 
Proudfit, 1984; Yaksh, 1985) with p-adrenergic agonists having no 
effect (Reddy & Yaksh, 1980). Additional evidence of the significance 
of az-adrenergic receptors to noradrenaline's action in the dorsal horn 
follows from the observation that specific adrenergic receptors 
antagonists inhibit the anti-nociceptive response of either 
noradrenaline or noradrenergic agonists with an effect directly 
correlated to az-adrenergic receptor affinity (Proudfit & Hammond, 
1981; Howe et al, 1983; Sagen & Proudfit, 1984; Peng, Liu & Willis, 
1996). The potential therapeutic benefits of this antinociceptive action 
at the az-adrenergic receptor has recently been explored using 
epidural clonidine as an a analgesice agent (Eisenach, Detweiler & 
Hood, 1993; Eisenach, DeKock & Klimscha, 1996).
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1.11 Morphological basis for the actions of the monoamines in 
the dorsal horn
From the preceding discussion it can be appreciated that the 
descending monoaminergic pathways have a selective anti­
nociceptive action within the spinal cord dorsal horn. For each of the 
monoamines implicated in this intrinsic anti-nociceptive system there 
has been a considerable volume of research directed at the 
behavioural and electrophysiological characteristics of the response. 
Data has therefore been gathered with reference to the behavioural 
and electrophysiological responses to stimulation of the descending 
tracts in addition to the effects of individual transmitters and their 
specific receptor subtypes on dorsal horn neurons and ascending tract 
fibres. However, despite extensive investigation the neural circuitry 
underlying these responses remains poorly understood.
Whilst innumerable possible pathways could be considered, three 
main circuits involving the monoamines within the dorsal horn can be 
outlined. Thus, the monoamines may operate either via direct pre­
synaptic inhibition on the primary afferent terminals or via direct post­
synaptic Inhibition on the ascending tract cells or indirectly via local 
dorsal horn interneurons which may in turn operate pre- and/or post- 
synaptically (figure 1.1).
Direct pre-synaptic inhibition (figure 1.1 A)
There have been numerous studies of the monoamines in the dorsal 
horn with no convincing evidence that either catecholaminergic or 
serotonergic terminals form axo-axonic synapses (the structural 
correlate of classical pre-synaptic inhibition) within the superficial 
dorsal horn. However, the monoamines have been shown to influence
49
the electrophysiological properties of primary afferent fibres as 
evidenced by an increase in the antidromic threshold or the 
observation of primary afferent depolarisation. Thus, though a classical 
direct pre-synaptic connection is unlikely, an alternative mechanism is 
implied. One consideration is that the monoamines may act via an 
intervening dorsal horn interneuron, a possibility that will be discussed 
below. A second is that the monoamines may operate via non-synaptic 
transmission. In support of this hypothesis the distribution of 
monoamine terminals places their highest concentration in the 
superficial dorsal horn and deeper laminae IV-VI, ideally suited to 
bathe the nociceptive primary afferent terminals located in these 
regions. In addition, there is evidence that primary afferent fibres 
express catecholaminergic and serotonergic receptors. It is therefore 
conceivable that a non-synaptic influence of monoamines on primary 
afferent terminals could contribute to the antinociceptive actions of the 
monoamines. Within the current limitations of experimental design 
however there is insufficient data to be able to confidently evaluate the 
significance of this pathway.
Direct post-synaptic inhibition (figure 1.1B)
In contrast to the morphological evidence regarding monoaminergic 
involvement in axo-axonic synapses, axo-somatic and axo-dendritic 
synapse have been repeatedly observed for both the catecholamines 
and serotonin in the dorsal horn. In some instances contacts from 
monoaminergic terminals on identified projection neurons have also 
been demonstrated. Thus contacts between serotonergic terminals 
and cells of the dorsal spinocerebellar tract (Jankowska et al, 1995; 
Maxwell & Jankowska, 1996), postsynaptic dorsal column (Nishikawa 
et al, 1983), spinomesencephalic tract (Hylden et al, 1986) and
50
spinothalamic tract (Hylden et al, 1986) have been identified. Contacts 
between catecholaminergic terminals and cells of the postsynaptic 
dorsal column (Doyle & Maxwell, 1993) and spinothalamic tract 
(Westlund et al, 1990) have also been identified. As has been 
discussed the predominant action of the descending monoaminergic 
systems in the dorsal horn is inhibition of nociceptive processing. In 
this case it would be hypothesised that the monoamines act to 
produce post-synaptic inhibition. This correlates with the presence of 
oc2c-adrenergic and 5HTia receptor suptypes which are concentrated In 
the dorsal horn.
Indirect action through local dorsal horn neurons (figure 1.1C)
In addition to a direct action either on the primary afferent terminal or 
the projection neuron, monoamines may also operate via an 
intervening local dorsal horn neuron (or neurons). In turn these 
neurons may then operate pre- and/or post-synaptically to influence 
the transmission of information from primary afferent to projection 
neuron. This association of serotonergic terminals with intrinsic dorsal 
horn neurons has been explored in a number of studies. Militec et al
(1984) examined the relationship of serotonergic contacts with cells in 
the superficial laminae of the cat identified by electrophysiological 
responses and morphological characteristics. Here they found that 
cells in lamina II, identified as stalked cells by the morphological 
description of Gobel (1978), received the greatest number of 
serotonergic contacts whilst marginal and islet cells received relatively 
few. Serotonin therefore would appear to form contacts predominantly, 
but not exclusively, with excitatory neurons in the superficial dorsal 
horn. One possibility therefore in considering the interactions of 
serotonin with intrinsic dorsal horn neurons to produce inhibition would
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be for serotonin to excite inhibitory neurons which in turn may act pre- 
and/or post-synaptically to produce inhibition. It is proposed that this 
pathway might operate via the excitatory 5 -HT3 receptor.
Outwith these ultrastructura! observations on the monoamines in the 
dorsal horn limited information is available regarding the dorsal horn 
cells which may receive monoamine contacts, in particular of their 
neurotransmitters and hence their possible role in sensory processing. 
Immunocytochemical observations have shown a limited number of 
contacts between serotonin terminals and enkephalin- (Glazer & 
Basbaum, 1976; Miller & Salvatierra, 1998) and neurotensin- 
immunoreactive (Miller & Salvatierra, 1998) neurons in the superficial 
dorsal horn. Beyond these reports however, little is known of the cells 
contacted by the monoamines.
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A Direct pre-synaptic
B Direct post-synaptic
C Intrinsic neuron
T
Figure 1.1. The descending monoamines may operate through a 
number of circuits to produce antinociception in the dorsal horn such 
as through direct pre-synaptic (A) or post-synaptic (B) contacts or via 
an indirect action through intrinsic dorsal horn neurons which may in 
turn act either pre- or post-synaptically (C).
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1.12 Neuronal subtypes within the dorsal horn
As has been stated the monoaminergic system may operate either
directly or indirectly to influence the transmission of information 
through the dorsal horn which is likely to be at least partly dependant 
on local dorsal horn neurons. To gain further insight into the actions of 
the catecholaminergic and serotonergic systems within the spinal 
dorsal horn knowledge of the neurons which may be targeted is of 
value.
y-Aminobutyric acid (GABA)
Within the central nervous system GABA has a major role as an 
inhibitory neurotransmitter. Investigations using antibody to either the 
GABA synthetic enzyme glutamic acid decarboxylase (GAD) or to 
GABA have revealed numerous immunoreactive profiles within the 
dorsal horn. Typically GAD-immunoreactive somata are small to 
medium sized and located in the superficial dorsal laminae l-lll, 
increasing in size in the deeper dorsal laminae (Barber, Vaughn & 
Roberts, 1982). Similarly, G AB A-i m m u no reactive somata are present 
throughout the spinal grey, with the exception of lamina IX, with the 
greatest concentration of somata in the superficial dorsal horn (Carlton 
& Hayes, 1990). It has been estimated that 28-43% of neurons in 
laminae l-lll of the rat dorsal are GABAergic with the proportion 
increasing through lamina I to III (Todd & McKenzie, 1989; Todd & 
Sullivan, 1990). In Golgi stained sections these cells typically have a 
dendritic architecture in an approximately rostrocaudal orientation 
within the lamina or with extension Into adjacent laminae (Todd & 
Mckenzie, 1989; Powell & Todd, 1992). Hence, GABA-immunoreactive 
neurons in the dorsal horn have an appearance typical of islet cells as 
described by Gobel (1978). In addition to the somatic labelling noted
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in GABA prepared material a significant punctate staining within the 
superficial laminae l-lll is present which is less prominent in deeper 
laminae (Carlton & Hayes, 1990). These profiles correspond to 
GABAergic terminals which in ultrastructural studies have been 
described as round with clear synaptic vesicles and occasional dense 
core vesicles. These studies have noted GABAergic terminals forming 
the pre-synaptic components of both axodendritic and axosomatic 
synapses with dorsal horn neurons in addition to forming axoaxonic 
synapses with unmyelinated primary afferent terminals (Barber et al 
1978; Todd & Lochead, 1990). Lamina II GABA-immunoreactive 
dendrites have also been identified as the pre-synaptic component at 
dendrodendritic synapses (Mitchell, Spike & Todd, 1993). Synaptic 
associations between GABAergic profiles and certain projection 
neurons such as the spinothalamic tract (Carlton et al, 1992; Lekan & 
Carlton, 1995) and postsynaptic dorsal column cells (Maxwell, Todd & 
Kerr, 1995) have in addition been reported. Whilst the great majority of 
GABAergic terminals within the superficial dorsal horn originate from 
local GABAergic neurons, some terminals arise within the brainstem 
and represent a descending inhibitory projection from this region 
(Millhorn et al, 1987; Antal et al, 1996). From this evidence therefore 
GABAergic neurons display the morphological requirements for a 
neuron that can act both pre- and post-synaptically within the dorsal 
horn to influence sensory processing.
GABA has been repeatedly identified as having a role in the inhibition 
of nociceptive processing at the level of the spinal dorsal horn. 
Administration of GABA antagonists produces both an increased 
background activity and stimulus response of nociceptive dorsal horn 
neurons which may be mediated via the GABAa receptor subtype
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(Peng, Lin & Willis, 1996). Furthermore, in behavioural studies the 
administration of GABAergic antagonists (Hao, Xu, & Weisenfield- 
Hallin, 1994), or experimental manoeuvres producing a loss of GABA 
in the dorsal horn, precipitate an altered perception of non-nociceptive 
stimuli as nociceptive (allodynia; Ibuki et al, 1997). Inhibition of the 
responses of nociceptive projection neurons, such as the cells of the 
spinothalamic tract, to an appropriate stimulus has also been 
documented for GABA (Lin, Peng & Willis, 1996b,c). As noted 
previously, stimulation in the region of the nucleus raphe magnus can 
result in the phenomenon of primary afferent depolarisation (Proudfit, 
Larson & Anderson, 1980; Lovick, 1983). To permit this there must 
either be a direct or indirect communication between descending tract 
neurons and primary afferent terminals. The involvement of 
GABAergic terminals in axo-axonic synapses on primary afferent 
axons (Todd & Lochead, 1992) and the presence of GABAergic 
receptors on primary afferent terminals (Desarmenien et al, 1984) 
therefore would provide the circuitry required for this inhibition. In 
support of this association the dorsal root potential is reduced 
(Thompson & Wall, 1996) and primary afferent depolarisation following 
nucleus raphe magnus stimulation is partly blocked (Lovick, 1983) by 
the application of GABAergic antagonists.
The identification of GABA as the major inhibitory neurotransmitter in 
the spinal cord has facilitated the characterisation of neurons under 
investigation in the dorsal horn as putative inhibitory or excitatory 
neurons based on their immunoreactivity for GABA. In a series of 
experiments Todd and co-workers have identified a number of 
transmitters which co-localise with GABA. Thus dorsal horn neurons 
containing glycine in lamina l-lll (Todd & Sullivan, 1990; Todd, 1991;
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Powell & Todd, 1992), choline acetyltransferase in lamina III (Todd, 
1991), nitric oxide synthase (Spike, Todd & Johnston, 1993; Laing et 
al, 1994), neuropeptide Y (Rowan, Todd & Spike, 1993), some 
enkephalinergic neurons (Todd et al, 1992), the somatostatin2A 
receptor (Todd, Spike & Polgar, 1993) and the majority of parvalbumin 
neurons in lamina II and III (Laing et al, 1994), contain GABA. GABA 
is not present in neurons which contain neurotensin (Todd, Russell & 
Spike, 1992) or somatostatin (Todd & Spike, 1993) and those that 
express either the neurokinin-1 receptor (Todd, Spike & Polgar, 1998) 
or the 1.1-opioid receptor, MOR-1 (Kemp et al, 1996).
Glycine
The neurotransmitter glycine, with GABA, contributes a significant 
inhibitory influence on dorsal horn processing. Glycinergic neurons 
have been identified within the dorsal horn, in particular in the laminae 
deep to lamina II (Ottersen & Storm-Mathisen, 1987; Todd, 1990). As 
noted above the glycinergic neurons in the superficial laminae of the 
dorsal horn colocalise GABA and include a subpopulation of islet cells 
(Todd & Sullivan, 1990; Todd, 1991; Powell & Todd, 1992). Within 
laminae 1,11 and III glycinergic neurons comprise approximately 9, 14 
and 30% of the neurons in each lamina respectively (Todd & Sullivan,
1990). The relationship of this transmitter to the transmitters which 
also colocalise with GABA reveals a subdivision of inhibitory neurons 
based on which transmitter or transmitters are colocalised with GABA. 
Thus it has been demonstrated that glycine containing neurons in the 
superficial dorsal horn often colocalise nitric oxide synthase (Spike, 
Todd & Johnston, 1993) but do not colocalise choline 
acetyltransferase (Todd, 1991; Spike, Todd & Johnston, 1993), met- 
enkephalin (Todd et al, 1992) or neuropeptide Y (Todd & Spike, 1993).
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Punctate staining corresponding to glycinergic axonal profiles can also 
be identified within the dorsal horn particularly deep to laminae I and II. 
These terminals have been shown to form the presynaptic component 
at axodendritic and axosomatic synapses. In addition, these 
glycinergic terminals form axo-axonic synapses where the post­
synaptic component has the characteristics of a primary afferent 
terminal (Todd, 1990; Todd & Sullivan, 1990; Spike et al, 1997). 
Functionally glycine has been implicated in the inhibition of nociceptive 
processing with an increased nociceptive response when glycine 
antagonists are applied (Peng, Lin & Willis, 1996) and inhibition of 
spinothalamic tract cells in response to brainstem stimulation that is 
partly glycine dependant (Lin, Peng & Willis, 1996b,c).
Nitric oxide synthase
Nitric oxide synthase (NOS) serves to catalyse the formation of the 
neurotransmitter nitric oxide. In addition, antibody to reduced 
nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase 
has the same immunoreactive distribution as NOS (Bredt et al, 1991: 
Laing et al, 1994). Immunoreactivity for NOS or NADPH diaphorase in 
the spinal cord reveals neurons throughout the dorsal horn with the 
highest density in laminae II and III and a concentration of punctate 
staining in lamina II (Bredt et al, 1991; Valtschanoff, Weinberg & 
Rustioni, 1992; Spike, Todd & Johnston, 1993; Laing et al, 1994). 
Typically, the neurons identified within the superficial dorsal horn have 
dendrites orientated in a rostrocaudal direction with occasional 
recurrent branches (Spike, Todd & Johnston, 1993). Combined 
immunocytochemical studies have demonstrated that the majority of 
these neurons co-localise GABA or glycine and GABA and hence they
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are presumed inhibitory with the proportion of cells co-localising GABA 
only increasing in deeper lamina III (Spike, Todd & Johnston, 1993). 
This study also demonstrated the lamina III choline acetyl transferase 
neurons co-localise NADPH diaphorase. Nitric oxide is implicated in 
the modulation of nociceptive information at the level of the dorsal horn 
with its release at this site implicated in the generation of hyperalgesia 
and allodynia (Wu et al, 1998).
Parvalbumin
Neurons immunoreactive for the calcium binding protein parvalbumin 
are present in the superficial dorsal horn distributed throughout lamina 
II and III (Yamamoto, et al, 1989; Yoshida et al, 1990; Antal et al, 
1991; Laing et al, 1994). The great majority of parvalbumin-containing 
neurons also contain GABA and glycine, and these are therefore 
presumably inhibitory (Antal et al, 1991; Laing et al, 1994).
Somatostatin and the somatostatin sstaa receptor 
Neurons immunoreactive for the neuropeptide somatostatin are 
predominantly found in lamina II of the superficial dorsal with 
occasional cells in the deeper dorsal horn (Hunt et al, 1981; Todd & 
Spike, 1992). These cells do not co-localise GABA and hence are 
presumed to be excitatory dorsal horn neurons (Todd and Spike, 
1993). Several different somatostatin receptors have been identified, 
of which one, the sst2a receptor, has been identified in the dorsal horn 
of the rat with immunoreactive neuronal bodies and punctate staining 
within lamina I and II (Schindler et al, 1997; Todd, Spike & Polgar, 
1998). The sst2a-immunoreactive neurons within this region are 
GABAergic with many also co-localising glycine (Todd, Spike & Polgar, 
1998). Hence, it is presumed that this receptor is expressed on
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inhibitory neurons in the dorsal horn. In support of a role in nociceptive 
processing, somatostatin has been shown to have an analgesic action 
in humans (Sicuteri et al, 1984; Williams et al, 1987). In addition, 
following its administration a reduction in c-fos expression in the 
trigeminal subnucleus caudalis has been shown in response to a 
noxious stimulus in the rat (Bereiter, 1997).
p-opioid receptor (MOR1)
Immunoreactivity for the ^i-opioid receptor (MORI) is typically 
identified as a dense band of immunostaining within lamina I and II of 
the dorsal horn in which small neurons, with dendrites orientated in an 
approximately rostrocaudal direction, are found spanning the border of 
lamina II with lamina III ( Arvidsson et al, 1995; Kemp et al, 1996; 
Gong et al, 1997; Zhang et al, 1998). Most of these cells are not 
GABA-immunoreactive and are hence presumed to be excitatory 
(Kemp et al, 1996). Opioid agonists are recognised as having potent 
analgesic properties (Martin, 1983) including depression of nociceptive 
processing in the dorsal horn (Yaksh & Rudy, 1978; Le Bars et al, 
1979) and a reduction in c-fos expression in the trigeminal circuitry 
following a noxious stimulus (Bereiter, 1997).
Neurotensin
The response to a noxious stimulus is diminished following the 
intrathecal application of the peptide neurotensin (Yaksh et al, 1982). 
Immunoreactivity for this peptide has been described in the superficial 
dorsal horn with a plexus of fibres in the lamina I/ll region and 
immunoreactive somata deeper in ventral lamina ll/lll region (Hunt et 
al, 1981; Seybold & Elde, 1982; Miller & Salvatierra, 1998). These
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neurotensin-immunoreactive neurons do not co-localise GABA and 
hence are regarded as excitatory dorsal horn neurons.
The Neurokinin-1 receptor
The neurokinin-1 receptor serves as the main receptor subtype for the 
tachykinin peptide substance P (Hershey & Krause, 1990) which is 
implicated in the processing of nociceptive information at the level of 
the spinal dorsal horn (Henry, 1976; De Koninck & Henry, 1991; Liu & 
Sandkuhler, 1995). Immunocytochemical studies have revealed 
substance P immunoreactivity in small diameter sensory afferents 
terminating in the region of lamina I/ll with a cluster in lamina V and 
lower density in the remaining dorsal horn (Cuello & Kanazawa, 1978; 
Ruda, Bennet & Dubner, 1986). Combined electrophysiology and 
immunocytochemistry has shown these terminals form synaptic 
associations with nociceptive neurons in the dorsal horn (Ma et al, 
1996,1997). Immunoreactivity for the NK-1 receptor has been 
identified in the dorsal horn with the greatest density of staining in 
lamina I, light staining in lamina II and intermediate staining in the 
deeper laminae (Nakaya et al, 1994; Bleazard, Hillan & Morris, 1995; 
Littlewood et al 1995). Within these regions distinct groups of NK-1 
receptor-immunoreactive neurons can be identified located in lamina I 
with a further population of large neurons located in lamina lll/IV which 
have prominent, dorsally orientated dendrites extending into the more 
superficial laminae. Very few of these neurons have been found to be 
GABA-immunoreactive hence they are presumed to be excitatory 
(Littlewood et al, 1995). There is accumulating evidence that the vast 
majority of NK-1 receptor positive neurons in lamina I and lamina lll/IV 
represent a population of projection tract neurons to brainstem regions 
associated with nociceptive processing (Yu et al, 1999; Marshall et al.
61
1996; Todd, McGill & Shehab, 2000). The neurons described in lamina 
lll/IV have also been shown to receive a selective innervation from 
substance P containing primary afferent terminals on their proximal 
and distal dendrites (Naim et al, 1997) with little input from myelinated 
or non-peptidergic terminals (Naim, Shehab & Todd, 1998; Sakamoto, 
Spike & Todd, 1999). These two groups of neurons may have differing 
roles in the processing of nociceptive information in the dorsal horn 
with lamina I neurons coding for the stimulus intensity whilst lamina 
lll/IV neurons may have a role in the detection of particular nociceptive 
stimuli (Doyle & Hunt, 1999).
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1.13 Objectives of the study 
Monoamines in the dorsal horn
As described, little information is available about the neuronal circuitry 
involving monoaminergic axons and the neurons of the dorsal horn. 
Previous investigations have identified synaptic contacts between 
monoaminergic terminals and morphologically identified dorsal horn 
cells or ascending projection neurons. However the exact nature of the 
cells contacted, in particular their neurotransmitter substances, has not 
been clearly identified. Clearly, further information as to the circuitry 
and transmitters involved in these pathways would be valuable for an 
improved understanding of monoamine-induced antinociception and 
the adaptation of and/or development of targeted analgesics. In the 
following series of experiments the association of monoaminergic 
terminals with identified dorsal horn cells is examined using a variety 
of immunocytochemical, imaging and analysis techniques in order that 
a better understanding of the monoamines and their connections in the 
dorsal horn might be achieved.
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1.14 General Methods 
Experimental animals
Adult female Albino-Swiss rats were used throughout these studies. 
These were obtained immediately prior to perfusion from the colony of 
The Laboratory of Human Anatomy, University of Glasgow. To 
minimise the influence of tissue lipofuchsin, in experiments prepared 
for fluorescence microscopy rats aged less than six months were 
used. All other animals used were aged between six and twelve 
months with an average weight of 250g.
Perfusion
Immediately following removal from the colony the animals were 
deeply anaesthetised by intraperitoneal injection of 1 ml of a solution of 
sodium pentobarbitone (60mg ml"^ ). Following confirmation of 
adequate anaesthesia by the loss of paw withdrawal to a painful 
stimulus (forceps crush), and before cessation of respiration, the 
thoracic cage was exposed through an anterior incision and a window 
cut in the thoracic cage. The left ventricle was then located, 
cannulated and a rinsing solution of warmed mammalian Ringer 
perfused with the right atrium then opened to allow the perfusate to 
flow freely. On confirmation of an adequate cannula position and free 
flow of Ringer the perfusing solution was switched to a solution of 
warmed fixative which had been prepared immediately prior to 
perfusion and a total of 1000ml of fixative was perfused under 
pressure. The optimum perfusion conditions identified in these 
experiments were such that fixative was introduced to the animal's 
circulatory system with the minimal possible delay from the onset of 
dissection (ideally less than one minute). In addition brisk fasciculation 
of skeletal muscles on introduction of the fixative and adequate
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clearing of blood from the liver were regarded as confirmation of 
fixative perfusion and clearing of the animal respectively. If any of 
these features was not observed then the fixation of the animal was 
likely to be suboptimal and the experiment was therefore abandoned 
at this point and another animal selected for perfusion.
Dissection
Following perfusion the vertebral column was exposed via a posterior 
skin incision and a dorsal laminectomy performed using blunt ended 
rongeurs thus revealing the spinal cord with intact dura from sacral to 
lower thoracic segments. The dura was then carefully opened along its 
length and individual spinal roots separated, lifted free from the 
exposed spinal cord and identified with reference to an atlas of rat 
spinal cord anatomy. The lumbar enlargement was then identified and 
lumbar segments L3 and L4 removed and placed in a solution of the 
same fixative as used in the perfusion for a period of postfixation of 
either 4 or 24 hours depending on the requirements of the antibodies 
under investigation
Sectioning
Following postfixation the blocks were washed in phosphate buffered 
saline prior to sectioning into 50|iim transverse or parasagital sections 
on a vibrating microtome (Vibratome, Oxford Instruments). In 
experiments using transverse sections of spinal cord the sections were 
now ready to be processed. Where the protocol required that 
parasagital sections be used each block was first bisected through the 
dorsal median fissure in the midsagital plane. The two hemi-blocks 
then obtained were mounted on the cut mid-sagittal face, sectioned 
through their entire extent from lateral to medial and gathered in a
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Petrie dish containing PBS. These sections were then viewed using a 
binocular dissecting microscope and those containing the substantia 
gelatinosa selected for further processing. This technique permitted 
the maximum number of sections containing superficial dorsal horn to 
be processed from each animal.
Processing for confocal microscopy
The sections obtained following the above processing were now 
placed in a solution of 50% ethanol for 30 minutes before being 
transferred to 10% normal donkey serum in PBS for one hour to bind 
free antibody sites. These two steps served to reduce the effect of 
background staining so improving staining quality. Following this the 
sections were transferred to the primary antibody solution. In each 
case the combinations of primary antibodies included in the primary 
antibody solutions were such as to permit identification of three types 
of immunofluorescence in each tissue section. For each of the 
following protocols the primary antibodies chosen were such as to 
include antibodies to reveal monoaminergic profiles using rat or rabbit 
anti-serotonin antibodies (both at 1:200 dilution) and mouse anti­
dopamine p-hydroxylase (1:500) together with a third antibody specific 
to a particular dorsal horn neuronal subtype. Thus in any one section 
the relationship of the monoamine-immunoreactive profiles to dorsal 
horn neurones could be examined. Primary antibody solutions were 
prepared in phosphate buffered saline containing 1% normal donkey 
serum and 0.1% Triton X-100. The sections were then incubated in the 
primary antibody cocktail for an incubation time dependant on the 
antibodies under investigation and the plane of the Vibratome sections 
being studied. After incubation in the primary antibody solutions the 
sections were rinsed with PBS and transferred to solutions containing
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fluorophores coupled to secondary antibodies specific to the primary 
antibody species such that each antibody species Included in the 
primary antibody cocktail could be identified separately using three- 
colour laser scanning confocal microscopy. To permit this, secondary 
antibodies raised in donkey were chosen which were coupled to the 
fluorophores fluorescein isothiocyanate (FITC), cyanine 5.18 (Cy-5) or 
lissamine rhodamine (LRSC; all Jackson Immunoresearch) with each 
antibody diluted 1:100 in PBS containing 0.1% Triton X-100 (no 
blocking serum). After a 3-hour incubation in the secondary antibody 
solutions the sections were again rinsed, wet mounted with anti-fade 
medium (Vectashield, Vector Laboratories Inc.) and stored at -20°C 
until analysed.
Control Experiments
In each case the specificity and staining characteristics of the 
antibodies under investigation have been extensively described 
previously. As additional controls in this series of experiments, for 
each protocol sections were collected and processed exactly as for 
experimental sections however with the omission of one of the primary 
antibodies under study. The tissue was then processed exactly as for 
the experimental tissue including addition of secondary antibody and 
the tissue examined with the confocal microscope. In each case the 
control did not show any discernable specific fluorescence for the 
omitted antibody.
Confocal Microscopy
Material prepared for immunofluorescence studies was examined 
using a three colour confocal laser-scanning microscope (BioRad 
MRC 1024) equipped with a krypton-argon laser producing excitation
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wavelengths of 488, 568, and 647nm and mounted on a Nikon 
Optiphot with stage motor. These wavelengths optimally excite FITC, 
LRSC and Cy-5 respectively hence allowing each to be identified in 
the sections under examination. All of the elements of this scanning 
apparatus are coordinated through a PC running BioRad designed 
software allowing the functions of the microscope to be controlled 'on­
screen' via the PC. Thus, once a field of view has been selected under 
direct epifluorescence the microscope can then be driven via the PC. 
Each of the emission channels can be selected and scanned either 
individually, thus minimising bleedthrough, or all three channels can be 
scanned at the same time and assigned a separate pseudocolour to 
aid differentiation. In addition the stage motor can be used to step 
through the section in set intervals in the z-plane. These functions 
therefore permit a desired field to be scanned in a series of steps in 
the z-plane with the resultant single or multi-channel images stored for 
later analysis. The images can then be analysed as single optical 
channels or combined to give a three-colour image for each optical 
section. In addition the series, or stack, of images in the z-plane can 
be merged to provide a single image through the profile of interest. 
These manipulations can either be performed through the BioRad 
supplied software or by using a freely available software package 
Confocal Assistant (distributed via the internet).
Antibodies
Appendix 1 lists the antibodies used in this series of experiments, their 
dilutions and commercial sources.
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1.15 Specific Methods
A. The relationship of the monoamines serotonin and 
noradrenaline to intrinsic dorsal horn neurons
Tissue from three experimental animals was prepared for each of the 
experimental conditions under study with the process of anaesthesia, 
perfusion and dissection as described in the general methods. For the 
purposes of these studies 4% formaldehyde in 0.1M phosphate buffer 
(pH 7.6) was used as the fixative solution. The mid-lumbar blocks 
obtained were then sectioned either in the transverse plane (for 
somatic labelling studies) or the parasagittal plane (for dendritic 
labelling studies). The sections were then incubated in 50% ethanol 
followed by 10% normal donkey serum prior to incubation in the 
primary antibody cocktails. As outlined in the general methods, each 
primary antibody cocktail included antibodies to serotonin and D-pH 
together with a third primary antibody to the specific dorsal horn 
neuronal subtype under investigation. In the studies where monoamine 
contacts on somatic profiles were the subject of the investigation either 
rabbit anti-GABA (1:1000), rat anti-glycine (1:5000), rat anti­
neurotensin (1:1000) or rat anti-somatostatin (1:100) antibodies were 
included as the third antibody in the cocktail. To provide more 
extensive dendritic labelling a second series of experiments were 
performed using either goat anti ChAT (1:100), rabbit anti-MORI 
(1:1000) or sheep anti-NOS (1:2000). All primary antibody dilutions 
were in PBS with 0.3% Triton X-100 and 1% normal donkey serum 
(bovine serum albumin with GABA and Glycine antibodies). Following 
a 48-hour incubation at room temperature the sections were rinsed 
then transferred to solutions containing species specific secondary 
antibodies coupled to fluorophores for a period of 3 to 4 hours. The
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sections were then rinsed, wet mounted with anti-fade medium and 
stored at -20°C until analysed
Scanning and Analysis 
Somatic labelling
Under direct epifluorescence five sections through the dorsal horn 
from each animal were examined in their entirety from medial to lateral 
extent and all immunoreactive somatic profiles identified. As they were 
identified series of images taken sequentially for each fluorophore 
were recorded through the immunoreactive profile with an oil 
immersion objective lens of X60 at an optical zoom of X1 at intervals of 
O .S jL im  in the z-plane. This process was repeated for all 
immunofluorescent somatic profiles that could be clearly identified 
within each dorsal horn. The individual images for each optical section 
were then examined and the presence or absence of monoamine 
contacts on immunoreactive somata recorded. Throughout this series 
of experiments a contact between two immunofluorescent channels 
was regarded as being present when the two colour channels were in 
direct apposition with no pixel of separation between them.
Somatic and dendritic labelling
Where the antibody under investigation permitted more extensive 
dendritic and somatic labelling parasagittal vibratome sections were 
used. From these four immunoreactive cells from each animal were 
selected at random, scanned and analysed. Using a x40 oil immersion 
objective lens with an optical zoom of 1.5, single sequential images 
were collected for each of the fluorescent channels at 1 |Lim intervals in 
the z-plane through the entire immunoreactive profile within the optical 
field of view. This process was then repeated for overlapping fields
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until the complete immunoreactive profile within the 50pm section had 
been recorded.
Once gathered, the images were used to trace the outline of the 
immunoreactive profile and to map onto the outline any monoamine 
contacts. This was achieved using a 3D neuron-tracing package, 
NeuroLucida for Confocal (MicroBrightField, Inc), with a dedicated 
analysis package, NeuroExplorer. Each reconstruction was generated 
by first merging the three individual optical images for each individual 
z-interval using Confocal Assistant to provide a series of three-colour 
images through the cell. The stack of optical images was then 
imported into the NeuroLucida program where the series of images 
could then be scrolled through one by one. If necessary, areas of 
particular interest could then be magnified for closer inspection within 
NeuroLucida. Each immunoreactive cell was now traced and all 
associated monoamine-immunoreactive contacts plotted on the 
outline. This process was repeated for each overlapping field until the 
entire profile had been reconstructed. The resultant image and its 
associated datafile were then used to calculate the total number of 
contacts on each cell and to perform a modified Sholl analysis (Sholl, 
1953) for monoamine contact densities calculated within a series of 
shells increasing in steps of 25pm radii centred on the cell body. The 
reconstructed images and contact density data obtained were then 
used to compare individual cells of a particular type and to permit 
different cell subtypes to be compared.
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Statistical analysis
Where the monoamine contact densities were compared between two 
different populations of immunoreactive dorsal horn neurons the data 
were tested for statistical significance using the Mann-Whitney 'U'-test 
for non parametric data.
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B. Ultrastructural analysis of monoamine contacts and inhibitory 
dorsal horn neurons
Adult female Albino-Swiss rats of between six and twelve months of 
age were anaesthetised, perfused with fixative solution containing 1% 
glutaraldehyde and 1% formaldehyde in phosphate buffered saline and 
mid-lumbar spinal cord blocks were removed and postfixed overnight. 
Transverse Vibratome sections (50pm thick) were then collected and 
placed in a 50% solution of alcohol for 30 minutes. The sections were 
then rinsed with PBS and excess aldehyde groups adsorbed by 
incubation in a 1% solution of sodium borohydride for 30 minutes. This 
step permits better antibody penetration in addition to reducing 
background staining. Following this, the sections were rinsed 
extensively in PBS with a minimum of 9 PBS changes over a 90 
minute period. Background staining was then further reduced by a 
one-hour incubation in blocking serum consisting of 10% normal goat 
serum in PBS. Next, the sections were rinsed and the primary antibody 
solution added. In each case the primary antibody solutions contained 
antibody to serotonin (rat anti-5-HT; 1:2000) together with antibodies 
to mouse anti-GABA (1:500) diluted in PBS with 1% normal goat 
serum. Following 48hours incubation at 7°C the sections were rinsed 
and placed in a solution containing biotinylated anti-rat antibody 
(1:200) with an anti-mouse antibody coupled to Inm gold particles 
(1:200) overnight. The sections were then rinsed and the gold particles 
intensified using a silver intensification reagent (IntenSE, Sigma 
Chemical Co., England). The sections were now reacted to reveal 
biotin binding using the avidin-biotin-peroxidase complex technique 
(ABC technique). This involved an overnight incubation in a fresh 
solution of avidin-biotin-complex (Vector Laboratories Ltd, England)
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followed by a further rinse with PBS then PB. The sections were now 
placed in a solution containing hydrogen peroxide plus 3,3'- 
diaminobenzidine diluted in phosphate buffer for a period of 
approximately 4 minutes. During this time the reaction was monitored 
constantly. Following the DAB reaction, the sections were rinsed 
further and processed for viewing on the electron microscope.
Firstly, the sections were postfixed in 1% osmium for 30 minutes then 
en bloc stained using a saturated solution of uranyl acetate in 70% 
acetone (30 minutes) prior to dehydration through a series of acetone 
rinses (90% for 10 minutes; 100% for 3x10 minute rinses) ending in a 
1:1 solution of acetone and Durcupan (Ihour). From the 
acetone/Durcupan solution the sections were then transferred to 
freshly prepared Durcupan overnight. The sections were then flat 
embedded in resin between two acetate foils and polymerised at 60°C 
for a minimum of 24 hours. Once this was complete, the sections were 
examined under light microscopy and those with the optimal staining 
chosen for further processing. These were then attached to resin 
blocks, trimmed to the area of Interest and serial ultrathin sections 
collected on Formvar coated copper grids. The sections were now 
ready for viewing with the electron microscope.
Electron Microscope
The sections prepared as described above were examined using a 
Phillips CM100 electron microscope with stage driver and goniometer 
attached to a frame grabber system to allow digital images to be 
viewed and captured by a linked PC and monitor. Also running on the 
PC was a package that permitted the X-Y coordinates of any point on 
a section to be recorded with reference to two user specified reference
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points. This could then be used to drive the stage remotely and 
relocate any field of interest in serial sections thus allowing one point 
to be followed through several ultrathin sections. Images were 
captured on an integral camera for printing at a later stage.
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C. The relationship of serotonin and noradrenaline to neurokinin-
1-immunoreactive dorsal horn neurons
Methods
Seven adult female Albino-Swiss rats were anaesthetised, perfused 
and dissected as has been described. Following a four hour 
postfixation period the fourth lumbar spinal cord blocks were sectioned 
in the parasagittal plane and those sections which included the 
substantia gelatinosa were selected for further processing. These 
sections were then incubated in 50% ethanol and blocked with 10% 
normal donkey serum as in the general methods. Following this the 
sections were transferred to the primary antibody solution containing 
rabbit anti-serotonin (1:200), mouse anti-D-pH (1:500) and guinea-pig 
anti-NK-1 (1:1000) for a two day incubation period. The sections were 
then rinsed and placed in secondary antibody solution containing 
fluorophore conjugated antibodies for a three-hour incubation. The 
sections were then rinsed, wet mounted with Vectashield and stored at 
-20°C until required.
Scanning and analysis
Immunoreactive profiles were first identified under direct 
epifluorescence with a X20 objective then scanned in their entirety 
within the vibratome section using a X40 oil immersion objective with 
an optical zoom of X I.5 as in the previous protocol. Relatively few 
lamina 11 I/IV NK-1-immunoreactive profiles are normally present within 
one vibratome section. Hence, to provide an adequate sample for 
analysis all lamina III/IV neurons that included the soma and dendrites 
within a vibratome section from each of the spinal cord sections 
available for analysis were scanned to permit suitable analysis to be 
performed. Each NK-1-immunoreactive cell was scanned in its entirety
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in overlapping optical fields and the resultant image files used to 
reconstruct the cell and associated contacts in 3D using the 
NeuroLucida software. The datafiles thus generated were then used to 
compare the distribution densities of the monoamine contacts on the 
NK-1-immunoreactive cells.
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1.16 Results
A. Monoamine immunoreactivity in the spinal cord
Using these experimental protocols the serotonin-immunoreactivity 
observed was consistent with previous reports for the rat spinal cord. 
Numerous serotonin-immunoreactive axons running in a rostrocaudal 
direction with multiple en-passant varicosities along their length were 
found within lamina I and outer lamina II. In the deeper laminae of the 
dorsal horn the serotonergic profiles were less frequent, particularly in 
inner lamina II, though immunoreactive profiles were still present. 
Occasional immunoreactive axons were seen to course out of the 
plexus in lamina l/ llo . through lamina ll| and into the region of lamina 
III/IV forming a distinct 'basket like' arrangement around presumed 
neuronal somata and proximal dendrites. This arrangement is 
illustrated in figure 1.2 which shows the serotonin-immunoreactivity in 
a parasagittal section of the rat mid-lumbar superficial dorsal horn. The 
dense band of immunoreactivity corresponding to the region of lamina 
l / l lo  can be appreciated with a representative 'basket-like' formation of 
serotonergic axons forming around a proximal dendrite and cell body 
of an unidentified neuron in lamina III. The highest density of 
immunoreactive profiles outside the dorsal horn was associated with 
the motor nuclei of the ventral horn and in the region of lamina X with 
sparse serotonin immunoreactivity in the intervening spinal grey. The 
penetration of the rabbit anti-serotonin antibody was such that the 
immunofluorescent signal was effectively uniform through the 
thickness of the section. However, with the rat anti-serotonin the 
penetration was less satisfactory with the immunofluorescent signal 
diminishing with increasing distance from the surface of the section 
beyond 10-15jum. Where possible therefore the rabbit anti-5-HT was 
used.
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The distribution of dopamine-p-hydroxylase-immunoreactive profiles 
corresponded to previous descriptions. The greatest density of 
labelling was observed in axons and terminals within the motor nuclei 
of the ventral horn. Dense D-pH-immunoreactivity was also present in 
laminae I/ll of the dorsal horn where immunoreactive axons running in 
a rostrocaudal direction were present, again showing multiple en- 
passant swellings. Relatively little D-pH-immunoreactivity was present 
in lamina III with intermediate levels in the deeper dorsal horn laminae 
IV/VI and lamina X. No serotonin or D-pH-immunoreactive somata 
were identified in any of the tissue sections examined during the 
course of these experiments.
B. The association of the monoamines with inhibitory dorsal horn 
neurons
Using antibodies produced specifically for use with formalin fixed 
material GABA- and glycine-immunoreactive profiles were revealed in 
a distribution corresponding to previous reports. A dense band of 
GABA-immunoreactivity was present in laminae l-lll of the dorsal horn 
consisting of both punctate staining, representing GABAergic axon 
terminals, and somatic labelling. Occasionally an extension of the 
immunoreactive label to the proximal few microns of a large dendrite 
was noted, however no detail on dendritic architecture beyond the first 
few micrometres could be derived. GABA-immunoreactive somata 
were found throughout the superficial dorsal horn with lowest 
frequency in lamina I and highest in lamina III.
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Glycine-immunoreactive profiles were similarly located in the 
superficial dorsal horn with both somatic and punctate labelling 
present. In general the density of labelling was less than in material 
prepared for GABA-immunoreactivity. This relatively low density of 
punctate labelling permitted somatic profiles to be more clearly 
identified. In a similar manner to GABA-immunoreactive somata, 
occasional immunoreactivity of the proximal dendrites was observed. 
As noted by previous investigators few glycinergic neurons were 
present in lamina I with the frequency of immunoreactive somata 
increasing in the deeper lamina, the highest density being observed in 
lamina III.
On no occasion was a basket like arrangement of serotonin- 
immunoreactive axons identified in relation to either GABA- or glycine- 
immunoreactive profiles. A total of 151 GABA-immunoreactive and 307 
glycine-immunoreactive neurons from lamina l-lll were examined for 
monoaminergic contacts from material prepared from three 
experimental animals (15 sections in total). Serotonin-immunoreactive 
profiles formed contacts with 24.5% (37 out of 151 neurons) of 
GABAergic and 27.7% (85 out of 307 neurons) of glycinergic somata 
within laminae l-lll (figure1.3). No differences were observed in the 
proportions of neurons in lamina II or III which received contacts from 
serotonin-immunoreactive terminals. Thus 25.6% and 24.2% of 
GABAergic neurons and 21.1% and 28.7% of glycinergic neurons in 
lamina II and III respectively were associated with serotonin contacts. 
Lamina I GABAergic and glycinergic neurons were too few to allow 
meaningful data to be derived.
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Figure 1.4A illustrates the association of serotonin-immunoreactive 
terminals to GABA- or Glycine-immunoreactive somata. In the majority 
of cases no contacts were present on either cell type. Where contacts 
were formed these were few in number (1 to 4 per cell) and not 
associated with a 'basket-like' arrangement of serotonin- 
immunoreactive terminals.
Noradrenergic axons formed contacts with few inhibitory neurons in 
the superficial dorsal horn. Thus D-pH-immunoreactive profiles were 
identified in relation to 13.2% (20 out of 151) GABAergic neurons and 
16.9% (52 out of 307) glycinergic neurons. This corresponded to 
10.9% of lamina II and 17.7% of lamina III GABAergic neurons 
receiving noradrenergic contacts and 14.9% of lamina II and 17.7% of 
lamina III glycinergic neurons. Figure 1.4B illustrates the frequency of 
association of monoaminergic contacts with GABA or glycinergic 
neurons.
C. The association of the monoamines with excitatory dorsal horn 
neurons
Neurons revealed with either neurotensin or somatostatin- 
immunoreactivity were observed in a distribution as previously 
described for these antibodies. Neurotensin labelled somata were 
present throughout the superficial dorsal horn in laminae l-lll with 
processes predominantly localised to the marginal zone. Somatostatin- 
immunoreactive somata were noted in lamina II with immunoreactive 
varicosities present in this lamina and in lamina I.
Serotonin-immunoreactive profiles contacted 42.6% (49 out of 115) of 
neurotensin-immunoreactive somata and 39.4% (87 out of 221) of
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somatostatin-immunoreactive neurons (figure 1.3). The proportion of 
lamina III neurotensin-immunoreactive neurons which received 
serotonergic contacts was greater than for neurons in lamina II (53.7% 
and 32.8% respectively). As with the GABA- and glycine- 
immunoreactive neurons no 'basket like' arrangement of serotonergic 
profiles was observed in association with somatostatin- or neurotensin- 
immunoreactive neurons. Figure 1.4A illustrates the association of the 
monoaminergic contacts with neurotensin and somatostatin- 
immunoreactive somata. As was noted for the inhibitory neurons 
where contacts were observed these were few in number for both 
neurotensin (1 to 4 contacts per cell) and somatostatin (1 to 3 contacts 
per cell) neurons.
As was observed with the inhibitory neurons few D-pH-immunoreactive 
terminals were found in association with either the neurotensin- or 
somatostatin-immunoreactive somata: 18.2% and 8.6% of cells 
respectively were identified as receiving contacts. The frequency of 
noradrenergic contacts on these neurons is illustrated in figurel 4B.
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D. The association of the monoamines with somatic and dendritic 
profiles of selected dorsal horn neurons
Though the antibodies used in the previous experiments revealed 
large numbers of somatic profiles, the distribution of immunoreactivity 
revealed little of the associated dendritic architecture. It is of value in 
understanding the relationships of the monoamines to dorsal horn cells 
to identify not only somatic profiles but also any associated dendritic 
arbor. As discussed this pattern of immunoreactivity has been 
observed with antibodies to choline acetyltransferase (ChAT), nitric 
oxide synthase (NOS) and the |Li-opioid receptor (M0R1 ). The 
association of these neurons with GABA has also been investigated 
with ChAT and NOS cells co-localising GABA and therefore presumed 
inhibitory. M0R1 cells do not contain GABA and are presumed 
excitatory. Each of the neuronal subtypes revealed with these 
antibodies have a dendritic architecture that is orientated in a 
predominantly rostrocaudal direction. Hence in a parasagittal section 
of the dorsal horn the maximum extent of the neuron can be 
examined. In total 13 (4,4,5) ChAT cells, 12 (6,3,3) MORI cell, 8 
(3,3,2) lamina I, 10 (3,3,4) lamina II and 10 (3,3,4) lamina III NOS 
cells were examined from three experimental animals (figures in 
brackets- number of cells from each animal).
Choline acetyltransferase-immunoreactive profiles were observed in a 
distribution that corresponded to the descriptions in previous published 
work. Immunoreactive somata were located in the dorsal horn in 
lamina III, IV and V with dendrites orientated in a predominantly 
rostrocaudal direction often emerging form a cell body with a long axis 
running dorsoventral. Punctate staining, representing cholinergic axon 
terminals, was also observed throughout the superficial dorsal horn
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with a particularly dense plexus spanning the border of inner lamina II 
with lamina III. This distribution is illustrated in the montage 
reconstruction of a ChAT-immunoreactive neuron in figure 1.5B. These 
neurons, located in lamina III, were of moderate size (mean diameter 
14|uim, range 8-20pm) with dendrites which could be traced to some 
distance from the cell body in a single vibratome section. Frequently 
medium to small diameter ChAT-immunoreactive dendrites appeared 
to orientate such as to enter the dense ChAT-immunoreactive plexus. 
On occasion neurons were noted where a dendrite initially coursed in 
a ventral direction deeper Into the dorsal horn before turning back on 
itself to terminate in the region of this plexus.
Nitric oxide synthase-immunoreactive profiles were present throughout 
the superficial dorsal horn with a plexus of terminals in the region of 
lamina II and somata of moderate size (mean diameter Mpm, range 4 
to 20pm) located in lamina I, II and III. From these, dendrites running 
in a rostrocaudal direction were observed that remained within their 
lamina of origin with occasional extension to neighbouring laminae 
(figure 1.7). Immunoreactivity for the p-opioid receptor was observed 
predominantly in a region corresponding to laminae I and II with small 
sized MOR1 somata (mean 8pm diameter, range 6 to 12pm) localised 
to a region in the inner part of lamina II at the boundary with lamina III 
Occasional somata were also noted in lamina III. From these somata 
dendrites radiated in a rostrocaudal orientation that frequently divided 
to generate branches which ran back towards the cell body. Typically 
the dendrites observed had many dendritic spines and remained within 
the band of MORI-immunoreactivity in inner lamina II. On one 
occasion, an immunoreactive axon was observed emerging from the
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somata which could be followed to some distance form the cell body 
into lamina III (figurel.9).
On no occasion in examining the relationship of the monoamines to 
ChAT- (figure 1.6), NOS- (figure 1.8) or MORI-immunoreactive 
somata (figure 1,10) and their associated dendrites was a 'basket-like' 
arrangement of serotonin-immunoreactive identified in association with 
these cells. However, occasional monoamine contacts were present 
distributed in a seemingly sporadic manner on these cells. The number 
of serotonin-immunoreactive contacts identified ranged from 4 to 33 
per ChAT cell (mean packing density 0.37 contacts/100 pm^), 2 to 12 
per MORI (mean packing density 0.42 contacts/100 pm^  ^ cell and 0 to 
23 per NOS cell (mean packing density 0.3 contacts/100 pm^). Little 
variation in the frequency of these contacts along the length of 
dendritic tree was observed (figure 1.11 A). Thus, though 5-HT- 
immunoreactive profiles were associated with ChAT-, MORI- and 
NOS-immunoreactive cells, they were few in number and did not 
display a 'basket-like' concentration around somata and proximal 
dendrites. There was no significant difference in the frequency of 
serotonin contacts observed on each of these cells (figure 1.19).
Noradrenergic axons formed few contacts on each of the cells 
observed (0-3 contacts per ChAT cell, 0-3 contacts per MORI cell and
0-11 contacts per NOS cell). As observed for the serotonin contacts on 
these cells the contacts appeared to be sporadic with no discernable 
pattern of distribution (figure 1.11B).
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E. Ultrastructural relationship of serotonin-immunoreactive 
profiles with inhibitory dorsal horn neurons.
Within the material prepared GABA-immunoreactive somata and 
medium to large sized dendrites were easily distinguishable by a 
heavier accumulation of silver intensified gold particles within their 
substance than the background gold particle density. Despite 
extensive observations of 15 GABA-immunoreactive somata in 
material prepared from three separate experimental animals, few 
serotonin-immunoreactive profiles were identified in close proximity to 
immunoreactive somata. On no occasion did the monoamine terminal 
form a synaptic relationship with the GABA-immunoreactive cell body. 
In each case the identified terminal was followed through consecutive 
ultrathin sections through the entire extent of the varicosity. In three 
instances though the varicosity lay in close proximity to the somatic 
membrane, an extension of the membrane of a surrounding glial cell 
intervened between the terminal and the cell body (figure 1.12).
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F. The association of the monoamines with Neurokinin-1- 
immunoreactive neurons in the dorsal horn
Immunoreactivity for the NK-1 receptor in these studies corresponded 
to previous descriptions. Frequent, relatively large immunoreactive 
neurons (mean 18pm diameter, range 8-24 pm) were present in 
lamina I. Typically these neurons had dendrites which radiated in an 
approximately rostrocaudal direction for some distance within lamina I 
(figure 1.16). Occasionally these lamina I cells were noted to have 
dendrites that, following a short rostrocaudal course, descended into 
the region of lamina II. In addition to these superficial cells, a 
significant number of cells were noted in the deeper dorsal horn in the 
region of lamina III/IV. As with the lamina I NK-1-immunoreactive 
neurons these were of large diameter (mean 20pm diameter, range 12 
to 30pm) however the dendrites of these neurons were typically 
orientated in a dorsoventral manner with a small number of large 
diameter dendrites projecting into laminae I and II (figure 1.13). 
Occasional cells with a dendrite which initially followed a rostrocaudal 
orientation were noted however in the sections where these dendrites 
could be followed to their termination they were found ultimately to turn 
dorsally and terminate in the more superficial laminae.
Laminae III/IV NK-1 neurons and the monoamines.
Parasagittal sections from seven experimental animals were analysed 
yielding a total of 33 NK-1-immunoreactive somata located in laminae 
III/IV with dendrites which could be followed into the superficial dorsal 
horn laminae. In all cases monoamine contacts were identified in 
association with these cells. The total number of serotonergic contacts 
ranged from 9 to 165 contacts per cell (mean packing density 0.63
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contacts per 100pm^) with between 1-36 D-pH contacts present per 
cell (mean packing density 0.12 contactslOOpm^). The frequency of 
these contacts is illustrated in figure 1.17A where the numbers of 
contacts per 100pm length of dendrite are plotted at increasing 
distances form the soma. As illustrated there is a tendency for 5-HT 
contacts to cluster around the proximal dendrites of these neurons 
whereas the NA contacts were relatively sparse and sporadically 
distributed across the dendritic tree.
Observation of these cells by direct epifluorescence and in merged 
series of confocal images revealed two distinct populations of NK-1- 
immunoreactive lamina III/IV neurons based on their association with 
serotonin-immunoreactive axons and terminals. In the first group of 
cells serotonergic axons and terminals are intimately woven around 
the proximal dendrites and somata of NK-1-immunoreactive neurons 
producing the 'basket like' distribution of serotonin-immunoreactive 
profiles as observed in dorsal horn sections prepared for serotonin- 
immunoreactivity. Figure 1.13A illustrates this arrangement for an NK-
1-immunoreactive cell from lamina III. The second population of cells 
were not associated with this 'basket like' arrangement of serotonergic 
axons though they did receive sporadic contacts from 5-HT- 
immunoreactive terminals (figure 1.13B). Of the 33 cells analysed, 16 
were associated with a 'basket-like' arrangement of serotonergic 
axons, 17 were not. The adjacent cells illustrated in figure 1.13, which 
were reconstructed using the NeuroLucida program, demonstrate each 
of these patterns of distribution. These cells were present within the 
same tissue section at a similar depth in the tissue, hence the 
observed difference in distribution is not a result of a difference in 
immunostaining or antibody penetration.
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Since two patterns of association of serotonergic axons with lamina 
III/IV NK-1 cells were observed, it was of interest to identify whether 
this correlates with any difference in contact frequency. This was 
achieved by comparing serotonin contact frequencies at increasing 
distances form the cell body in the two populations of cells. This 
analysis revealed that the basket associated group received a 
significantly greater frequency of 5-HT contacts on proximal dendrites 
(defined as those within a 100pm radius of the soma) than cells not 
associated with a basket arrangement of serotonergic axons (mean 
number of contacts per lOOpm+SD = 13+5.8 and 5+2.9, respectively: 
p<0.001, Mann-Whitney U-test). At distances greater than 100pm from 
the cell body there is no significant difference in the frequency of 
contacts between the two cell groups (figure 1.15B).
Lamina I NK-1 neurons and the monoamines.
Twelve lamina I NK-1-immunoreactive neurons from 4 experimental 
animals were analysed. As with the lamina III/IV neurons all were 
associated with serotonin contacts ranging from 8 to 174 contacts 
(mean packing density 0.6 contacts per lOOpm^). Dopamine-p- 
hydroxylase contacts were however uncommon with only 0 to 12 
contacts per cell (figurel. 16). As noted for the deeper dorsal horn NK- 
1 neurons the 5-HT-immunoreactive contacts tended to be clustered 
around the proximal dendrites whilst the D-pH contacts were 
sporadically distributed across the dendritic profile (figure 1.18). Unlike 
the cells of lamina III/IV the lamina I NK-1-immunoreactive cells did not 
display any clear morphological division in respect to the arrangement 
of serotonergic axons around the soma and proximal dendrites with no 
'basket like' associations seen. Occasional serotonergic axons were
89
noted which ran parallel to NK-1 somata or dendrites for a distance 
forming several en-passant contacts (figure 1.17). However, where 
these were present they did not correlate with any significant 
difference in contact frequency on these cells as compared to those 
lamina I cells which did not have a serotonin axon running in parallel.
Comparison of serotonin contact frequencies on different types 
of dorsal horn cells.
From the above data lamina III/IV neurokinin-1 receptor 
immunoreactive neurons are associated with two different distributions 
of serotonin axons on proximal dendrites which correlates with a 
difference in the frequency of contacts that can be identified on the 
proximal dendrites of these profiles. Furthermore, in both the lamina I 
and lamina III/IV populations of NK-1-immunoreactive neurons there is 
a tendency for serotonin contacts to cluster around the proximal 
dendrites which was not observed in the studies of ChAT-, NOS- or 
MORI-immunoreactive neurons. In figure 1.19 the serotonin contact 
densities are plotted for the lamina III/IV neurons (basket and non­
basket cells), ChAT neurons, MORI neurons and lamina III NOS 
neurons. This demonstrates the higher frequency of 5-HT contacts 
associated with the proximal dendrite (within a 100pm radius of the 
soma) on these NK-1 neurons with respect to the other populations of 
cells examined. This is true even for the non-basket NK-1 neurons 
where on the proximal 100pm the mean number of contacts was 5+2.9 
compared to 1.9+1.3 on ChAT neurons, 1.8+1 on MORI neurons or 
2+1.5 on lamina III NOS neurons (p<0.01 in all cases; mean number of 
contacts + SD; Mann-Whitney U-test). A similar clustering of serotonin 
contacts around the proximal dendrites of lamina I NK-1 neurons was 
noted. The frequency of contacts on these proximal dendrites was
90
significantly greater than on lamina I NOS cells (8+5.8 and 1.2+1.3 
contacts per 100pm respectively in the first 100 pm). Thus, uniquely 
for the cells examined in this study, the NK-1 receptor-immunoreactive 
neurons in the dorsal horn are associated with greater numbers of 
serotonergic contacts on proximal dendrites than any other neuron 
examined. For all cells studied the frequency of D-pH contacts was 
relatively low.
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Figure 1.2. Serotonin immunoreactivity in the superficial dorsal horn of the rat 
lumbar spinal cord. This projected image composed of 21 single images in the z- 
plane taken at 1pm intervals demonstrates the distribution of serotonin- 
immunoreactive profiles in the superficial dorsal horn. A dense band of 
immunoreactivity corresponding to rostrocaudally orientated axons and associated 
terminals in the lamina l / l lo region is present with a lower density of profiles in the 
deeper lamina. In addition to the rostrocaudal axons a 'basket-like' formation of 
serotonin-immunoreactive axons is present formed by axons extending out of the 
lamina II region and encircling an unidentified cell body and it's associated 
proximal dendrite within lamina Ml (scale bar 50pm).
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Figure 1.3. A proportion of each of the four dorsal horn cell types examined in 
transverse sections received somatic contacts from monoaminergic terminals. This 
series of confocal images, created from single optical sections, illustrates 
examples of serotonergic contacts observed in relation to these cells 
(arrowheads). Noradrenergic contacts (asterisk) were infrequent (green - 
neurotransmitter; red - 5-HT; blue - D-(5H; scale bar 10pm).
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Figure 1.4. Serotonin contacts were identified on a proportion of all cell types 
examined (A). Few lamina I GABA or Gly neurons were encountered hence the 
interpretation of the data for this lamina is limited. In lamina II examples of all three 
cell types were encountered with a similar proportion of cells for each subtype 
associated with serotonergic contacts. In lamina III a greater proportion of 
neurotensin than GABA or glycine neurons received 5-HT contacts. For all cell 
types examined the frequency of contacts from D-pH-immunoreactive terminals 
was low (B).
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Figure 1.5. Choline acetyltransferase neurons were found within the lamina III 
region with dendrites which coursed in an approximately rostrocaudal direction 
Occasional cells were observed where a dendrite which initially followed a ventral 
course deeper into the dorsal horn before turning back on itself to enter the region 
of the plexus of ChAT-immunoreactive terminals spanning the lamina ll/lll border.. 
Using the individual images for each field of view and with the aid of the 
NeuroLucida package these cells were traced and monoamine contacts plotted on 
the resultant image. An example of this technique is illustrated in image A for the 
cell in the montage image B. As can be appreciated, though monoamine contacts 
are present these are few and distributed across the entire dendritic profile (circles 
- 5-HT contacts; triangles D-pH contacts; scale bar 50pm).
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Figure 1.6. At a higher magnification the relationship of the monoamine terminals 
to the ChAT-immunoreactive neurons can be appreciated. As can be seen from 
the merged series of several images through the cell body (A), no basket-like 
clustering of 5-HT terminals around the soma and proximal dendrites is observed. 
This is confirmed by examining each of the colour channels individually where no 
clear association between 5-HT (C) or D-pH (D) terminals and the ChAT profile 
exists. Plates E and F show single merged optical images through the soma and a 
proximal dendrite. Two serotonergic contacts are present on the dendrite in F 
(arrowheads; scale bar 10pm).
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Figure 1.7. NOS-immunoreactive neurons were identified throughout lamina l-lll 
with a plexus of terminals in the region of lamina II as shown in the montage image 
of two cells located in lamina II (B). Typically, these neurons had dendrites which 
were orientated in a rostrocaudal direction. Tracing the cells and plotting 
monoamine contacts on this outline demonstrates the relative paucity of contacts 
associated with these cells (A; circles - 5-HT contacts; triangles - D-pH contacts; 
scale bar 50pm).
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Figure 1.8. In this series of higher magnification, projected images of the cell in 
figure 1.7 no clear association between NOS- (B), 5-HT- (C) or D-pH- 
immunoreactive (D) profiles can be identified. This is confirmed in the single 
optical sections through the cell body (E) and proximal dendrite (F) where a single 
5-HT contact is present on the proximal dendrite (arrowhead; scale bar 10pm).
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Figure 1.9. Montage reconstruction of a typical M0R1-immunoreactive neuron 
located at the margin of lamina ll/lll (B). As is common in MOR1-immunoreactive 
neurons in the dorsal horn dendrites were orientated in a rostrocaudal direction 
and had numerous dendritic spines. Recurrent dendritic branches were also 
commonly noted. In addition, the cell illustrated here displays another common 
feature of MORI-immunoreactivity with axonal labelling evident (arrow). As with 
the ChAT- and NOS-immunoreactive neurons sparse monoamine contacts were 
scattered across the dendritic profile (A; circles - 5-HT; triangles - D-pH; scale bar 
50pm).
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Figure 1.10. This series of projected confocal images through the M0R1 cell in 
figure 1.09 illustrates the relationship of the monoamines to MORI cells (A,B,C,D). 
No basket like formation of serotonergic axons with these neurons was identified 
though occasional monoamine contacts were present distributed in a sporadic 
manner across the dendritic profile. One such 5-HT contact is illustrated in the 
single merged optical section in image F (arrowhead). A feature of M0R1- 
immunoreactivity in the dorsal horn is the appearance of axonal staining in some 
cells (E; arrow - axon; scale bar 10pm).
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Figure 1.11. Shell analysis of the distribution of serotonin (5-HT; A) and 
noradrenaline (D-(3H; B) contacts on ChAT-, NOS- and MOR1-immunoreactive 
neurons. Contact frequencies are expressed per 100|im length of dendrite within 
concentric shells of increasing radii in 25pm steps, centred on the cell body. The 
mean 5-HT contact frequencies for the three cell types were similar across the 
dendritic profile with few contacts present showing no clear pattern of distribution 
(A). Noradrenergic contacts were uniformly infrequent in each of the cells 
examined and as with 5-HT showed no particular distribution pattern (B).
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Figure 1.12. In the ultrastructural observations on the association of serotnin- 
immunoreactive profiles with GABAergic somata, no synaptic contacts were 
observed. However, on several occasions DAB labelled serotonergic boutons 
(arrow) were encounterd which formed close associations with immunogold 
labelled GABAergic somata as illustrated above. In each case a glial process was 
identified interposed between the bouton and somatic membranes (scale bar 
0.5pm).
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Figure 1.13. Reconstructions and images of two NK-1-immunoreactive cells with 
cell bodies in lamina IV (A and B) which lie adjacent to each other in the same 
spinal cord section. The upper images show the 5-HT contacts associated with 
these cells plotted on outlines created using the NeuroLucida package. Cell A was 
associated with a basket-like arrangement of 5-HT-immunoreactive axons and 
terminals whereas cell B was not. Note the very large numbers of contacts 
associated with the dorsally directed proximal dendrite and the soma of cell A. The 
lower image shows a montage image of these two cells created from series of 
projected confocal images from multiple overlapping fields (scale bar 50pm).
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Figure 1.14. (A-D) A series of projected confocal microscope images through the 
soma and proximal dendrite of an NK-1-immunoreactive neuron located in lamina 
III showing the presence of a basket-like arrangement of 5-HT axons around the 
soma and proximal dendrite (A and C). Noradrenergic axons do not appear to form 
any particular pattern of association (D). Examining these associations in three- 
colour, merged images in single optical sections (E and F; images from cell A 
figure 1.13) this relationship is found to correspond to a high frequency of 
serotonergic contacts on the proximal dendrite and soma of these cells 
(arrowheads). A single noradrenergic contact is present on the proximal dendrite 
(asterisk: green - NK-1, red - 5-HT, blue - D-pH; scale bar A-D 25pm; scale bar E 
& F 10pm).
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Figure 1.15. Sholl analysis of the distribution of serotonergic (5-HT) and 
noradrenergic (D-pH) contacts on lamina lll/IV NK-1-immunoreactive cells. In each 
case the data presented is for mean contact frequencies expressed per 100pm 
unit lengths of dendrite within shells with radii increasing in 25pm increments 
centred on the soma. Serotonergic contacts on these cells were more frequently 
identified than noradrenergic contacts which were sparse. Furthermore, 
serotonergic contacts tended to be concentrated around the proximal dendrites 
whilst noradrenergic contacts were evenly distributed (A). Serotonergic axons 
were noted to form basket-like arrangements around the proximal dendrite and cell 
body of 16 out of the 33 cells examined. When the serotonin contacts on these two 
groups of cells was compared (B) a significantly greater frequency of 5-HT 
contacts was identified on the proximal dendrites of the basket-associated group 
(basket cells) than the cells not associated with baskets (non-basket cells). At 
distances greater than 100pm from the cell body there was no significant 
difference between the two groups (*p<0.0001; # - not significant; Mann-Whitney 
U-test).
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Figure 1.16. Reconstruction (A) and images (B) of an NK-1-immunoreactive 
neuron located in lamina I. Typically these cells had dendrites orientated in a 
rostrocaudal direction and were associated with frequent 5-HT contacts (circles). 
Few noradrenergic contacts were observed on these cells (triangles; scale bar 
50pm).
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Figure 1.17. Higher magnification images of the fields illustrated in figure 1.16 A & 
B. Though serotonin contacts are frequent on the lamina I NK-1 neurons, they do 
not form the 'basket-like' arrangements as identified on a proportion of the deeper 
NK-1 neurons (A, C). As is indicated in the single optical section in image E the 5- 
HT axons, orientated in the same rostrocaudal plane as the NK-1 neurons, formed 
en-passant contacts with the NK-1 cell bodies and proximal dendrites 
(arrowheads). Noradrenergic contacts were, as in the other cell subtypes 
examined, infrequent (F; arrow - D-pH contact; scale bar 10pm).
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Figure 1.18. Serotonin-immunoreactive profiles formed relatively frequent contacts 
with lamina I NK-1-immunoreactive neurons when compared to noradrenergic 
profiles. In addition 5-HT contacts were more commonly associated with the 
proximal dendrites of these cells with the frequency of contact decreasing with 
increasing distance from the cell body.
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Figure 1.19. Neurokinin-1-immunoreactive neurons appear unique amongst the 
subtypes of neurons examined in receiving a relatively high frequency of 
serotonergic contacts when compared to non-NK-1 dorsal horn cells. Thus the 
lamina lll/IV NK-1 neurons had a significantly greater serotonin contact density 
than the ChAT, MORI and lamina III NOS neurons (NOS III) which were 
examined in this study (+ = p<0.001; Mann-Whitney U-test). Similarly the lamina I 
NK-1 neurons received greater frequencies of 5-HT contacts than the lamina I 
NOS neurons (NOS I; x = p<0.001; Mann-Whitney U-test). There was no 
significant difference in contact frequencies between the lamina I NK-1 neurons 
and lamina lll/IV NK-1 neurons.
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1.17 Discussion 
Methodoiogicai considerations
For each of the antibodies employed in this study the antibody staining 
and distribution conformed to previous descriptions. In particular the 
antibodies to GABA and glycine produced specifically for use in 
formalin fixed material (Row, Wright & Vaney, 1995) provided a 
staining pattern that corresponded to that reported in previous studies 
(Todd & Sullivan, 1990). The resolution afforded by the confocal 
microscope permitted highly detailed analysis of the association 
between monoamine terminals and dorsal horn neurons and, when 
combined with the NeuroLucida package, the analysis could be 
extended to provide a full 3-dimensional analysis of the relationships of 
the profiles within the vibratome sections. The combination of confocal 
microscopy with 3-dimensional reconstruction and analysis used in this 
study is one that has not previously been applied to the investigation of 
dorsal horn neuronal circuitry. Clearly the ability to relate profiles in 3- 
planes and analyse this relationship with minimal difficulty adds to the 
data that can be generated and conclusions that can be drawn from a 
single investigation. Previous investigations have been limited by the 
resolution of light (Miletic et al, 1984) and fluorescence microscopy 
(Miller & Salvatiera, 1998) or a small sample of neurons identified on 
morphological features rather than immunocytochemical features 
(Marlier et al, 1991). Furthermore, the ability to generate datasets 
including volume and surface area of selected profiles extends the 
potential for analysis.
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Distribution of monoamine contacts in the dorsal horn
The principal finding of this study is that the descending serotonergic 
system preferentially forms large numbers of contacts with neurokinin- 
1 receptor immunoreactive neurons in lamina I and laminae lll/IV of 
the spinal dorsal horn. Furthermore, within this population of cells 
there is a subpopulation (approximately 50%) of the NK-1 receptor- 
immunoreactive neurons in lamina lll/IV which receive large numbers 
of contacts from 5-HT axons. This large number of contacts has been 
shown to correlate with serotonergic axons clustered around the 
somata and proximal dendrites of these NK-1 cells. In contrast 5-HT 
terminals formed few contacts with either excitatory (neurotensin, 
somatostatin, |i-opioid receptor) or inhibitory (y-aminobutyric acid, 
glycine, choline acetyltransferase, nitric oxide synthase) dorsal horn 
local circuit cells. Noradrenergic terminals were few in number and 
distributed evenly along the dendritic tree for all cell types examined. 
These observations suggest that the serotonergic system in the dorsal 
horn preferentially targets a subpopulation of neurons which almost all 
project to supraspinal regions associated with nociceptive processing 
(Yu et al, 1999; Todd, McGill & Shehab, 2000).
Previous investigations have recorded serotonergic contacts 
associated with neurons in the cat dorsal horn of a similar frequency to 
the non-NK-1 neurons in the present investigation (Nishikawa et al, 
1983; Miletic et al, 1984). Similarly, serotonergic contacts have been 
more frequently observed in association with dendritic than somatic 
profiles (Ruda et al, 1982; Light et al, 1983; Maxwell, Leranth & 
Verhofstad, 1983; Hylden et al, 1986; Marlier et al, 1991). Attempts to 
further characterise the targets for these serotonergic terminals either 
by morphological characteristics or immunocytochemical profiles have
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identified both inhibitory and excitatory neurons receiving contacts 
from serotonergic terminals (Glazer & Basbaum, 1976; Miletic et al, 
1984; Miller & Salvatiera, 1998) with some suggestion that there is a 
preferential innervation of inhibitory neurons (Militec et al, 1984). 
Whilst confirming that a proportion of excitatory and inhibitory local 
circuit cells receive serotonergic contacts this study has failed to 
identify a preferential innervation of inhibitory dorsal horn cells. Indeed, 
the reverse appears the case for somatic contacts where a greater 
proportion of excitatory neurons received somatic serotonin contacts 
than was the case for inhibitory neurons. In the work of Militec et al 
(1984) examining dorsal horn neurons in lamina I and II far greater 
numbers of serotonergic contacts per cell in each of the subtypes they 
studied were identified. This may arise due to the greater spatial 
resolution afforded by confocal microscopy when compared to light 
microscopy for identifying appositions. Hence, the higher absolute 
numbers of contacts observed in their study may have arisen as a 
result of an overestimate of the number of appositions. In addition, the 
neurons analysed in this study were identified as specific 
subpopulations based on their immunoreactivity. Militec and co­
workers examined neurons based on their morphology. This study has 
shown that serotonergic terminals have the capacity to preferentially 
target subpopulations of cells within the dorsal horn. Thus in the small 
sample of neurons studied in the previous work a number of different 
neurons may have been included in each population so influencing the 
data. It would seem unlikely this could have such a significant effect as 
to produce such a high number of contacts as they observed however 
as in the corresponding laminae and neurons in this study contact 
numbers of the range they report were only found in relation to the NK- 
1 neurons.
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In the ultrastructural observations in this study, no synaptic contacts 
were identified between serotonergic terminals and the somata of 
inhibitory neurons revealed by GABA-immunoreactivity, though 
occasional close appositions were noted. Previous ultrastructural 
observations on serotonergic profiles in the dorsal horn have recorded 
few or no axosomatic synaptic associations in the superficial dorsal 
horn (Ruda & Gobel, 1980; Ruda, Coffield & Steinbusch, 1982; Light, 
KavooKjian & Petrusz, 1983; Maxwell, Leranth & Verhofstad, 1983). 
Thus, the failure to identify synapses formed by serotonergic terminals 
on GABA-immunoreactive somata is in keeping with previous studies 
and suggests at least some of the few contacts observed with confocal 
microscopy may be non-synaptic.
Serotonergic contacts on projection tract neurons have also previously 
been described (see introduction for references), though no attempt 
had been made to identify the receptor characteristics of these 
neurons. In the present work the observation of a distinct population of 
neurons with a significantly higher frequency of serotonin contacts 
than any of the other neurons examined is one which had previously 
only been described with lamina I projection neurons (Hylden et al, 
1995). In the present study the neurons of lamina I and Lamina lll/IV 
which possess the substance P receptor neurokinin-1 have been 
shown to receive a greater frequency of serotonergic contacts than 
any of the other cell types examined in this study. Furthermore, 
approximately 50% of the lamina lll/IV neurokinin-1 receptor- 
immunoreactive neurons were associated with clusters of serotonergic 
axons around their somata and proximal dendrites. This observation 
corresponded to a higher frequency of serotonergic contacts on these 
cells than those without this clustering. The arrangement of
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serotonergic axons clustering around neuronal profiles observed here 
has not previously been described for serotonin in the dorsal horn. A 
distinction between two populations of cells based on the number of 
serotonergic contacts each receives has previously been made in the 
cat by Hylden et al (1986) who described two populations of lamina I 
projection neurons in this way. In the present study no clear separation 
of lamina I NK-1 receptor neurons could be made. It is conceivable 
that the NK-1 cells examined in this investigation could correspond to 
the more densely innervated population described in the cat by Hylden 
and co-workers. However, in this study cells were observed with 
contact numbers from 8 to 174 per cell. It is likely then that if a 
distinction between sparsely and densely innervated neurons exists in 
lamina I of the rat dorsal horn, NK-1 neurons would be included in both 
groups. Alternatively in the rat a clear distinction between groups of 
neurons based on their serotonin innervation may not exist within 
lamina I.
The observation of a distinct configuration of serotonergic axons in this 
investigation which formed 'basket-like' structures around proximal 
dendrites and somata of cells in the region of lamina lll/IV led to the 
investigation of which cells may be associated with such a distribution 
of axons and whether this corresponded to a higher frequency of 
serotonergic contacts. Given the location of these profiles and their 
outline traced by the serotonergic axons the population of neurons 
which most closely resembled this description were the lamina lll/IV 
neurokinin-1 receptor-immunoreactive neurons described by Todd and 
co-workers (see Naim et al, 1997). This hypothesis has been 
confirmed in the present study where two populations of lamina lll/IV 
cells immunoreactive for the NK-1 receptor have been identified based
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on their relationship to serotonergic axons and a correspondingly 
higher frequency of serotonergic contacts. This division would appear 
to be valid as examples of both types of neuron were present in 
material from each of the animals perfused and could be identified 
within the same section. Hence it is unlikely this observation resulted 
from an artefact of processing. Todd & colleagues (2000) have shown 
that almost all of the neurokinin-1 cells in lamina lll/IV of the rat dorsal 
horn project to brainstem centres involved in nociceptive processing. 
The densely innervated NK-1 cells identified in this investigation are 
therefore likely to represent a subgroup of projection neurons. 
Previous investigations into the relationship of serotonergic terminals 
to projection neurons have observed a wide range of contact 
frequencies on labelled cells (Nishikawa et al, 1983; Hylden et al, 
1986; Jankowska et al, 1995). These investigations did not however 
identify any subgrouping of the projection cells based on frequency of 
serotonergic contacts. This may suggest that the current observation is 
of a unique population of cells in the dorsal horn laminae lll/IV which 
are NK-1 receptor-immunoreactive and receive a dense serotonergic 
innervation. Alternatively, the previous investigations may have 
included examples of these cells though their presence would have 
been obscured in the mixed sample of neurons examined in these 
papers. By selecting a relatively large population of cells and focussing 
on one specific receptor subtype in the present study the distinction 
between the two populations could be appreciated.
A common feature of all cells examined in this study was the relative 
paucity of noradrenergic contacts and their sporadic distribution across 
the immunoreactive profiles with both somatic and dendritic contacts 
observed. In no case was a population of cells identified where the
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frequency of noradrenergic contacts appeared higher than in 
comparable neurons. For all the cell types examined the total number 
of noradrenergic contacts ranged from 0 to a maximum of 36. This 
observation is consistent with previous studies on the noradrenergic 
innervation of the dorsal horn where few contacts on dorsal horn cells 
have been described (Doyle & Maxwell, 1993). The present estimate is 
likely to be a reasonable representation of the distribution of 
noradrenergic terminals in the dorsal horn. Ultrastructural observations 
have previously identified noradrenergic synapses to be commonest 
on medium sized dendrites (described as 0.5-2|um diameter) though 
also present on large and small dendrites (Doyle & Maxwell, 1991). In 
the current study dendrites of this diameter were included in the 
analysis hence significant numbers of noradrenergic contacts should 
not have been omitted. A higher frequency of contacts on these 
medium sized neurons was not observed in this case. This may reflect 
the possibility that the present study cannot differentiate between close 
appositions and synaptic contacts. Hence, an overestimate of the 
number of contacts on large and small sized dendrites is conceivable. 
In the work of Doyle & Maxwell the number of contacts were based on 
true synaptic contacts.
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Functional considerations
Clearly from the present data it can be seen that neither the 
serotonergic nor noradrenergic systems form large numbers of 
contacts with dorsal horn local circuit neurons. However, neurons in 
lamina I and lamina lll/IV immunoreactive for the neurokinin-1 
receptor, almost all of which are projection tract neurons, in contrast 
do receive relatively large numbers of serotonergic contacts. Thus, the 
descending serotonergic system would appear to selectively target 
projection tract neurons in the dorsal horn. As has been discussed, the 
descending monoaminergic systems have a selective role in 
antinociception at the level of the dorsal horn thus the findings of the 
present study must be interpreted in light of this action and the 
previous investigations of the monoaminergic pathways.
Monoamines and intrinsic dorsal horn cells
In the modulation of nociceptive information within the superficial 
dorsal horn one of the many possible theoretical circuits requires the 
monoamines to act via local dorsal horn neurons which in turn may 
operate either pre- or post-synaptically to mediate inhibition. Contacts 
between monoaminergic terminals and dorsal horn local circuit 
neurons have previously been described (Glazer & Basbaum, 1976; 
Hoffert et al, 1983; Miletic et al, 1984; Miller & Salvatierra, 1998). In 
this investigation examining the somatic and dendritic profiles of a 
wide variety of inhibitory and excitatory dorsal horn neurons, 
monoamine contacts were found to be relatively infrequent and 
distributed across the entire immunoreactive profile. At first inspection 
this may imply a minimal influence of monoaminergic terminals on 
these neurons. Contradicting this assertion however is the substantial 
evidence form behavioural and electrophysiological studies to suggest
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that the monoaminergic systems, at least in part, produce their 
antinociceptive action via alternative neurotransmitters which are 
located in the neurons of the dorsal horn. For example, in the 
response of the dorsal horn to serotonin or its agonists there is 
evidence of an involvement of a variety of transmitters located within 
neurons of the dorsal horn. The inhibitory neurotransmitters GABA and 
glycine have both been demonstrated to produce an antinociceptive 
action at the level of the dorsal horn (Willcockson et al, 1984) which 
can be blocked by selective antagonist agents. Administration of 
selective GABA antagonists can also produce a partial inhibition of the 
of the antinociceptive effects of brainstem stimulation (Lin, Peng & 
Willis, 1994) as well as a partial inhibition of the antinociceptive 
responses to 5-HT (Yang et al, 1998) or a specific 5-HT3 receptor 
agonist (Alhaider, Lei & Wilcox, 1991). In addition, serotonergic 
contacts have previously been reported on enkephalin containing 
neurons which in the dorsal horn are thought to represent a 
subpopulation of GABAergic neurons (Glazer & Basbaum, 1976; Miller 
& Salvatierra, 1998). In turn dorsal horn neurons utilising GABA as a 
transmitter have been demonstrated to form axo-axonic synapses on 
unmyelinated primary afferent terminals (Todd & Lochead, 1990) and 
to form contacts with projection neurons within nociceptive pathways 
(Lekan & Carlton, 1995). These neurons would therefore appear to be 
ideally placed as interneurons in a model neural circuit of the dorsal 
horn between the descending monoaminergic axons and the 
nociceptive pathways of the dorsal horn permitting both pre- and post- 
synaptic inhibition. It is conceivable that the few contacts between 
monoaminergic terminals and inhibitory neurons described in the 
present study may be sufficient for this pathway to operate. Of 
particular importance to the proposed interaction of these neurons is
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the failure to demonstrate classical synaptic associations between 
serotonergic axon terminals and GABAergic somata suggesting that if 
this pathway is of significance it is likely to operate via non-synaptic 
transmission.
The significance of non-synaptic or volume transmission in the CNS 
has been debated for some considerable time (Golgi, 1891) with a 
recently developing interest in light of the expanding ultrastructural 
observations regarding putative neural circuits in the CNS (see Zoli et 
al, 1998). The proposal is that classical synapses need not be a 
prerequisite for intercellular communication. Instead, in addition to this 
mechanism, neurons may communicate via non-synaptic means 
through transmitter-receptor interactions where the transmitter is 
present at a sufficient concentration within the bathing extracellular 
fluid with the associated receptor expressed on the membrane of the 
target neuron, not necessarily within the synaptic cleft. Within the 
dorsal horn, noradrenaline (Rajaofetra, et al, 1992; Ridet et al, 1993) 
and serotonin (Maxwell, Leranth & Verhofstad, 1983; Ridet et al, 1993) 
typically form few classical synapses, with non-junctional varicosities 
being frequent. Evidence from several locations within the CNS 
suggests that the monoamines may indeed operate in part through 
non-synaptic transmission with serotonin release in regions of the CNS 
where synaptic specialisations are few corresponding with a high 
density of high affinity serotonin receptors (Bunin & Wightman, 1998). 
In the dorsal horn several receptor subtypes which have been 
identified, in particular 5-HTia (Marlier et all991b) and 5 -HT3 (Glaum & 
Anderson, 1988) receptors are found in high concentration. Of these 
the 5 -HT1A receptor subtype has a high affinity for serotonin whilst the 
5 -HT3 receptors have a relatively low affinity (Hoyer, 1990). In the
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model of monoaminergic circuitry in the dorsal horn, it would be 
proposed that serotonin would excite inhibitory dorsal horn neurons, 
an action via the 5-HT3 receptor. From the data presented in this study 
the action of serotonin on these neurons might be expected to operate 
via volume transmission (figure 1.20C). From the foregoing discussion 
however the expectation of the involvement of the low affinity 5 -HT3 
receptor does not satisfactorily correlate with volume transmission. 
Clearly this association, in particular the monoamine receptor subtypes 
expressed by the dorsal horn local circuit neurons, requires further 
investigation.
Monoamines and dorsal horn neurokinin-1 receptor- 
immunoreactive neurons.
In the superficial dorsal horn the neuropeptide substance P is localised 
to small diameter primary afferent fibres which convey nociceptive 
information (Lawson, Crepps & Perl, 1997) and produce excitation of 
nociceptive neurons (Henry, 1976; Liu & Sandkühler, 1995). The 
corresponding receptor for this peptide, the NK-1 receptor, is in turn 
located on a population of neurons in lamina I and lamina lll/IV which 
almost all project to brainstem regions involved with nociceptive 
processing (Todd, McGill & Shehab, 2000). This study has shown that 
in comparison to the intrinsic dorsal horn neurons studied, the NK-1 
receptor-immunoreactive neurons of both lamina I and lamina lll/IV are 
targeted by large numbers of serotonin-immunoreactive terminals with 
approximately half of the lamina lll/IV neurons receiving a particularly 
high density of contacts. Thus, it would appear that the serotonergic 
system preferentially targets this population of nociceptive, projection 
tract neurons within the dorsal horn. Preliminary ultrastructural studies 
suggest that, as with intrinsic dorsal horn neurons, synaptic contacts
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between serotonin terminals and neurokinin-1 receptor- 
immunoreactive profiles are infrequent though close appositions are 
noted (Maxwell, unpublished observations). However, the high density 
of serotonergic terminals associated with these neurons is likely to be 
of functional significance delivering a preferentially high concentration 
of serotonin to the extracellular fluid surrounding these profiles which 
by volume transmission is proposed to result in inhibition of these 
cells. In particular the high density of serotonergic terminals around the 
proximal dendrites and somata of the basket-associated cells would be 
expected to deliver an even higher concentration of serotonin at these 
sites. As has been established the neurokinin-1 cells of the dorsal horn 
represent a population of nociceptive projection tract neurons thus 
these serotonin terminals are directed towards the postsynaptic 
inhibition of these cells. It may be expected based on the density of 
specific receptor subtypes and the proposed direct inhibition that these 
cells would express the 5-HTia receptor subtype which has a relatively 
high affinity for serotonin and so is suited to non-synaptic transmission 
(figurel .20A).
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Figure 1.20. Proposal for the neural circuitry involving serotonin and nociceptive 
cells of the dorsal horn. From the data presented serotonin terminals (red) would 
appear to preferentially target NK-1 neurons (green) in lamina I and lamina lll/IV of 
the dorsal horn which are also the targets for nociceptive primary afferent 
terminals (black). In mediating the inhibitory action of serotonin on these projection 
neurons it would seem, of the receptor subtypes present within the dorsal horn, 
the 5 -H T ia  would be expected to be of importance to this pathway (A). In addition 
to this direct post-synaptic action, an action via the excitation of inhibitory dorsal 
horn neurons (blue) is also proposed (B). With the low frequency of contacts which 
have been identified on these cells this may operate in part via a volume 
transmission mechanism at the 5 -HT3 receptor subtype. Finally, though there is no 
morphological evidence to support a synaptic influence at the primary afferent 
terminal, 5-HT may still operate via volume transmission to produce pre-synaptic 
inhibition in this pathway. Evidence would suggest the presence of both 5 -H T ia  
and 5 -HT3 receptor subtypes on these terminals.
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Chapter 2: The Cholinergic System in the
Spinai Cord
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2.1 The cholinergic system in the spinal cord
Activation of the cholinergic system in the spinal cord has a key role in 
a number of pathways producing antinociception (Iwamoto & Marion, 
1993; Naguib & Yaksh, 1994; Abram & Winne, 1995), a rise in blood 
pressure (Feldman, Terry & Buccafusco, 1996), depolarisation of 
motoneurons (Zieglgansberger & Reiter, 1974) and generation of 
programmed motor responses (Cowley & Schmidt, 1994). In addition, 
therapeutic agents have been identified acting via cholinergic 
receptors that have potential clinical applications in pain control 
(Swedberg et al, 1997). Despite this, relatively little is known about the 
cholinergic system in the spinai cord or the cholinergic receptor 
subtypes that may be of greatest value for therapeutic development.
2.2 Cholinergic profiles in the spinal cord
The distribution of cholinergic profiles in the spinal cord has been 
explored in a number of immunohistochemical studies using antibodies 
to the acetylcholine synthetic enzyme choline acetyltransferase. This 
technique is of particular value as immunoreactivity for this enzyme 
can be detected in somata, terminal boutons and medium to large 
sized dendrites of cholinergic neurons therefore allowing a great deal 
of the architecture of these ceils to be studied within one preparation. 
As may be expected from the involvement of acetylcholine in sensory, 
motor and autonomic pathways immunoreactive profiles are found 
throughout the spinal grey matter. Cholinergic neurons can therefore 
be Identified in the motor nuclei of the ventral horn throughout the 
rostrocaudal extent of the spinal cord, in lamina X around the central 
canal, in the intermediate grey particularly in relation to autonomic 
nuclei and in the dorsal horn where they are concentrated in laminae 
III, IV and V. A similar distribution of immunoreactivity has been
124
described in rat (Barber et al, 1984; Borges & Iverson, 1986; Ichikawa 
et al, 1997), cat (Aqullonius, Eckernas & Gillberg, 1981; Kimura et al, 
1981) and man (Aqullonius, Eckernas & Gillberg, 1981; Gillberg et al, 
1982; Schafer et al, 1995).
2.3 Cholinergic ventral horn ceiis
Within the ventral horn choline acetyltransferase immunoreactivity is 
associated with both large and small motoneurons which correspond 
to the cholinergic efferent neurons innervating the skeletal muscles 
(Schafer et al, 1995). In addition to these choline acetyltransferase 
immunoreactive somata identified within the motor columns their 
dendrites can also be identified forming distinct bundles of 
immunoreactive profiles coursing throughout the ventral horn between 
the motor columns (Barber et al, 1984). Many of these cholinergic 
ventral horn neurons also receive synaptic contacts from cholinergic 
axons which may partly arise as recurrent collateral branches (Nagy, 
Yamamoto & Jordan, 1993; Schafer, Eiden and Weihe, 1998). At the 
ultrastructural level the synapses between cholinergic terminals and 
the ventral horn motoneurons exhibit a specific structural 
specialisation, the so called C-terminal, which has a postsynaptic 
specialisation formed by a subsurface cistern of endoplasmic reticulum 
separated from the plasma membrane by a relatively constant lOjum. 
The exact functional importance of this structure is unclear though it 
has been suggested it may perhaps be involved in calcium regulation 
at the synaptic junction. There is a strong association between the C- 
terminal and choline acetyltransferase immunoreactivity and as such it 
has been proposed as a morphological correlate for cholinergic 
terminals in this location (Nagy, Yamamoto & Jordan, 1993; Li et ai,
1995).
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2.4 Cholinergic dorsal horn cells
As noted above, choline acetyltransferase immunoreactivity reveals 
cholinergic neurons within laminae III, IV and V of the dorsal horn. 
These neurons give rise to dendrites running in a predominantly 
rostrocaudal direction with many extending into more superficial 
laminae and to some distance from the cell body (Barber et al, 1984; 
Todd, 1991). Combined immunocytochemistry for cholinergic profiles 
with antibodies to other neurotransmitters has revealed that the 
cholinergic dorsal horn cells contain GABA hence they are presumed 
to be inhibitory (Todd, 1991; Laing et al, 1994).
In addition to immunoreactive somata a dense region of punctate 
immunoreactivity is present at the inner lamina II border with lamina III 
representing a plexus of cholinergic terminals (Ribeiro-da-Silva & 
Cuello, 1990; Todd, 1991). Whilst there is evidence of a descending 
cholinergic projection from brainstem nuclei (Bowker et al, 1983) it is 
thought that the bulk of the terminals in this plexus originate from 
spinal cholinergic neurons as little immunoreactivity is lost following 
lesioning of the descending projection fibres (Kanazawa, et al, 1979). 
An origin in primary afferent terminals is also regarded as unlikely as 
choline acetyltransferase has not been identified in dorsal root ganglia 
of the rat (Barber et al, 1984). Ultrastructural studies of the cholinergic 
terminals within lamina II| and lamina III have shown them to form 
predominantly symmetrical synaptic contacts with dendritic structures. 
Cholinergic terminals are also present in lamina I and lamina Ho though 
in a lower density than around the lamina I I/Ill border and more often 
associated with symmetrical axo-axonic synapses (Ribeiro-da-Silva & 
Cuello, 1990). Many of the primary afferent sensory axons within the 
superficial dorsal horn terminate as structures termed glomeruli which
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have been subdivided into two distinct types based on morphological 
criteria. In type I glomeruli the central axon Is thought to derive from 
unmyelinated primary afferents whilst in type II the central axon is 
thought to derive from myelinated primary afferents (Ribiero-da-Silva & 
Coimbra, 1982). Cholinergic dendrites have been observed 
postsynaptic to both type I and type II synaptic glomeruli, in addition 
cholinergic axons form symmetrical axo-axonic synapses with the 
central axons of each type of glomerulus. Cholinergic axon terminals 
have also been identified pre-synaptic to dorsal horn dendrites, again 
forming symmetrical synapses (Ribeiro-da-Silva & Cuello, 1990). Thus 
from this arrangement of contacts primary afferent activity may 
influence cholinergic neurons within the dorsal horn via axodendritic 
associations. Cholinergic dorsal horn neurons in turn may result in 
both pre- and post-synaptic inhibition of information processed in the 
dorsal horn (primarily nociceptive information) via axo-axonic and axo­
dendritic synapses.
2.5 Cholinergic neurons in the intermediate grey
Throughout the rostrocaudal extent of the spinal cord small to 
intermediate sized cholinergic neurons can be identified in the 
intermediate grey matter. In segments of the spinal cord associated 
with the origins of autonomic efferents larger cholinergic neurons, 
representing preganglionic autonomic neurons, are interspersed 
among these small to intermediate sized cholinergic cells (Barber et al 
1984; Borges & Iversen, 1986). Lamina X has been noted to be 
particularly rich in small cholinergic neurons and dendritic profiles. 
From this region dendritic bundles extend through the surrounding 
grey matter to the dorsal, ventral and intermediate grey (Borges & 
Iversen, 1986).
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2.6 Cholinergic receptors in the spinal cord
Application of acetylcholine to neurons within the spinal cord has been 
revealed to be associated with both muscarinic and nicotinic receptor 
specific response. Muscarinic receptor associated responses in the 
spinal cord are associated with a variety of responses including 
antinociception (Yaksh, Dirkson & Harty, 1985; Naguib & Yaksh, 1994; 
Abram & Winne, 1995; Eisenach, 1999), hypertension (Buccafusco,
1996) and both excitation and inhibition of motor neurons (Kurihara et 
al, 1993). Similarly nicotinic receptor responses have been shown to 
produce antinociception (Damaj et al, 1998; Marubio et al, 1999; Pan, 
Chen & Eisenach, 1999) and hypertension (Khan, Taylor & Yaksh, 
1994).
Both muscarinic and nicotinic receptors have been identified within the 
spinal cord. Autoradiographic studies have localised muscarinic 
receptors throughout the spinal grey with highest densities in laminae 
II and III of the dorsal horn, lamina X and lamina IX with similar 
distributions in rat, cat and man (Kayaaip & Neff, 1980; Gillberg & 
Aqullonius, 1985; Giiiberg, d’Argy and Aqullonius, 1988). The 
pathological process which underlies the debilitating condition 
amyotrophic lateral sclerosis produces a loss of neurons in the spinal 
motor nuclei and has been shown to result in a significant reduction in 
binding of muscarinic receptors in the ventral horn suggesting their 
presence on motor neurons (Gillberg & Aqullonius, 1985).
To date five distinct muscarinic receptor subtypes have been identified 
by molecular techniques, confirmed pharmacologically and denoted 
m1-m5 (Caulfield, 1993). Each of the receptors m1 to m4 have been
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identified immunocytochemically within dorsal root ganglion with m2 
and m4 receptors localised to small to medium sized neurons whilst 
m1 and m3 receptors do not show any particular distribution 
(Bernardini, Levey & Augusti-Tocco, 1999). Autoradiography for the 
m2 receptor has shown that it is distributed throughout the dorsai and 
ventral horns whilst the m3 receptor is predominantly localised to 
iaminae I to III. The m4 receptor is iess specifically localised but is, 
nevertheless, present in the spinal cord. The m l receptor has not been 
detected in the spinal cord by this technique (Hoglund & Baghdoyan,
1997). These investigations are restricted in the conclusions that can 
be drawn as there is significant cross-reactivity within the agents used 
for the receptor subtypes. Conclusions on each of the receptor 
distributions have therefore been based on a knowledge of the kinetics 
of each receptor and using this information, together with varying the 
incubation times of the labelled agonist with or without presaturation of 
the other subtypes, to derive this data on receptor distributions. 
Though this approach does provide valuable data on general 
distributions of the muscarinic receptors it is likely to lead to significant 
and unavoidable errors as a result of overlap in labelling between the 
receptor subtypes. As specific antibodies to the muscarinic receptor 
subtypes become more widely available immunocytochemical 
techniques can be added to the observations which already exist so 
allowing a greater understanding of the distribution of muscarinic 
receptors in the spinal cord to be gained.
This approach has been employed in investigating the distribution of 
the m2 receptor subtype in the rat spinal cord. Mice lacking the m2 
receptor demonstrate a significant reduction in antinociception and 
motor responses on administration of a non-specific muscarinic
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agonist suggesting a role for this receptor in nociceptive processing 
and motor control (Gomeza et al, 1999). In pharmacological studies 
the role of this receptor in nociception has been debated with either no 
roie (Naguib & Yaksh, 1997; Honda et ai, 2000) or an antinociceptive 
effect, possibly through a pre-synaptic action (Bleazard & Morris, 
1993) suggested. Recently the distribution of immunoreactivity for a 
specific m2 receptor antibody in the spinal cord has been investigated 
Yung & Lo (1997). Here m2-immunoreactive profiles were found to be 
abundant in the superficial laminae of the dorsal horn particularly in 
relation to punctate structures with no somatic labelling noted. In the 
ventral horn m2-immunoreactive profiles in apposition to presumed 
large motoneuron cell bodies were present. The absence of somatic 
staining in these experiments is of interest and at seeming variance to 
previous results using autoradiographic detection of the m2 receptor 
where it had been suggested that motoneurons do express the m2 
receptor (Viiaro et al, 1992). Recently the m2-receptor has also been 
identified immunohistochemicaliy on smali diameter dorsal root 
ganglion cells (Haberberger, Henrich, Courad & Kummer, 1999).
Nicotinic cholinergic receptors have been reported to be significant in 
nociceptive and autonomic reflexes and, though present in lower 
concentrations than muscarinic receptors, nicotinic receptors have 
been demonstrated in high concentration in the superficial dorsal horn 
by autoradiography (Gillberg & Aqullonius, 1985; Gilberg, d’Argy & 
Aqullonius, 1988) and immunohistochemistry (Swanson et al, 1987). In 
addition receptor is also expressed on dorsal root ganglion ceiis (Polz- 
Tejra, Hunt & Schmidt, 1980). Nicotinic receptors are also present in 
the intermediate and ventral grey of the spinal cord (Swanson et al, 
1987; Gilberg, d’Argy & Aqullonius, 1988). Administration of a nicotinic
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receptor agonist has been shown to produce an increase in the 
threshold for a response to nociceptive stimuli (Lawand, Lu & 
Westlund, 1999) which is lost in mice lacking the nicotinic receptor 
(Marubio et al, 1999).
As described above the muscarinic m2 receptor is thought to be of 
some significance to responses throughout the spinal cord and in 
particular to the nociceptive pathway. Little detailed information is 
currently available on the cells which express this receptor and hence 
the circuits that it is involved in. In the following studies the distribution 
of the m2 receptor within the spinal cord is examined with particular 
attention to the cells within the superficial dorsal horn which express 
this receptor. In addition the relationship of the receptor to the 
cholinergic ceiis of the spinal cord is examined in detail.
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2.7 Methods 
Experimental animals
Adult female Albino-Swiss rats of less than six months of age were 
used throughout. The procedures for anaesthesia, perfusion and 
fixation were as described in the general methods section in chapterl 
with 4% formaldehyde in phosphate buffer used as the fixative.
A. Distribution of m2-immunoreactive cells within the dorsal horn
Following an overnight postfixation period, mid lumbar spinal cord 
blocks from three animals were sectioned into 50|Lim transverse 
vibratome sections, incubated with 50% ethanol then transferred to a 
blocking solution of 10% normai donkey serum. The sections were 
then placed In the primary antibody cocktail containing rat anti-m2 
(1:500) and mouse anti-NeuN (1:500), diluted in PBS with 1% normai 
donkey serum and 0.3% Triton X-100. Following an overnight 
incubation in primaries the sections were rinsed with PBS and 
transferred to the secondary antibody solutions containing FITC-anti- 
rat (1:100) and Cy-5-anti-mouse (1:100) in PBS with 0.3% Triton X- 
100 for a two hour incubation. The sections were then stained for 
propidium iodide by incubating in a solution of propidium iodide (1:100) 
with RNAase (1:100) in PBS for 30 minutes at 35°C. They were then 
rinsed, mounted with Vectashield and stored until analysed. Propidium 
iodide is excited at 568nm and has an emission spectrum distinct from 
those of FITC and Cy-5. Hence, using the three-colour confocal 
microscope NeuN, m2 receptor and propidium iodide stained profiles 
could be distinguished in a single tissue section.
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Scanning and Analysis
Two complete dorsal horn sections from each of the three animals 
were examined. Overlapping series of 15 consecutive images at lium 
intervals in the z-plane were gathered for each dorsal horn beginning 
from the first 'full-face' image scanned from the surface of the section. 
Each series of sections were scanned using a x40 oil immersion 
objective lens. To scan each of the dorsal horn sections in their 
entirety between 25 and 35 overlapping series of images were 
therefore required. The series of images obtained were then viewed 
and a representative sample of dorsal horn neurons, identified by their 
double iabeiiing with NeuN and propidium iodide, examined for the 
presence or absence of m2 receptor-immunoreactivity. The sampled 
neurons were then plotted on an outline of the dorsal horn traced with 
a standard graphics package and their m2 receptor-immunoreactivity 
noted on this diagram. Data from each animal could then be pooled on 
a composite plot of the dorsal horn of the fourth lumbar segment.
Modified Optical Dissector Technique
In the quantitative analysis of the proportion of neurons within the 
dorsal horn expressing the muscarinic m2 receptor a modification of 
the optical dissector technique was employed to avoid selection bias 
towards larger immunoreactive somata (Coggeshall, 1992). This bias 
arises as a single optical section through a tissue which contains cells 
of varying diameters will result in a greater chance of a large cell being 
sampled than a small cell. Unless this bias is taken into consideration 
in the sampling method a disproportionate sample of large cells will be 
included in the data. To be confident of minimising the influence of this 
bias a method must be employed to counter this tendency to sampie
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large cells. One method of achieving an unbiased sample is by 
employing the optical dissector technique.
As applied to the current investigation two of the series of images 
acquired as described above were selected, the first as the 'reference 
section' and the second the 'look-up section'. The separation between 
these two images was such that there was no possibility of a neuronal 
nucleus lying entirely between the two images. For this series of 
experiments the separation between these two optical sections was 
7|Lim with the reference section being at S^m in the series of images 
and the look-up section being at 12|Lim. These images were then 
compared with cells selected for analysis only if their nuclei were 
present in the reference section and absent from the iook-up section. 
By this sampling scheme, bias towards large cells should be excluded 
and a representative sample of superficial dorsal horn cells obtained.
In this series of experiments the analysis was performed by taking the 
series of images through the tissue section for the NeuN- 
immunoreactivity, merging these and saving the subsequent merged 
image as a single reference file. Single optical sections representing 
reference and look-up images were then selected as described above 
at 5 and 12pm through the stack of images. These images were then 
merged selecting a different pseudocolour (green or red) for the 
reference and the look-up images. The resultant merged image 
therefore allowed identification of nuclei within the reference and look­
up sections in different colours. Any nucleus present in the reference 
section and in the look-up section was then automatically attributed a 
pseudocolour representing the merging of the two images (see figure 
2.1). These cells were then excluded form analysis. Cells which were
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included in the sample using this method were then followed through 
serial images with the m2 receptor and NeuN images merged. The 
presence or absence of receptor for each of the cells was then noted.
Imaiic 12nuiuc ^
Figure 2.1. In the modified optical dissector technique, as applied in this series of 
experiments, a series of 15 images were gathered at 1pm intervals in the z-plane 
for NeuN immunoreactivity . Of these, the 5th (image 5) was then selected as the 
reference image and the 12th (image 12) as the look-up image. These images 
were then merged using Confocal Assistant with each being assigned a separate 
colour (5 + 12). Any nucleus present in both reference and look-up section 
appeared in the resultant image with a pseudocolour assigned by the software 
representing the merging of the two separate colours. These cells were excluded 
from further analysis with only those cells present in the reference and not the 
look-up sections included (circles).
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B. Quantitative analysis of the subtypes of dorsal horn neurons 
expressing the m2-receptor
Transverse vibratome sections from three animals for each protocol 
were collected as has been described in the previous section. 
Following incubation in ethanol and blocking serum these were then 
placed in primary antibody solutions containing PBS with 1% NDS plus 
0.3% triton X-100 and antibody to the m2 receptor (rat anti-m2; 1:500). 
To this either sheep anti-NOS (1:2000), mouse anti-parvalbumin 
(1:100), rabbit anti-neurotensin (1:1000), guinea-pig anti-sst2A 
(1:2000), guinea-pig anti NK-1 (1:1000) or rabbit anti-GABA (1:1000) 
was added as antibody to a population of dorsal horn cells of interest. 
The sections were incubated in this primary antibody solution for one 
day following which they were rinsed, transferred to the secondary 
solutions containing the appropriate fluorophore coupled antibodies for 
3 hours, rinsed, wet mounted and stored until required.
Analysis
A total of nine dorsal horn sections was analysed for each of the 
primary antibody combinations (three dorsal horns form each animal). 
In each case the entire thickness of the vibratome section was 
scanned using the confocal microscope from the first complete optical 
field to the last in 2pm z-steps using a X40 oil immersion objective 
lens. Series of images were gathered through the medio-lateral extent 
of laminae l-lll with each optical field scanned overlapping such that 
the entire superficial dorsal horn was sampled. The series of images 
obtained was then examined In its entirety and all immunoreactive 
dorsal horn cells identified. These cells were then followed through the 
series of optical sections and examined for the presence or absence of
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m2 receptor-immunoreactivity and the details noted on an outline of 
the dorsal horn. Data was therefore obtained on the m2 receptor 
status and location for each immunoreactive dorsal horn cell in the 
vibratome section. By transferring this data to a composite drawing of 
a standard L4 dorsal horn section, the results for each of the separate 
dorsal horns could then be pooled.
C. The relationship of the m2 receptor to choline 
acetyltransferase-immunoreactive neurons in the dorsal horn and 
lamina X.
Fourth lumbar spinal cord blocks from four experimental animals were 
sectioned in the transverse plane and placed in 50% ethanol then 10% 
NDS as has been described. The sections were then incubated for 24 
hours in a primary antibody solution containing rat anti-m2 (1:500) and 
goat anti-ChAT (1:100) diluted in PBS with 1% NDS and 0.3% Triton 
X-100. Following this the sections were transferred to secondary 
antibody solutions containing FITC anti-rat and LRSC anti-goat (both 
1:100) in PBS for 3 hours before being mounted with anti-fade medium 
and stored. In two separate animals one week prior to perfusion the 
animal was pre-injected with 250pl of a 2mg/ml solution of fluorogold 
(i.p.) to act as a retrograde tracer of autonomic efferents so staining 
lateral horn cells. The eighth thoracic and fourth lumbar spinal cord 
blocks were then collected, sectioned and processed as has been 
described above with the addition of rabbit anti-fluorogold antibody 
(1:5000) to the primary antibody solution which was in turn revealed 
with Cy-5 anti-rabbit included in the secondary antibody solution.
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Analysis
Four sections from each of the animals were examined. First, a series 
of overlapping images through the entire thickness of the tissue 
section was gathered at a low magnification (X20 objective) for ChAT- 
immunofluorescence. These images were then used to generate a 
montage image of the ChAT-immunoreactive profiles in the cord 
section. ChAT-immunoreactive neurons are sparse in the dorsal horn, 
thus the montage generated as described above clearly showed each 
of the ChAT-immunoreactive neurons in the cord section. Using this 
montage for reference, each of the neurons was then re-scanned for 
both ChAT and m2-immunoreactivity using a X40 oil immersion 
objective with an optical zoom of 1.5. The cells were then closely 
examined for the presence of m2-immunoreactivity and this 
information recorded on the original montage image. For the mid- 
lumbar sections obtained from the fluorogold pre-injected animals 
sections from the region corresponding to the intermediolateral grey 
were also examined for the presence or absence of fluorogold 
staining. The thoracic sections from these animals were examined to 
confirm that the fluorogold injection had been successful and that 
labelled presynaptic sympathetic motor neurons could be clearly 
identified.
D. The relationship of the m2 receptor to small and large 
motoneurons of the ventral horn.
Motoneurons of the gastrocnemius-soleus (G-S) group were 
retrogradely labelled in three adult female Albino-Swiss rats, under 
Halothane anaesthesia, by an intramuscular injection of fluorogold 
(100pl of a 2mg/ml solution). After a seven day survival the animals 
were anesthetised, perfused with 4% formaldehyde in phosphate
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buffer and the 4th and 5th lumbar segments were removed. These 
were then postfixed for 4 hours prior to sectioning in the transverse 
plane as has been described. The sections were then incubated in 
50% ethanol followed by 10% NDS for 1 hour prior to transferring them 
to the primary antibody cocktail for a two day incubation at room 
temperature. The antibody cocktail consisted of rabbit anti-fluorogold 
(1:5000), goat anti-ChAT (1:100) and rat anti-m2 receptor (1:1000) in 
PBS with 1% NDS plus 0.3% Triton X-100. The sections were then 
rinsed and placed in solution containing fluorophore coupled antisera 
which consisted of FITC anti-rat, LRSC anti-goat and Cy-5 anti-rabbit 
antibodies (all 1:100) in PBS with 0.3% triton X-100. Following a two- 
hour incubation the sections were rinsed, mounted on glass slides with 
anti-fade medium and stored at -20°C until required.
Analysis
Sections were examined using the confocal microscope to determine 
the relationship between the G-S motoneurons, the receptor and 
ChAT-immunoreactive terminals. Series of six sequential optical 
sections at 1 pm intervals were then gathered from ventral horn nuclei 
which contained Fluorogold-labelled cells using a X20 objective lens. 
Cells with obvious nucleoli were chosen for analysis. Each cell was 
now numbered and examined for the presence or absence of m2 
receptor-immunoreactivity with a subjective estimate of the intensity of 
receptor immunoreactivity recorded. In addition the number of 
cholinergic contacts on each cell was counted and averaged for each 
of the six optical sections. Finally, diameters of cell bodies were 
measured with a Kontron KS 400 image analysis system and 
expressed as diameters of an equivalent circle thus permitting the
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circumference of each cell to be estimated and the number of 
cholinergic contacts expressed per micron of circumference.
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2.8 Results
A. The distribution of the acetylcholine m2 muscarinic receptor in 
spinal cord.
Muscarinic m2 receptor-immunoreactivity was present throughout the 
grey matter of the spinal cord (figure 2.2). A high density of labelling 
was present within the superficial laminae of the dorsal horn (lamina I 
and II). Much of this labelling was noted to be punctate though a 
significant number of clearly labelled somatic profiles was present with 
labelling uniformly present around the cell membrane which 
occasionally extended to the proximal dendrites. Deeper laminae of 
the dorsal horn displayed a lower density of staining with both punctate 
and somatic labelling present. In the thoracic cord a small number of 
neurons in the region of the intermediolateral cell column were noted 
which were immunoreactive for the muscarinic m2 receptor and 
showed immunoreactivity for fluorogold following retrograde transport 
of the tracer from an intraperitoneal injection (figure 2.3). Around the 
central canal in the region of lamina X numerous medium to large 
sized neurons were present. Coursing from this region and from the 
region of the lateral grey a number of m2 receptor-immunoreactive 
profiles with the appearance of large axons or dendrites are present 
linking to the motor nuclei of the ventral horn. Within the ventral horn 
motor nuclei numerous medium to large sized neurons are noted 
which display strong receptor immunoreactivity.
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B. The distribution of muscarinic m2 receptor-immunoreactive 
somata in the dorsai horn.
Six complete sections of dorsal horn were sampled from three 
experimental animals (two from each animal) and analysed using the 
modified dissector method. In total 285/1246 (22.9%) dorsal horn 
neurons sampled were immunoreactive for the m2-receptor. These 
cells were distributed throughout the superficial and deep dorsal horn 
laminae though the proportion of positive cells in each laminar region 
increased from the superficial to deep laminae (figure 2.4). All of the 
cells sampled were NeuN-immunoreactive and hence assumed to be 
neuronal. The lowest proportion of m2-immunoreactive neurons 
identified corresponded to those located in lamina I where only 9.3% 
(10/107) of neurons sampled expressed the receptor. The highest 
proportion of m2-receptor-immunoreactive neurons was identified in 
the deeper dorsal horn in laminae IV-Vl where 28.6% (172/601) of 
neurons were receptor positive whilst 19.1% of lamina I I/Ill (103/538) 
cells were immunoreactive for the receptor (figure 2.5).
As has been noted m2-receptor-immunoreactive neurons are also 
present around the central canal in the region of lamina X. With the 
same form of analysis the proportion of neurons in lamina X that 
displayed m2 receptor-immunoreactivity was calculated. Of the 
neurons sampled 23.8% (15/63) were immunoreactive for the receptor.
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c. Quantitative analysis of the subtypes of dorsal horn neurons 
expressing the m2-receptor
The above data demonstrates that the muscarinic m2 receptor is 
present on a significant proportion of neurons in the superficial dorsal 
horn, particularly in the lamina I I/Ill region where a number of neuronal 
subtypes have been described. Examining the relationship of this 
receptor to specific neuronal subtypes in this region reveals that the 
proportion of cells expressing the receptor is not uniform amongst 
those cells examined (figure 2.6). One thousand and ninety-four 
GABA-immunoreactive neurons were identified throughout laminae I to 
III of which 34% displayed immunoreactivity for the m2 receptor with 
little variation in proportion of positive cells between the laminae. The 
distribution of the GABA-immunoreactive cells from the nine dorsal 
horn sections which were analysed is illustrated in figure 2.7. This 
illustration serves to demonstrate the uniform distribution of cells which 
were double immunofluorescent for GABA and the m2 receptor. A 
similar proportion of NOS-immunoreactive neurons was identified as 
m2 receptor-immunoreactive (28%; figure 2.8). In contrast however 
there was a clear variation in the proportion of cells which were 
positive within each of the laminae with 4%, 20% and 55% of NOS- 
immunoreactive neurons m2 receptor-immunoreactive in lamina I, II 
and III respectively (figure 2.6). Furthermore, within lamina III it is the 
deeper placed NOS cells which tended to express the m2 receptor 
(figure 2.8). A correlation between cell location and m2 receptor- 
immunoreactivity was also noted for parvalbumin-immunoreactive 
neurons (figure 2.9). Of the 125 parvalbumin neurons identified 8% 
(14/125) were identified as m2 receptor positive with the proportion 
remaining constant through lamina II and III (figure 2.6). The 
parvalbumin cells which were sampled were distributed evenly across
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the mediolateral extent of the dorsal horn around the border of lamina 
II with lamina III. However, m2 receptor-immunoreactive neurons were 
found almost exclusively amongst the cells at the medial extent of this 
region with all but two of these cells identified here. The two cells not 
at this medial location were identified at the extreme lateral margin of 
the dorsal horn grey matter with no m2 positive parvalbumin neurons 
noted between these two groups. Of the 456 sst2A-immunoreactive 
neurons examined, 115 (25%) were found to co-express the m2 
receptor with a greater proportion of the lamina II immunoreactive 
neurons positive than lamina I neurons (27% and 7% respectively; 
figure 2.10).
Thus of the presumed inhibitory dorsal horn neurons examined, with 
the exception of parvalbumin-immunoreactive neurons, between 25 
and 30% are m2 receptor-immunoreactive. This contrasts with 
neurotensin-immunoreactive neurons which are presumed excitatory. 
Of the 151 neurotensin-immunoreactive neurons sampled from 
laminae I to III none expressed the m2 receptor (figure 2.11). Low m2 
receptor-immunoreactivity was also noted with lamina I NK-1 receptor- 
immunoreactive neurons of which only 12% (15/122) were m2 receptor 
positive. In contrast the proportion of the deeper dorsal horn NK-1 
receptor-immunoreactive neurons which expressed the m2 receptor 
was higher with 42% (36/86) immunoreactive (figure 2.12).
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D. The relationship of the m2 receptor to choline 
acetyitransferase-immunoreactive neurons in the dorsai horn and 
iamina X.
As previously described choline acetyltransferase neurons were 
identified throughout the deeper dorsal horn laminae (lll-VI) and 
around the central canal in the region of lamina X. In total, 41% 
(101/246) of ChAT-immunoreactive neurons in the dorsal horn and 
lamina X were immunoreactive for the muscarinic m2 receptor. The 
proportion of cells immunoreactive for the receptor was similar in 
lamina III (46%) and lamina X (44%) with fewer cells in lamina IV-Vl 
immunoreactive (37%; figure 2.14B). Figure 2.13 illustrates the 
distribution of ChAT-immunoreactive neurons in one of the dorsal horn 
sections examined with an example of an m2 receptor-immunoreactive 
neuron whilst in figure 2.14A a composite drawing of all the ChAT- 
immunoreactive neurons has been generated showing the distribution 
of the receptor positive and receptor negative neurons in the nine 
dorsal horn sections examined. This composite illustration highlights 
the variation in proportion of receptor positive neurons dependant on 
their location within the respective laminae that is not immediately 
apparent in single dorsal horn sections. Within lamina lll-V and lamina 
X the receptor positive cholinergic neurons have a uniform distribution 
which mirrors that of the receptor negative cells. In lateral lamina VI 
however the composite plot reveals a focus of cholinergic neurons 
which show a high proportion of m2 receptor-immunoreactivity. The 
nature of these neurons is not immediately apparent though it is 
conceivable that they may correspond to a caudal extension of the 
intermediolateral cell column in the animals under investigation. In the 
same animals as used for the initial observation of the distribution of 
m2 receptor neurons which had received an intraperitoneal injection of
145
fluorogold the tracer was examined for in the region of this cluster of 
m2 positive cholinergic neurons. Confirming previous studies on the 
extent of the neurons of the intermediolateral cell column in the rat, no 
fluorogold neurons were identified in any dorsal horn section examined 
from the mid-lumbar spinal cord (figure 2.15).
E. The relationship of the m2 receptor to small and large 
motoneurons of the ventral horn.
Typically, retrogradely labelled neurons of the gastrocnemius-soleus 
group were found in the ventral horn of the fourth lumbar segment in a 
column located in the dorsal part of the lateral motor nucleus. This 
distribution corresponds to that identified by previous investigators 
(Nicolopolous-Stournaras & lies, 1983; Peyronnard et al, 1986). A total 
of 153 motoneurons (50, 70 and 33 from each of the three animals) 
was examined for the presence of m2 receptor-immunoreactivity and 
cholinergic contacts. Figure 2.17A shows the frequency of receptor- 
immunoreactivity in relation to cell diameter. With increasing cell 
diameter the proportion of cells which were receptor immunoreactive 
increased such that cells with diameters greater than 40|Lim were 
almost always m2 receptor immunoreactive (99/100 cells). These cells 
characteristically displayed intense immunoreactivity for the m2 
receptor which was evenly distributed along the surface of the cell and 
extended along the proximal dendrites (figure 2.16). In contrast to 
these large cells, the proportion of smaller cells (less than 35|iim in 
diameter) which were receptor-immunoreactive was lower (60%) with 
immunoreactivity for the receptor being relatively weak if present 
(figure 2.16). This difference correlated with the frequency of 
cholinergic terminals identified in apposition with these groups of cells. 
Typically the larger cells were associated with numerous cholinergic
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terminals whilst smaller cells received few or no cholinergic contacts 
(figure 2.17B).
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Figure 2.2 The distribution of the muscarinic m2 receptor (green) and choline 
acetyltransferase profiles (red) in the rat thoracic spinal cord. This montage image, 
created from multiple merged, projected two-colour images of a section from the 
eighth thoracic spinal cord block, demonstrates clearly the distribution of m2 
receptor- and ChAT-immunoreactivity. The m2 receptor is present on profiles 
throughout the spinal grey. In the dorsal horn there is a relatively high density of 
labelling within lamina I and lamina II though staining is also noted in the deeper 
laminae with both punctate and somatic labelling identified. M2 receptor- 
immunoreactivity is also present in high density in the motor nuclei of the ventral 
horn, lamina X and in the region of the intermediolateral cell column. 
Interconnecting each of these areas were numerous immunoreactive profiles 
consistent with large axons or dendrites. ChAT-immunoreactive profiles 
corresponded to previous descriptions with scattered neurons in the deeper dorsal 
horn, the intermediolateral cell column, lamina X and the motor nuclei of the 
ventral horn (scale bar 250pm).
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Figure 2.3. In the region of the intermediolateral cell column a proportion of ChAT- 
immunoreactive neurons (red in A) which were also m2 receptor-immunoreactive 
(green in A) neurons were identified. Following an intraperitoneal injection of 
fluorogold these cells were immunoreactive for fluorogold (blue in A) and hence 
thought to be autonomic efferent neurons (asterisk - m2 receptor positive cell; 
circle - m2 receptor negative cell; single optical sections; scale bar 50pm).
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Figure 2.4. Double labelled propidium iodide (red) and NeuN-immunoreactive 
(blue) profiles, corresponding to neurons, were identified throughout the dorsal 
horn as illustrated in the montage image reconstructed from the projected, merged 
images through one of the dorsal horns used in the analysis (A). As illustrated in 
the single optical sections in images B & C, immunoreactivity for the muscarinic 
m2 receptor (green; C) is present on a proportion of these cells (asterisks) 
associated with a uniform expression over the cell body and proximal dendrites. 
Non-m2 receptor-immunoreactive neurons are also present (circles)
150
m2 positive 
cells (%) 15
Lamina I Lamina ll/lll Lamina IV-VI Lamina X
Figure 2.5. Cells immunoreactive for the muscarinic m2 receptor were identified in 
all laminae of the lumbar dorsal horn and lamina X. Of the cells sampled from the 
dorsal horn, 22.9% were m2 receptor-immunoreactive however the proportion of 
immunoreactive cells varied between the laminae with the cells of the deeper 
laminae (IV-VI) more commonly receptor positive. A similar proportion of the 
neurons in the region of lamina X were receptor positive (23.8%) as in the dorsal 
horn.
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Cell Type Location m2 +ve Total % positive
GABA lamina 1 23 72 32
lamina II 192 616 31
lamina III 158 406 39
NOS lamina 1 1 27 4
lamina II 68 337 20
lamina III 67 122 55
parv lamina 11 6 76 8
lamina III 5 60 8
sst2a lamina 1 3 45 7
lamina II 112 411 27
neurotensin lamina 1 0 7 0
lamina II 0 72 0
lamina III 0 72 0
NK-1 lamina 1 15 122 12
lamina lll/IV 36 86 42
Figure 2.6. Frequency of m2 receptor expression on different subtypes of cells in 
the dorsal horn related to laminar location.
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Figure 2.7. Composite image illustrating the distribution of the 1094 GABA- 
immunoreactive neurons sampled in this study and their relationship to the 
muscarinic m2*receptor. GABA-immunoreactive neurons which expressed the m2 
receptor were identified throughout the superficial horn and corresponded to 
between 31% and 39% of the GABA-immunoreactive neurons within each lamina. 
This relationship is illustrated in the confocal images where the GABA- 
immunoreactivity (red) and m2 receptor-immunoreactive in a single optical section 
from lamina II is shown. Both m2 receptor positive (red stars) and m2 receptor 
negative (white stars) GABA neurons can be clearly identified. In addition, an m2 
receptor-immunoreactive neuron which was not GABA-immunoreactive is noted 
(X; scale bar 25pm)
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Figure 2.8. Composite image showing the locations of NOS-immunoreactive cells 
which were m2 receptor positive or negative in the superficial dorsal horn. As 
illustrated m2-receptor immunoreactive NOS cells were present in each of the 
laminae l-lll. However the proportion of m2 receptor positive cells increased from 
lamina I to III such that though only 4% of lamina I cells were immunoreactive for 
the receptor this figure was 55% in lamina III. The confocal images illustrate for a 
single optical section the relationship of this receptor to two NOS-immunoreactive 
neurons in lamina III (stars). An m2 receptor-immunoreactive cell which was not 
NOS-immunoreactive is also noted (circle; scale bar 10pm).
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Figure 2.9. Immunoreactivity for the m2 receptor was infrequent in relation to 
parvalbumin-immunoreactive cells in the superficial dorsal horn as illustrated in the 
composite image showing m2 receptor positive and m2 receptor negative 
parvalbumin neurons In the superficial dorsal horn. Those parvalbumin neurons 
which were m2 receptor-immunoreactive were located at the medial or lateral 
extremes of the dorsal horn. The series of confocal images illustrates in a single 
optical section the relationship of the m2 receptor to a parvalbumin neuron (star). 
An m2 receptor negative parvalbumin-immunoreactive neuron is also noted (circle; 
scale bar 25pm).
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Figure 2.10. Immunoreactivity for the m2 receptor was more commonly identified 
in association with sstzA-immunoreactive neurons in lamina II than lamina I as 
illustrated in the composite image showing the locations of all m2 receptor positive 
and negative sst2A neurons sampled. Several sst2A-immunoreactive neurons 
(stars) are present in the single optical sections showing m2- and sst2A- 
immunoreactivity in lamina II of the dorsal horn. Of these a single sst2A neuron is 
m2 receptor-immunoreactive (red star; scale bar 25pm).
156
NCLMtlVC Posiluc
Figure 2.11. Composite image illustrating the locations of m2 receptor negative, 
neurotensin-immunoreactive neurons in the superficial dorsal horn. A total of 151 
neurotensin-immunoreactive neurons was sampled with no m2 receptor- 
immunoreactive cells identified. Examples of two neurotensin cells located in 
lamina II are shown in the single optical sections (scale bar 10pm).
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Figure 2.12. Composite image illustrating the pooled data on the locations of m2 
receptor positive and m2 receptor negative neurokinin-1-immunoreactive neurons 
in the dorsal horn. Few lamina I NK-1 neurons (12%) were noted to also be m2 
receptor immunoreactive. However in the deeper laminae (lll-IV) the frequency of 
m2 receptor positive neurons was found to be greater (42%). The single optical 
section confocal images illustrate an NK-1 neuron in lamina III which was also m2 
receptor-immunoreactive (scale bar 25pm).
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Figure 2.13. In this montage image constructed form multiple merged images 
through overlapping optical fields the choline acetyltransferase-immunoreactivity in 
the dorsal horn and lamina X is illustrated. A dense plexus of ChAT- 
immunoreactive profiles was confirmed around the border of lamina II and III with 
immunoreactive somata scattered throughout the deeper laminae of the dorsal 
horn (laminae lll-VI). In addition, numerous ChAT-immunoreactive somata were 
identified around the central canal in lamina X. Many of the ChAT-immunoreactive 
somata also expressed the m2-receptor. In the fields corresponding to area A and 
B in the montage image, single optical sections are presented illustrating an m2 
positive lamina III neuron and an m2 negative lamina V neuron adjacent to an m2 
positive neuron which is not ChAT-immunoreactive.
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Figure 2.14. Muscarinic m2 receptor-immunoreactive ChAT cells were identified 
throughout the dorsal horn laminae lll-VI and lamina X as illustrated in this 
composite image showing the locations of m2 positive and m2 negative ChAT 
cells (A). A relatively high density of m2 receptor-immunoreactive neurons was 
identified in the region of lateral lamina VI in a location which might suggest a 
caudal extension of the intermediolateral cell column. However following an 
intraperitoneal injection of fluorogold ChAT neurons in this location do not show 
immunoreactivity for fluorogold and therefore are not thought to be autonomic 
efferent neurons (figure 2.15). Choline acetyltransferase-immunoreactive neurons 
were frequently found to express the m2 receptor with similar proportions of cells 
in lamina III (46%) and lamina X (44%) m2 receptor positive whilst fewer lamina 
IV-VI cells were receptor positive (37%). This data is illustrated in B with the 
equivalent data for all neurons at each location included for comparison.
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Figure 2.15. As illustrated in figure 2.14A a cluster of ChAT-immunoreactive 
neurons which express the m2 receptor is located in the region of lateral lamina 
VI. It is conceivable that these neurons may represent a caudal extension of the 
intermediolateral cell column in these animals. To explore this possibility animals 
were injected with the retrograde tracer fluorogold intraperitoneally. Sections were 
then processed for m2-, ChAT and fluorogold-immunoreactivity to identify labelled 
cells. As illustrated in this series of single optical sections through a cluster of 
ChAT-immunoreactive neurons in this region no fluorogold-immunoreactivity was 
identified in relation to these cells. The cluster of neurons identified as m2 
receptor-immunoreactive therefore would not appear to be autonomic efferent 
neurons (asterisk - m2 receptor-immunoreactive cell; scale bar 50pm).
161
Figure 2.16. Confocal microscope images of immunofluorescence for Fluorogold 
(A,D), the m2 receptor (B,E) and choline acetyltransferase (C,F) associated with 
two groups of motoneurons in the ventral horn. A, B and C show large 
motoneurons which were immunoreactive for the m2 receptor (B) and a small cell 
which is not labelled (asterisk). Note that immunoreactivity for the receptor is 
associated particularly with plasma membranes and is present on numerous 
dendrites which were often also labelled for ChAT (C). D, E and F show further 
examples of a group of motoneurons. Large motoneurons are positive for the 
receptor (E), but on this occasion, a small cell is also weakly positive (asterisk). 
The arrows in C and F indicate some of the appositions made by cholinergic axons 
with large motoneurons. Note that in B and E these axons do not exhibit 
immunoreactivity for the m2 receptor (scale bar - 50pm).
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Figure 2.17. (A) Histogram illustrating the relationship between cell diameter and 
immunoreactivity for the m2 receptor. Almost all immunonegative cells are small 
(less than 40pm diameter). (B) Relationship between the numbers of cholinergic 
contacts (expressed as numbers of contacts per pm cell circumference) and cell 
diameter. Small cells receive few or no contacts.
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2.9 Discussion
The muscarinic m2 acetylcholine receptor in the dorsal horn.
The principal finding of this study is that the acetyichoiine m2 
muscarinic receptor is present on a significant proportion (22.9%) of 
neurons in the lumbar dorsal horn and that there is a demonstrable 
selectivity of expression of the receptor on different neuronal subtypes. 
This first observation contradicts that of Yung and Lo (1997) where in 
a similar investigation of the distribution of m2 receptor- 
immunoreactivity in the rat spinal cord they failed to identify neuronal 
profiles expressing the receptor. Though these studies were similar in 
design, there are some methodological differences that may explain 
these varying observations. In both studies the receptor antibody used 
was a rat monoclonal antibody to the muscarinic m2 receptor obtained 
form the same source (Chemicon) though the dilution required in the 
present experiment for satisfactory staining was 1:500 as opposed to 
1:2000 in the Young & Lo study. It is unlikely however that this could 
account for the complete absence of somatic staining in their study. 
Neither is the fixative used likely to have had a major influence. In their 
investigation the fixative used included 0.1% glutaraldehyde. During 
the preparatory work for this investigation the antibody was tested with 
fixatives which included glutaraldehyde with no discernable loss in 
staining pattern. The strain of rat used in either study is different with 
Young & Lo employing Sprague-Dawley rats as opposed to the Albino- 
Swiss animals used here. It is reasonable to assume that as for other 
neuronal systems (see the variation in the monoaminergic system for 
example; Proudfit & Clark, 1991) the cholinergic system may show 
variation both between species and between strains. Thus it is 
conceivable that the variation may arise as a result of a true difference 
in the cholinergic circuitry of Sprague-Dawley versus Aibino-Swiss
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rats. It is more likely however that the observed difference is as a 
result of the superior spatial resolution afforded with confocal 
microscopy and the ability of this technique to reveal a field in a single 
optical plane minimising the influence of surrounding immunoreactive 
profiles. This imaging technique therefore allows immunoreactive 
profiles to be studied with minimal interference from surrounding 
immunoreactivity.
Cholinergic mediated analgesia involves the acetylcholine muscarinic 
receptors, in particular the muscarinic m2 receptor (Bleazard & Morris, 
1993; Iwamoto & Marion, 1993; Gomeza et al, 1999). Little is known 
however of the neural circuitry involving these receptors within the 
dorsal horn. In this study it has been demonstrated that 
immunoreactivity for the m2 receptor can be detected on the ceil 
bodies of a significant proportion of neurons within the dorsal horn. 
Furthermore the receptor is expressed on a variable proportion of the 
neuronal subtypes which were examined with greater numbers of 
neurons in the deeper laminae receptor positive than in lamina I. This 
distribution corresponds to that of the cholinergic Innervation of the 
dorsal horn where numerous cholinergic terminals form a dense 
plexus spanning the inner lamina 11/ lamina III border (Todd, 1991). 
None of the neurons in the superficial dorsal horn immunoreactive for 
the excitatory neurotransmitter neurotensin were m2 receptor- 
immunoreactive. This contrasts with the presumed inhibitory neurons 
examined which (with the exception of parvalbumin-immunoreactive 
neurons) were commonly m2 receptor-immunoreactive. This was most 
evident for the NOS-immunoreactive neurons of the deeper lamina III 
where the majority (55%) of neurons showed receptor- 
immunoreactivity. This group of NOS-immunoreactive neurons
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frequently co-locallse GABA (Spike, Todd & Johnston, 1993). Thus, 
this investigation suggests the m2-receptor preferentially targets the 
inhibitory local circuit neurons in the dorsal horn. The muscarinic m2 
receptor is recognised to have a role in mediating antinociception in 
the dorsai horn which is presumed to arise through a lowering of cAMP 
levels in the target cell resulting in an inhibitory response (Richards, 
1991). Cholinergic mediation of antinociception has also been 
described as operating via the facilitation of the release of inhibitory 
neurotransmitters in the superficial dorsal horn such as GABA (Baba 
et al, 1998) and nitric oxide (Xu et al, 2000). However, the expression 
of this receptor on inhibitory cells implies that acetylcholine would 
inhibit rather than facilitate these neurons. Therefore, to explain 
acetylcholine's facilitation of the release of inhibitory neurotransmitters 
alternative, non-m2 receptors must also be expressed by these cells 
(Baba et al, 1998). The action of acetylcholine on the neurons of the 
superficial dorsal horn therefore appears complex and likely to involve 
multiple cholinergic receptors, the overall effect being to reduce 
nociceptive transmission in the dorsal horn.
As discussed in the previous chapter, neurons in lamina i and lamina 
lll/IV of the dorsal horn which are immunoreactive for the substance P 
receptor neurokinin-1 respond to nociceptive stimuli and almost all 
project to brainstem regions associated with nociceptive processing 
(Todd, McGill & Shehab, 2000). This study has shown that a 
proportion of these neurons are immunoreactive for the muscarinic m2 
receptor hence suggesting that, via this receptor, acetylcholine may 
act to inhibit nociceptive transmission in ascending neurons.
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Much of the muscarinic receptor mediated antinociception in the dorsal 
horn is iikely to arise form the cholinergic neurons which are located in 
this region as, though a descending cholinergic system has been 
described (Bowker et al, 1983), transection of these descending tracts 
has little influence on the effect of muscarinic antagonists on 
nociceptive responses (Zhou & Gebhart, 1992). In the present study 
the distribution of cholinergic neurons in the dorsai horn confirmed the 
results of previous investigations (Barber et al, 1984). Of these 
neurons a significant proportion were found to be immunoreactive for 
the muscarinic m2 receptor, particularly the cells of lamina III. Thus, it 
would appear that a proportion of the cholinergic neurons in the dorsal 
horn are likely to be subject to an inhibitory influence from 
acetylcholine operating through the m2 receptor. The source of this 
cholinergic inhibition is unclear though a release from terminals of local 
dorsal horn neurons providing a feedback loop in the nociceptive 
pathway is entirely feasible.
Intriguingiy a population of cholinergic neurons which were commonly 
m2 receptor-immunoreactive was identified in the lateral part of the 
deep dorsai horn. This cluster of cells is in a corresponding location to 
the intermediolateral cell column of the upper lumbar and thoracic 
spinal cords. However, as would be expected from their mid-lumbar 
origin, these cells failed to show immunoreactivity for fluorogold 
following an intraperitoneal injection of this tracer substance and so 
would not appear to be autonomic efferents. It is possible that these 
cells correspond to a specific group of cholinergic dorsal horn 
interneurons that as yet have not been functionally identified.
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In addition to examining the cholinergic cells of the dorsal horn this 
study also considered m2 receptor expression of the cholinergic 
neurons of lamina X. As with the dorsal horn neurons a significant 
number were identified as m2 receptor-immunoreactive. The neurons 
of this region are known to give rise to an extensive dendritic arbor 
permeating the extent of the spinal grey matter (Borges & Iverson, 
1986). This region is also known to include a population of neurons, 
many of which are choline acetyltransferase-immunoreactive, which 
are active during programmed motor activity (Carr et al, 1995; Huang 
et al, 2000). The expression of the m2 receptor on many of these 
neurons again suggests that these cells are subjected to an inhibitory 
influence mediated by acetylcholine which may serve as a feedback 
control mechanism.
The muscarinic m2 acetylcholine receptor in the ventral horn.
This study has demonstrated the presence of immunoreactivity for the 
muscarinic m2 acetylcholine receptor on motoneuron celi bodies and 
dendrites in the rat spinai motor nuclei. Furthermore a differential 
expression has been identified between the iarge and smali neurons of 
these motor nuclei where most large neurons, which have also been 
shown to receive relatively high densities of cholinergic terminals, 
express the receptor whilst smaller neurons frequently do not.
The distribution of the m2 receptor as demonstrated by the highly 
sensitive and specific techniques of immunocytochemistry and 
confocai microscopy in the present investigation confirms the 
observations based on in situ hybridisation studies in which m2 
receptor has been shown to be associated with motoneurons (Vilaro et 
al, 1992). These observations are however at variance with those of
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Yung and Lo (1997) in their immunocytochemicai investigation of the 
m2 receptor in the rat. In their study they reported 'no m2 
immunoreactivity has been found in the perikarya of motor neurons' in 
addition to a conclusion that much of the immunoreactivity which they 
had observed was related to axonal profiles as opposed to the 
dendritic labelling reported in this study. In addition they report that no 
ChAT-immunoreactive terminals were present in the ventral horn. This 
is at variance to previously reported data (see Nagy, Yamamoto & 
Jordan, 1993). It is likely that, as discussed above, these differences 
may in part be explained by the superior spatial resolution and 
minimisation of the interference of background immunoreactivity that 
the protocol used in this investigation affords.
The identification of a higher density of cholinergic terminals on larger 
motoneurons of the ventral horn when compared to smaller 
motoneurons confirms previous observations (Barber et ai, 1984; 
Borges & Iverson, 1986). Corresponding to this variation in density of 
cholinergic terminals on motoneurons this study has aiso 
demonstrated a parallel differential distribution of the m2 receptor on 
small and large motoneurons. It has been suggested that there is a 
difference in size within the motoneuron groups of the rat ventral horn 
with the y-motoneurons typically smaller (less than 35|Lim) than the a- 
motoneurons. Thus from the present data it would appear that there is 
a preferential innervation of a-motoneurons by cholinergic terminals 
and that the acetylcholine released may act on these neurons through 
the m2 muscarinic receptor. In contrast y-motoneurons receive few 
cholinergic terminals and so the influence of acetylcholine on these 
cells may be expected to be less significant.
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In studying the effects of acetylcholine on neonatal rat spinal 
motoneurons Kurihara et al (1993) described both an excitatory 
response and an inhibitory response thought to be mediated by 
muscarinic m3 and m2 receptors respectively. Thus the expression of 
two different muscarinic receptors by these neurons would appear to 
produce opposing responses to one transmitter substance. In addition 
the present investigation has shown that immunoreactivity for the m2 
receptor is diffusely expressed across the dendritic and somatic 
membrane and therefore not soiely localised to synaptic 
specialisations. This distribution favours a diffuse, non-synaptic mode 
of transmission which may be associated with fine tuning the cells' 
response rather than a rapid synaptic response. The origins of the 
cholinergic terminals identified in this study on these motoneurons 
remains unclear though it would appear that at least some represent 
recurrent collateral branches from local motoneurons (Cullheim, 
Kellerth & Conradi, 1977). Hence the complex circuitry involving these 
terminals and the muscarinic receptors is presumed to permit fine 
tuning of motor responses within the motor nuclei.
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Appendix 1: Antibodies used in these studies
Primary
antibody
Species Dilution Source
5-HT rat 1:200 Eugene Tech
5-HT rat 1:2000 (e) Eugene Tech
5-HT rabbit 1:200 Affiniti
ChAT goat 1:100 Chemicon
D-pH mouse 1:500 Affiniti
Fluorogold rabbit 1:5000 Chemicon
GABA rabbit 1:1000 Dr DV Row
GABA mouse 1:500 (e) Affiniti
Glycine rat 1:5000 Dr DV Row
m2 receptor rat 1:500 Chemicon
M0R1 rabbit 1:1000 Gramsch
NeuN mouse 1:500 Chemicon
Neurotensin rabbit 1:1000 Peninsula
NK-1 guinea-pig 1:1000 Affiniti
NOS sheep 1:2000 Dr PC Emson
Parvalbumin Mouse 1:100 Sigma
Somatostatin rabbit 1:100 Peninsula
SSt2A guinea-pig 1:2000 Gramsch
e - dilution used for uitrastructural studies.
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